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Abstract 
Spastic cerebral palsy (SCP) relates to a specific movement-related impairment 
characterised by a velocity-dependent resistance to stretch. Muscle weakness and 
decreased range of motion (ROM) are characteristics of the paretic limb in 
individuals with SCP. However, there are no data on the in vivo determinants of 
strength and ROM in adults with SCP. The aim of the thesis was to examine the 
factors associated with impaired plantarflexion, maximal voluntary isometric 
contraction (MVIC) and joint ROM in the paretic limb of physically active men with 
SCP compared to the contralateral non-paretic limb and individuals without 
neurological impairment. Passive stiffness, myotendinous junction displacement 
and ROM of the paretic gastrocnemius medialis (GM) were not different from the 
control muscles. However, the elastic modulus of the paretic GM was two times 
stiffer than the control GM muscles. MVIC torque of the paretic plantarflexors was 
42% and 52% less than the non-paretic (P = 0.007) and control limbs (P < 0.001), 
respectively. The paretic gastrocnemius ACSA was 20% smaller than the control 
group (P = 0.004) only. Paretic agonist activation was 36% and 39% less than the 
non-paretic (P < 0.001) and control groups (P < 0.001), whereas paretic antagonist 
coactivation was 3-fold higher compared to the non-paretic (P < 0.001) and control 
group (P < 0.001). Agonist muscle activation accounted for 57% of variation in 
paretic plantarflexion MVIC torque (P = 0.007). When accounting for GM 
architecture, neural properties and moment arm length, no difference in GM 
specific force was established. Finally when the tendon elastic properties and 
Young’s modulus were calculated at a standardised force, no difference was 
observed in tendon stiffness properties across all experimental groups. These 
findings suggest that in active adults with SCP, weakness is due to a reduction in 
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muscle size and impaired muscle activation. Furthermore, in the presence of no 
decline in ROM there remained an alteration in the passive elastic properties of 
the muscle, but not the tendon. 
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Chapter 1 
 
Introduction to cerebral palsy 
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The term cerebral palsy (CP) describes a range of postural and movement 
disorders that result from a non-progressive lesion sustained to the developing 
brain (Bax et al. 2005). Although the damage is non-progressive, it is possible for 
the clinical manifestations in motor function and posture to change throughout 
maturation (Hanna et al. 2009; Essex 2003). Variations in the presentation of 
physical impairment has been suggested to be due to the location, size and 
severity of the lesion (Koman et al. 2004). Across all the variants of diagnoses, 
individuals with CP suffer from peripheral anomalies including; limited range of 
motion (ROM), weakness, poor balance and sensory deficits (Graham and Selber 
2003; Aagaard et al. 2001; Alhusaini et al. 2010; Damiano et al. 1995b; Elder et al. 
2003). The spectrum of disablement can range from individuals who are 
independent and ambulant with subtle impairments, to severely impaired patients 
that are non-ambulatory requiring care.  
 
In order to distinguish and understand the differences between the constituent CP 
groups, it is common practice for clinicians to diagnose the specific movement 
limitation and if appropriate, its peripheral location (Koman et al. 2004). The 
movement limitation ranges from increased tonicity in the muscles, often referred 
to as hypertonia or spasticity, through to impaired voluntary coordination and 
balance of muscle movements (ataxia), and hyper excitable and involuntary 
muscle contractions during rest (athetosis). It is also common for individuals to 
have a mixture of these symptoms. When individuals with CP are diagnosed with 
ataxia or athetosis, such deficits in sensory control affect the whole body. Whereas 
the topography of hypertonia/spasticity is described using the following terms: 
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hemiplegia (involvement of the arm and leg on the same side of the body); diplegia 
(involvement in both legs); quadriplegia (involvement in all four limbs); and double 
hemiplegia (involvement in all four limbs, with impairment more substantial in two 
limbs).  
 
Approximately 2 per 1000 individuals have CP (Cans et al. 2008; Odding et al. 
2006) and it is considered to be the most common paediatric disability (Kuban and 
Leviton 1994). The number of people that have particular movement impairments 
in a specific location is considerably reduced when referring back to the estimated 
prevalence statistics. Odding and colleagues (2006) reported that out of all the 
various combinations of CP impairment, spastic hemiplegic CP were the most 
commonly diagnosed in paediatric units. Therefore, for the purpose of consistency 
within the thesis and acknowledging the prevalence of the diverse range of CP 
impairments in relation to participant recruitment, active and ambulant men with 
spastic hemiplegic CP were considered for inclusion. 
 
The majority of the research conducted to assess the neuromuscular physiology of 
individuals with spastic CP (SCP) is conducted in paediatric groups (Friden and 
Lieber 2003; Malaiya et al. 2007; Marbini et al. 2002; McNee et al. 2009; 
Mohagheghi et al. 2007; Rose et al. 2008; Stackhouse et al. 2005; Vaz et al. 
2006). Children with CP are largely sedentary (Longmuir and Bar-Or 2000) and it 
is possible that the degree of impairment observed in such individuals may be 
accentuated through reinforced sedentary behaviour. In individuals without 
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neurological impairment, it has regularly been reported that reduced usage of the 
muscle-tendon unit (MTU) through a range of antigravity models resulted in 
reduced force generation during maximal voluntary contraction (Adams et al. 
1994; de Boer et al. 2007; Reeves et al. 2002; Sargeant et al. 1977), atrophy of 
skeletal muscle (Alkner and Tesch 2004; Narici and Cerretelli 1998), reduced 
fascicle length and pennation angle (Kawakami et al. 2000; de Boer et al. 2008; 
Narici and Cerretelli 1998; Reeves et al. 2002), and decreased stiffness of the 
tendon (Kubo et al. 2000; Maganaris et al. 2006; Reeves et al. 2005). In addition 
to these observations, decreases in neural voluntary activation have also been 
recorded as a result of disuse (Ruegg et al. 2003; Stevens et al. 2006). As it is 
possible that sedentary lifestyles may accentuate the severity of impairment, it is 
important to address the neuromuscular and tendon properties of active 
individuals with SCP. Furthermore, as the physical manifestations of the lesion 
proceed to evolve throughout maturation, the findings identified in children may not 
apply to fully matured physically active adults. Indeed, it is well established that the 
MTU alters throughout maturation in regard to aspects of muscle recruitment, 
muscle size, moment arm and tendon properties (Morse et al. 2008b; O'Brien et al. 
2010a, b; Pang and Ying 2006; Waugh et al. 2012).  
 
In order to assess the degree of functional impairment, the Gross Motor Function 
Classification System (GMFCS) was developed, which involved rating the quality 
of movement whilst a child with CP completed a series of tasks (Palisano et al. 
1997). In total the child is required to complete 66 tasks of; a) lying and rolling, b) 
sitting, c) crawling and kneeling, d) standing, and e) walking, running and jumping. 
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This in turn helps the classifier to rank the child into one of 5 levels, level 1 being 
the most able children that show little impairment through to level 5 who struggle 
with anti-gravitational postural control. Although such systems provide a coherent 
template to rate the impairment of such individuals, the inter- and intra-reliability of 
these measures are somewhat questionable (Damiano et al. 2006). Moreover, the 
level of information obtained in relation to factors effecting movement is negligible. 
Therefore a number of studies have used objective tests to establish what the 
main determinants of motor function are. In paediatric patients with SCP, muscular 
strength and joint ROM in the paretic limb have been linked with impaired 
functional performance (Alhusaini et al. 2010; Damiano and Abel 1998; Elder et al. 
2003; Stackhouse et al. 2005; Vaz et al. 2006). Therefore the aim of the present 
review will be to establish what the determinants of MTU strength and joint ROM 
are in the paretic limb of individuals with SCP.  
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Chapter 2 
 
Literature review 
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2.1 Introduction 
Spasticity is a specific movement disorder which is classically defined as a 
velocity-dependent resistance to stretch in the paretic limb of individuals with 
cerebral palsy (CP; Lance 1981). The aetiology of spastic cerebral palsy (SCP) 
originates from damage to the immature brain, where the subsequent neural 
communication between the central nervous system and paretic muscles have 
been demonstrated to have secondary impacts on the morphology of the paretic 
contractile tissue (Friden and Lieber 2003; Lieber et al. 2003). These 
neuromuscular impairments have been regularly linked with two characteristic 
functional impairments; these are: 1) lower muscle strength (Blundell et al. 2003; 
Damiano and Abel 1998; Damiano et al. 1995a; Damiano et al. 2001; Damiano et 
al. 1995b; Elder et al. 2003; McNee et al. 2009; Stackhouse et al. 2005), and 2) 
restricted joint range of motion (Alhusaini et al. 2010; Barber et al. 2011a; Vaz et 
al. 2006). Therefore in this review it is explored and discussed what underlying 
mechanisms and determinants contribute to the functional limitations in individuals 
with SCP. 
 
2.2 Muscle weakness  
The degree of paretic skeletal muscle torque generated during maximum voluntary 
isometric contraction (MVIC) has consistently been reported to be lower than the 
non-paretic contralateral limb in individuals with hemiplegic SCP and age-matched 
controls without neurological impairment (Table 2.1). Based on the available 
literature the MVIC torque is between 42-73% lower in individuals with SCP 
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compared to individuals without neurological impairment. This weakness in SCP 
muscle has been suggested to be more prominent in the distal musculature (i.e in 
the plantarflexor muscles) as opposed to proximal musculature such as the hip 
extensors (Wiley and Damiano 1998). Although the detriments in strength may not 
seem significant when considered in isolation, high correlations have been 
identified between MVIC force and walking velocity (r = 0.71; Damiano and Abel 
1998), and isokinetic torque and the Gross Motor Function Measure (GMFM; r = 
0.70 - 0.83; Damiano et al. 2001) in children with SCP. This suggests that greater 
strength in individuals with SCP is associated with improved motor performance 
and gait. In contrast to clinical measures which usually reflect the degree of 
spasticity within the joints of the lower limb there is no relationship between ROM 
and GMFM (Damiano et al. 2001).  
 
Although the focus of the present review is to examine muscular weakness in 
individuals with SCP, stroke populations share similar clinical manifestations a 
result of damage to the brain (Sheean 2002). It has been reported that in the 
paretic limb of stroke individuals ranging from 42-85 years MVIC elbow flexion and 
extension were up to 53 and 47% lower compared to age-match controls without 
neurological impairment (Ada et al. 2003; Canning et al. 1999). Similarly the MVIC 
torque generated by elderly individuals with stroke in their quadriceps and 
hamstring musculature was up to 44 and 61% weaker, respectively when 
compared to individuals without neurological impairment (Newham and Hsiao 
2001). Although the deficit in strength observed across extensor and flexor muscle 
groups, it is apparent that the flexor muscles are the most impaired based upon 
the results presented. Moreover, the variation in strength data observed in stroke 
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individuals has also been suggested to depend on how long the participants were 
examined after the insult to their brain (Newham and Hsiao 2001). Even though 
similarities in MTU function exist between stroke and SCP individuals compared to 
controls without neurological impairment, there are a number of factors that may 
not relate to SCP cohorts. Within the aforementioned data reported on patients 
with stroke (Canning et al. 1999; Ada et al. 2003; Newham and Hsiao 2001), age-
related confounding factors such as sarcopenia and physical inactivity could 
influence the MVIC data obtained (Morse et al. 2007b; Morse et al. 2005b; Morse 
et al. 2005c) and potentially overestimate the severity of the impairment. Thus as a 
result of such confounding factors, the application of this data within SCP is 
questionable; therefore data on individuals with SCP will be addressed only. 
 
As the majority of the information currently available in SCP muscle weakness is 
based on children (Elder et al. 2003; Stackhouse et al. 2005) or adolescents with 
unspecified levels of maturation (Barber et al. 2012), such findings may not be 
applicable to adult populations, in fact, the clinical manifestations associated with 
SCP are acknowledged to change during maturation (Hanna et al. 2009; Koman et 
al. 2004). Furthermore, throughout maturation MVIC strength is known to increase 
considerably with age in indviduals without neurological impairment (O'Brien et al. 
2010a). Therefore, any weakness identified in children with SCP may not reflect 
the neuromuscular impairments experienced in adults with SCP. Nevertheless, 
based on the determinants of muscle strength, weakness in individuals with SCP 
should in fact be considered in relation to neural factors (activation and 
coactivation) and morphological factors (muscle size). 
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Table 2.1. Percentage difference in MVIC between the paretic (P) and non-paretic 
(N-P) limbs of individuals with SCP, and the limb of controls without neurological 
impairment (C).  
Author 
Age (CP vs. 
C) 
Muscle  Topography 
P vs. C 
(%) 
P vs. N-
P (%) 
Barber et al. (2012) 15-21 & 15-
20 
PF DNC -55 NA 
Elder et al. (2003) 5-12* PF 
DF 
Hemiplegic -56 
-42 
-25 
-30 
Stackhouse et al. 
(2005) 
7-13 & 8-12 KE 
PF 
Diplegic -56 
-73 
NA 
DNC, did not confirm; NA, not applicable; PF, plantarflexors; DF, dorsiflexors; KE, 
Knee extensors; C, Control. *Age range was reported for both groups.  
 
2.3 Determinants of muscle weakness 
2.3.1 Neural function 
The ability to recruit skeletal muscle is positively related to MVC torque; in 
contrast, the level of antagonist muscle coactivation during activation of the 
agonist is inversely related to the net MVC torque (Macaluso et al. 2002). In 
individuals with upper motor neuron impairment and spinal cord lesions, weakness 
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may be associated with either a decrease in agonist activation and/or an increase 
in antagonist coactivation, stemming from impaired efferent and afferent inhibition 
and excitation pathways of the extrapyramidal and pyramidal tracts (Brown 1994; 
Nielsen et al. 2007; Sheean 2002; Walshe 1935). Although these findings are from 
individuals with upper motor neuron impairment and spinal cord lesions, these 
findings may also contribute to muscle tendon unit (MTU) weakness in the paretic 
limbs of individuals with SCP (Damiano et al. 2000; Wiley and Damiano 1998; 
Ikeda et al. 1998).  
 
2.3.2 Coactivation 
Common findings in SCP studies have reported increased coactivation of the 
antagonist muscle during gait and MVC (Damiano 1993; Ikeda et al. 1998; 
Damiano et al. 2000; Elder et al. 2003; Stackhouse et al. 2005). Levels of 
antagonist coactivation as measured by electromyography (EMG) during 
plantarflexion (PF) MVC in the paretic limb of children with SCP have been 
reported to be between ~35-50%, which was 10-35% higher than the control 
groups (Elder et al. 2003). In addition, Stackhouse et al. (2005) reported similar 
values in the paretic tibialis anterior coactivation during PF MVIC (~40%), which 
was reported to be ~20% higher than age-matched controls. Coactivation of the 
paretic semitendinosus muscle during knee extension MVC was also reported to 
be 83% higher than in the control group. This increased level of coactivation 
during knee extension may be a protective reflex response as a result of increased 
relative torque (torque/body mass) generated by the quadriceps femoris. In 
individuals without neurological impairment, such contributions from the antagonist 
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muscle have previously been shown to reduce the torque measured during 
contraction of the agonist (Hassani et al. 2006; Macaluso et al. 2002). Whereas in 
individuals with SCP, the greater level of antagonist coactivation may act to 
stabilise the joint, by increasing joint stiffness and limit the degrees of freedom 
during motor performance (Damiano 1993; Damiano et al. 2000; Graham and 
Selber 2003). Macaluso et al. (2002) reported that increased antagonist 
coactivation has been associated with muscle weakness in healthy and active 
elderly women, and although such data may apply to individuals with SCP, a direct 
association has yet be demonstrated. Furthermore, no information is currently 
available regarding the paretic antagonist coactivation properties during MVC in 
adults with SCP. 
 
2.3.3 Agonist activation 
In addition to impaired antagonist activation, individuals with spastic hemiparesis 
also exhibit impaired agonist activation during MVC (Elder et al. 2003; Stackhouse 
et al. 2005). This has been linked to the individuals’ inability to discharge certain 
motor units in the paretic muscle (Gemperline et al. 1995). By superimposing an 
electrical stimulation through the muscle during MVIC in vivo, adults suffering from 
stroke were found to have a 25-40% deficit in quadriceps femoris voluntary 
activation (Newham and Hsiao 2001). This is consistent with the deficits reported 
in children with SCP, where the neural activation was 49% and 33% lower in the 
triceps surae and quadriceps femoris, respectively (Stackhouse et al. 2005). 
Whether this also applies to adults with SCP remains to be seen, as maturational 
differences have demonstrated that children without neurological impairment have 
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an underdeveloped ability to maximally activate the agonist musculature during 
MVIC (O'Brien et al. 2010a; Paasuke et al. 2000). 
 
It is apparent that children with CP have a decreased voluntary ability to maximally 
activate their agonist musculature compared to children without neurological 
impairment (Elder et al. 2003; Stackhouse et al. 2005). Although such research 
has not reported the activity status of their participants, children with CP are 
suggested to live a sedentary lifestyle compared to age-matched counterparts 
without neurological impairment (Longmuir and Bar-Or 2000). Such information 
may provide invaluable information when interpreting the results as the neural 
deficits associated with muscle spasticity may be impaired further as 
demonstrated in disuse models (Stevens et al. 2006; de Boer et al. 2007; de Boer 
et al. 2008). Therefore, previous increases in the strength of the paretic muscles in 
children with SCP after physical training interventions (Andersson et al. 2003; 
Blundell et al. 2003; Damiano and Abel 1998; Damiano et al. 1995b; McNee et al. 
2009) may be due to potential increases in muscle activation as a result of the 
participants increased physical activity over the intervention period. To eliminate 
the effects of disuse when assessing the paretic muscle activation properties, 
further research should assess physically active individuals with SCP to assess 
the neural impairment and minimise the effects of disuse. 
 
2.3.4 Muscle size  
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It is well established that muscle size is a key determinant of strength in individuals 
without neuromuscular impairment (Fukunaga et al. 1996). In individuals with 
SCP, there is a lack of information in the assessment of muscle weakness, relative 
to the size of the agonist muscle(s). The only study to quantify muscle size and 
MVIC torque was Elder et al. (2003) where the paretic plantarflexor volume 
measured using magnetic resonance imaging (MRI) was ~39% lower (Figure 2.1) 
compared to the non-paretic muscle and individuals without neurological 
impairment. This deficit in muscle volume was associated with lower paretic 
muscle torques during MVIC. Because of the sedentary lifestyle of SCP children 
(Longmuir and Bar-Or 2000), muscle atrophy is likely to result from environmental 
disuse, as well as muscle disuse resulting from the neural impairment (Lieber et al. 
2004). 
 
 
Figure 2.1. MRI scans from the lower limbs of a child with hemiplegia (a) paretic 
leg, (b) non-paretic leg, and (c) leg of an age-matched child without neurological 
impairment. Calibration bars are 8 cm (Elder et al. 2003). 
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Although muscle atrophy is likely to be a major determinant of the weakness 
associated with SCP, when differences in muscle mass are accounted for, there 
remains a difference between individuals with SCP and age-matched controls 
(Elder et al. 2003).  For example, Elder et al (2003) calculated the amount of 
torque relative to muscle ACSA of the PF (Nm.cm-2) and reported that the relative 
torque of the paretic limb was up to ~40% lower than the non-paretic limb and the 
limb of age-matched controls. Given the large decrement in muscle activation 
capacity this decrease in MVC/ACSA is not surprising. Indeed, Urbancheck et al. 
(2001) has previously demonstrated how ‘unrecruitable’ muscle mass contributed 
to declines in MVC/ACSA in the elderly. Therefore, it would be expected (although 
it remains unreported) that neural factors such as decreased agonist activation 
and increased coactivation contribute to reductions in MVC/ACSA in SCP. It 
should be noted that the measurement of ACSA in pennate muscle may result in 
an underestimation of the true physiological CSA (PCSA) of the muscle (Figure 
2.2; Narici et al. 1992). This is due to the fact that pennate muscle measured via 
ACSA (perpendicular to the longitudinal axis of the muscle) does not reflect the 
true physiological contractile area of a pennate muscle (the area perpendicular to 
the angle of pennation). To date, no studies have specifically assessed PCSA and 
muscle specific force in individuals with SCP. Without any data addressing the 
properties of the whole muscle specific force in the paretic limb, it is impossible to 
understand its intrinsic force-producing capacity. A paucity of such studies may be 
due to children with SCP being assessed, as the muscle in the paretic limb has 
been suggested not to be developed enough to obtain clear architectural data 
using ultrasonography or other scanning methods (as discussed by Elder et al. 
2003).  
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Figure 2.2. Schematic diagram of pennate muscle illustrating the difference 
between ACSA (solid black line) and PCSA (dashed black line) measures 
(adapted from Narici et al. 1992).  
 
2.3.5 Muscle morphology  
Although neural factors are likely to contribute primarily to the observed decrease 
in MVC/ACSA in individuals with SCP, it is possible that as with disuse and 
ageing, some changes in morphology may also contribute. There is evidence that 
fibre type may have an influence on muscle specific force or MVC/ACSA. Some 
studies have reported increased prevalence of type I muscle fibres in individuals 
ranging from 6-18 years with SCP (Ito et al. 1996; Marbini et al. 2002). Such 
findings may contribute to muscle weakness as the ability to generate force 
relative to fibre CSA in type I has been reported to be approximately 2-fold lower 
compared to type IIa and type IIx fibres (Bottinelli et al. 1999). This may be a 
reflection of progressions in the manifestations of SCP, as the impairment in 
children and adolescents are suggested to progress until full maturation (Hanna et 
al. 2009). Furthermore, variations in fibre type distribution may reside in what 
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muscle the biopsy was taken from, as the muscles such as the soleus are known 
to have an increased proportion of type I fibres (Schiaffino et al. 1989). In adults 
with spasticity following stroke an increase in type II fibres was reported (Sjostrom 
et al. 1980). Increases in type II fibre expression have been observed in 
individuals with spinal cord lesion, where all fibres in the paretic muscle are 
converted to type II fibres as a result of impaired neural input to the musculature 
(Grimby et al. 1976). Although the leg of individuals with SCP are only partially 
paretic, the observed decrease in type II muscle fibre size may be due to impaired 
neural communication, or disuse (Lieber et al. 2004; Marbini et al. 2002). 
 
In addition to the possible contribution of fibre type to lower MVC/ACSA, the 
increase of non-contractile material within the muscle may also contribute. Indeed, 
muscle fibre packing has theoretically been linked with differences in specific force 
measurements, where fibre density is hypothesised to change as a result of 
deviations in intramuscular fat, extracellular matrix or the ‘tighter’ packing of 
muscle fibres (Jones et al. 1989). A consistent finding observed in children with 
SCP is that the intrinsic material of the paretic muscle contains elevated lipid and 
extracellular matrix content relative to contractile tissue compared to age-matched 
controls (Booth et al. 2001; Lieber et al. 2003; Marbini et al. 2002). This has 
pronounced effects including an inducement to overestimating muscle size and 
underestimating MVC/ACSA. Lieber et al. (2003) reported that in vitro samples of 
SCP muscle from various locations in the arm were comprised of approximately 
60% extracellular matrix and only 40% contractile tissue, whereas the muscle of 
individuals without neurological impairment comprised of 95% muscle and 5% 
extracellular matrix (Figure 2.3). Given these compelling findings, it still needs to 
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be considered that biopsy studies are not necessarily representative of the whole 
muscle (Lexell et al. 1986, 1984). As biopsy samples are so small there is high 
chance of obtaining a subsection of the muscle where there is a high collagen and 
fat region, though this caveat is widely acknowledged. 
 
 
Figure 2.3. Muscle fibre size variation in (A) non-paretic extensor carpi radialis 
brevis muscle,  and (B) paretic flexor carpi ulnaris muscle (Lieber et al. 2004).  
 
2.4 Joint range of motion  
The flexibility of the paretic limb when stretched to end range of motion (ROM) is 
regularly reported to be limited in individuals with SCP (Alhusaini et al. 2010; 
Barber et al. 2011a). Although many studies comment on the limited ROM in the 
paretic limb, very few studies have quantified the deficits compared to limbs of 
individuals without neurological impairment. Alhusaini et al. (2010) reported that 
whilst children (age = 6-11 years) with SCP laid supine with their foot attached to a 
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custom-made potentiometer footplate, the passive dorsiflexion end ROM achieved 
was 13.4 deg, which was 5.5 deg less than age-matched controls without 
neurological impairment. Similarly whilst assessing males and females with SCP 
(age ranging from 15-21 years), Barber et al. (2011a) reported that passive end 
dorsiflexion ROM was 6 deg, whereas age-matched controls achieved an ankle 
angle of 21 deg. The joint ROM in the ankle has received considerable attention 
regarding flexibility because individuals with SCP often have equinus foot 
positioning during stance and gait. Given that measuring end ROM around a joint 
can provide an indirect measure of MTU stiffness, tests such as the touch-toe 
and/or sit-and-reach tests are convenient and quick methods to assess MTU 
stiffness (Magnusson et al. 1997; Cornbleet and Woolsey 1996). Both the touch-
toe and sit-and-reach tests require individuals to maintain full extension of the 
knee joint whilst maximally flexing around the hip and vertebrae, extending both 
arms and reaching as far as possible to obtain a distance achieved from the step 
or board, respectively. As the hip and vertebrae contribute to the single distance 
attained by the individuals completing the test, it is impossible to determine 
specifically where the ROM resides. As both of these tests are typically employed 
to test hamstring flexibility, Cornbleet and Woolsey (1996) measured the hip joint 
angle using an inclinometer during the sit-and-reach test in children without 
neurological impairment, which was suggested to provide a more accurate and 
reliable prediction of hamstring flexibility. Similar findings were also reported in 
young men and women where hip flexion angle was correlated (r = -0.79) with the 
distance achieved during the touch-toe test (Kippers and Parker 1987), conversely 
such tests have also been suggested to be unreliable and have a high level of 
variability in test-retest assessments (Merritt et al. 1986; Moran et al. 1979). As the 
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data obtained from such assessments of flexibility do not account for a number of 
confounding variables impacting on the measurement including pain, stretch 
tolerance and reflex responses of the MTU; thus reducing the reliability and 
meaningfulness of such tests (Magnusson et al. 1996a; McNair and Stanley 1996; 
Toft et al. 1989).  
 
2.5 Passive stiffness measurements 
The passive stiffness of material being extended is indicative of the resistive 
mechanical properties of the tissue to stretch (Magnusson 1998). Previously the 
passive torque-angle relationship has been used to calculate the stiffness of the 
MTU, whilst accounting for the neural and psychological shortcomings associated 
with end ROM measurements in individuals without neurological impairment 
(Gajdosik et al. 2005; Gajdosik et al. 1999; Magnusson et al. 1996a; Magnusson 
et al. 1996b). Such measurements are typically conducted in various postures on 
an isokinetic dynamometer with the joint being passively rotated at a 
predetermined velocity until volitional end ROM, whilst simultaneously measuring 
muscle electromyography (EMG), joint angle and passive torque (Alhusaini et al. 
2010; Kay and Blazevich 2009; Morse 2011; Morse et al. 2008a). Few studies 
have assessed the passive properties of the paretic MTU (Table 2.2). Stiffer MTUs 
have been reported to improve walking and jogging economy in individuals without 
neurological impairment (Gleim et al. 1990). However, in individuals with 
hypertonic CP, increased MTU stiffness of the paretic forearm musculature along 
with muscle weakness has been associated with impaired motor function during 
the Jebsen-Taylor hand function test (Taylor et al. 1973; Vaz et al. 2006), which 
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comprised of placing objects into a can, stacking wooden discs and picking up five 
containers as quickly as possible. Similar findings have also been reported in the 
PF muscles during gait (Dietz et al. 1981). These observations suggest that the 
relationship between MTU stiffness and motor function describe a parabolic curve, 
such that there is an optimal level of MTU stiffness to maximise motor function. 
Beyond this optimal point, any further increments in MTU stiffness in fact impede 
motor function. 
 
Table 2.2. Relative difference in MTU stiffness between the paretic (P) limb of 
individuals with SCP and the limb of controls without neurological impairment (C).  
Author Age (CP vs. C) Muscle P vs. C (%) Passive velocity 
Vaz et al. (2006) 6-11* WF +24 5 deg/s-1 
Barber et al. (2011a) 
15-21 vs. 
15-21 
PF +34 20 deg/s-1 
DNC, did not confirm; NA, not applicable; PF, plantarflexors; WF, wrist flexors. 
*Age range was reported for both groups.  
 
As the functional properties of the muscle and tendon are different, it is difficult to 
distinguish the difference in material properties between the contractile and/or 
elastic components. In recent years the in vivo elastic properties of the muscle 
have been assessed in individuals without neurological impairment using 
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ultrasonography to monitor the displacement of the myotendinous junction (MTJ), 
whilst simultaneously collecting passive torque, angle and  EMG data (Abellaneda 
et al. 2009; Kay and Blazevich 2009; Morse 2011; Morse et al. 2008a). The 
apparatus and procedures have been shown to be a valid and reliable in the 
assessment of passive muscle/MTU properties (Morse 2011; Morse et al. 2008a). 
However, very little is understood about the influence, if any, the variation in 
testing postures/positions have on the passive measures (Kay and Blazevich 
2009; Magnusson 1998; Magnusson et al. 1997; Morse 2011; Morse et al. 2008a).  
 
In relation to the assessment of the paretic muscle passive stiffness in individuals 
with CP and stroke, a number of studies imply that they have assessed the 
stiffness of the muscle, when they have in fact assessed MTU stiffness (Vaz et al. 
2006; Harlaar et al. 2000; Alhusaini et al. 2010). Currently no information 
addresses the in vivo properties of the paretic muscle, despite the fact that 
differences are regularly reported between children with SCP and age-matched 
controls without neurological impairment. Furthermore, understanding the neural, 
MTU and architectural determinants associated with mechanical stiffness of a 
tissue is fundamental to understanding the limitations in paretic muscle flexibility. 
 
2.6 Determinants of passive stiffness 
2.6.1 Neural stretch reflex 
As a result of a lesion to the central nervous system, spasticity is often associated 
with hyperexcitability of the stretch reflex (Sanger et al. 2003). In the assessment 
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of passive stiffness it is imperative that any neural reflexes are suppressed in 
order to examine the mechanical properties of the muscle in isolation. In relation to 
the definition of spasticity (Lance 1981), the most common method of ensuring 
that monosynaptic and/or polysynaptic reflexes are limited is by rotating the joint at 
an angular velocity that is slow enough not to elicit a neural response. In the 
paretic biceps muscle of individuals with spasticity and hypertonia, the relationship 
between angular velocity and muscle EMG is suggested to be linear (Figure 2.4; 
Sheean and McGuire 2009; Given et al. 1995). Whether this characteristic applies 
to muscles in the lower extremities of individuals with SCP has yet to be 
determined. Nevertheless when the passive mechanical properties of the paretic 
MTU have been studied in individuals with SCP, no quantification of EMG 
activation has been reported (Barber et al. 2011a; Vaz et al. 2006). Conversely in 
individuals without neurological impairment, resting EMG signal during passive 
stretch has been assessed and is reported to be no higher than 3% (Gajdosik et 
al. 2005; Morse 2011; Morse et al. 2008a); such minimal activation is considered 
to be a ‘normal’ level of activation during rest, so whether this would be similar in 
individuals with SCP has yet to be determined. 
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Figure 2.4. Velocity-dependent resistance to stretch in the biceps of individuals 
with spastic hemiplegia (Above; Given et al. 1995) and hypertonia (Below; Sheean 
and McGuire 2009). 
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2.6.2 Muscle structure and intrinsic properties 
It is well established that the size of the muscle influences the passive 
MTU/muscle stiffness (Magnusson et al. 1997; Morse 2011; Morse et al. 2008a). 
In individuals without neurological impairment, larger hamstring muscles have 
been associated with increased passive MTU stiffness (Klinge et al. 1997; 
Magnusson et al. 1997). In light of these findings, it would be expected that the 
smaller paretic muscle of children with SCP would be more compliant in 
comparison to the larger muscles of age matched controls. However, increased 
stiffness in the paretic muscle has been reported consistently in individuals with 
SCP (Barber et al. 2011a; Vaz et al. 2006), which may relate to alterations in 
architectural and/or the intrinsic properties of the SCP muscle.  
  
As individuals with SCP typically have smaller muscles (Elder et al. 2003; McNee 
et al. 2009), decreases in fascicle length may in part explain why such a difference 
occurs in the size of the contractile material (Malaiya et al. 2007; Mohagheghi et 
al. 2007). Indeed whilst children lay prone with their ankles at a relaxed angle 
hanging off the end of a plinth, ultrasonography was used to assess the length of 
the gastrocnemius medialis muscle fascicles in children ranging 4-13 years. 
Architectural images from the mid-belly of the muscle were obtained, and the SCP 
fascicles were found to be 8% shorter compared to children without neurological 
impairment (Malaiya et al. 2007). However, when the participants ankle angle was 
secured into a fixed position on an isokinetic dynamometer, Barber et al. (2011a) 
reported no difference between resting fascicle length of individuals with SCP and 
age-matched controls without neurological impairment. Whilst in the prone 
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position, the ankle was passively stretched at 20 deg.s-1 until volitional end ROM, 
whilst fascicle elongation was recorded using ultrasonography. Subsequently 
findings showed that the passive fascicle strain of the paretic limb was 47% less 
than age-matched controls without neurological impairment at an equivocal peak 
ankle torque. This suggests that paretic muscle fibres have a diminished ability to 
elongate with increased torque. This is consistent with in vitro findings 
demonstrating that SCP sarcomere lengths are 20% shorter and the elastic 
modulus of paretic muscle fibres is 49% stiffer than that of individuals without 
neurological impairment (Friden and Lieber 2003). Such findings may reside in the 
cellular properties of the paretic SCP muscle when compared to individuals 
without neurological impairment.  
 
At a cellular level, titin has been suggested to influence the passive properties of 
the contractile tissue (Labeit and Kolmerer 1995; Neagoe et al. 2003). Titin is a 
large protein that spans over 1 µm in length, running from the Z discs to the M 
lines of the sarcomeres (Labeit and Kolmerer 1995). The titin protein has 
previously been reported to account for nearly all of the passive load placed on a 
single muscle fibre from a frog (Magid and Law 1985); demonstrating that the 
protein is a key determinant of the muscle fibre elasticity in situ. Although, no 
information is available on the influences of titin in the passive properties of the 
skeletal muscle in individuals with SCP, a number of different isoforms are 
suggested to exist in skeletal and cardiac muscle (Neagoe et al. 2003). It is 
thought that the differences in isoforms are predominantly due to the size of the 
PEVK domain within the titin protein (Figure 2.5), where it has been shown that 
cardiac isoforms are far smaller and stiffer than other variants of the protein found 
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in skeletal muscle. Indeed as the neural activation and subsequent environment of 
the skeletal and cardiac muscles are very different, this affects the expression of 
the titin protein isoform. Based on this concept of a changed environment, 
individuals with SCP may also have a different isoform expression within the 
paretic musculature. 
 
 
Figure 2.5. Schematic diagram of the various titin isoforms and how they are 
arranged in (A) skeletal muscle and (B) cardiac muscle (Neagoe et al. 2003). 
 
Any difference in muscle stiffness that remains after accounting for differences in 
muscle (Blundell et al. 2003; Andersson et al. 2003; Damiano and Abel 1998; 
McNee et al. 2009; Damiano et al. 1995b; Dodd et al. 2003), must be attributable 
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to the intrinsic elastic properties of the muscle in individuals with SCP (Friden and 
Lieber 2003; Lieber et al. 2003). Indeed clear differences have also been reported 
in the intramuscular content of the extracellular matrix within SCP muscle when 
compared to the muscle of individuals without neurological impairment (Lieber et 
al. 2003). Muscle samples were obtained from paediatric patients with and without 
SCP from a variety of muscles in the upper extremities. The samples were then 
passively elongated to assess the material properties of the muscle bundles with 
the extracellular matrix intact, which was then compared to passive properties of 
single SCP and control muscle fibres. Inevitably the stiffness of the muscle 
bundles in both SCP and control groups were stiffer than their respective single 
fibre counterparts. However when the SCP and control muscle bundle were 
compared, the control bundle was reported to be ~40 times stiffer than the SCP 
bundle. This was reported to be due to the differences in material composition of 
the muscle. The spastic muscle sample was found to consist of 40% extracellular 
matrix, whereas the control sample only contained 5% extracellular matrix. 
Whether these findings are representative of the material properties of the whole 
SCP muscle is yet to be confirmed (Lexell et al. 1986, 1984). Although the quantity 
of extracellular matrix was greater in the SCP muscle, it is unlikely to contribute to 
greater fascicle stiffness, as the control muscle had a lower quantity of 
extracellular matrix and greater fibre stiffness. Moreover, Ito et al. (1996) 
established that there was no observable difference in the histological structure of 
SCP muscle compared to samples from neurologically unimpaired fibres. The 
apparent contention in the existence, and contribution, of greater extracellular 
matrix to passive stiffness in SCP may be due to the population sampled, where 
the muscle biopsy was obtained from, or the relative degree of impairment within 
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the SCP participants. However, there remains no data on the intrinsic passive 
properties of SCP muscle under stretch. In order to determine the influence of the 
intrinsic properties of the muscle on passive stiffness, muscle size, architecture 
and activation would need to be accounted for whilst the SCP is stretched.  
 
Additionally, it is possible during muscle contraction that from the propagation of 
the action potential and the subsequent release of calcium from the sarcoplasmic 
reticulum may be impaired in CP. In the elderly populations and after 10-weeks of 
disuse, there is evidence for impairment in release and reuptake of calcium that 
contributes to sarcopenic weakness (Hunter et al. 1999; Thom et al. 2001). 
However, there remains no published data on calcium in individuals with SCP. 
 
2.7 Tendon properties 
During passive elongation and MVIC, the tendon is known to contribute to the 
degree of fascicle lengthening and shortening respectively (Maganaris and Paul 
1999, 2002; Morse et al. 2008a). Furthermore, the tendon elastic properties have 
been linked to a number of functional measures, such as balance (Onambele et al. 
2007; Onambélé et al. 2008) and rate of force development (Morse et al. 2005a). It 
is well established that disuse leads to an increase in the compliance of the tendon 
(de Boer et al. 2007), and combined with the sedentary nature of individuals with 
SCP (Longmuir and Bar-Or 2000), it could be predicted that any change in the 
passive or contractile properties of the muscle may be linked to deviations in 
tendon compliance. However, as the passive properties of the MTU under stretch 
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show a resistance to stretch (however this remains contentious), it is possible that 
an increase in stiffness of the tendon may contribute to the increased passive 
torque. Again, as with both weakness and a reduced ROM, the measurements in 
children may not reflect the mature MTU, and there is a scarcity of data on the 
elastic properties of the tendon in individuals with SCP.  
 
2.8 Effects of maturation in individuals with SCP 
All of data investigating the active and passive neuromuscular properties of 
individuals with SCP have been conducted on children and/or adolescent cohorts 
(Alhusaini et al. 2010; Vaz et al. 2006; Barber et al. 2011a; Elder et al. 2003; 
Malaiya et al. 2007; Mohagheghi et al. 2007; Stackhouse et al. 2005). Although 
these studies may apply to adult populations with SCP, there are a number of 
differences that have been shown to exist between children and adult populations 
(Falk et al. 2009; O'Brien et al. 2010b). For example, it is has been established 
that neural activation, muscle size and moment arm is lower by up to 13, 66 and 
26%, respectively in children compared to adults without neurological impairment 
(Morse et al. 2008b; O'Brien et al. 2010a). This is particularly relevant when 
inferring SCP impairments as it is likely that the neural impairment is the main 
determinant of skeletal muscle strength between adults with SCP and individuals 
without neurological impairment, though no information currently quantifies 
activation/coactivation properties at present. It is likely that there is a difference in 
strength between children and adult populations with SCP; though no data 
currently addresses the magnitude and what variables account for these 
differences.  
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With regards to the material properties of the tendon, children without neurological 
impairment are known to have more compliant tendons compared to adults, as 
identified by stiffness and Young’s modulus measures (O'Brien et al. 2010b). 
O’Brien et al. (2010b) reported that tendon stiffness could be accounted for by the 
children having a 34% smaller tendon ACSA compared to the adults, whereas the 
differences in Young’s modulus are due to differences in the intrinsic tendon 
structures. This may be due to deviations in collagen fibril packing (Parry et al. 
1978), collagen fibril diameter (Dressler et al. 2002), concentration of decorin (Del 
Santo Jr et al. 2000) and/or cartilage oligomeric matrix protein (Smith et al. 2002). 
Nevertheless, whether these differences in maturation apply to individuals with 
SCP has yet to be determined and requires further research. 
 
2.9 Passive muscle and tendon stiffness methods 
In order to assess the previously discussed muscle and tendon properties 
accurately and reliably, it is imperative that the level of measurement error is 
limited. Two predominant factors constitute measurement error; systematic bias, 
and random error, both of which account for the learning and/or fatigue effects on 
the tests, and the variability of the biological and/or mechanical properties of the 
variable measured, respectively (Atkinson and Nevill 1998). In order for the 
method, or its constituents to be suggested as reliable and valid, it is essential that 
the protocol is sensitive enough to detect a true change in performance.  
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The agreement between measures of muscle MVC torque have consistently been 
reported as reliable in individuals without neurological impairment (Alfredson et al. 
1998; Impellizzeri et al. 2008), patients that have suffered from a stroke (Hsu et al. 
2002) and individuals with CP (Ayalon et al. 2000). Conversely limited information 
is available when referring to reliability of passive muscle and tendon properties in 
vivo. The assessment of passive muscular properties originally consisted of the 
indirect testing procedures such as the touch-toe (Magnusson et al. 1997), sit-and-
reach tests (Cornbleet and Woolsey 1996). Using these methods, various studies 
have identified that estimations of passive MTU properties are not reliable, due to 
the influence of psychological and neural factors increasing the error in the 
measure (McHugh et al. 1998; McNair and Stanley 1996). With the use of surface 
EMG to account for muscle activation and ultrasonography to monitor 
myotendinous junction displacement during stretch protocols, numerous studies 
have directly measured the passive properties of the gastrocnemius medialis in 
vivo (Kay and Blazevich 2009; Morse 2011; Morse et al. 2008a). The assessment 
of the passive muscle properties utilise two predominant postures, the prone 
(Morse 2011; Morse et al. 2008a) and seated postures (Kay and Blazevich 2009), 
however a limitation within the literature at present is that no study has addressed 
whether the two postures are comparable and reliable.  
 
Although little information is currently available in the effect of posture on the 
passive muscular properties during stretch, Morse (2011) suggested that the 
ultrasonography component of the assessment is a valid tool over small distances, 
by reporting a mean error of 0.06 mm, and R2 of 0.999 over 1 mm increments 
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using a micrometer calliper. Whilst the measurement of displacement during 
passive stretch manoeuvres has not been validated directly, numerous studies 
have consistently shown that ultrasonography is a reliable and valid tool for 
assessing tendon elongation (Maganaris and Paul 1999), muscle fascicle length 
(Narici et al. 1996), muscle cross sectional area (Reeves et al. 2004a) and muscle 
volume (Esformes et al. 2002). However, there are no data regarding the validity 
or reliability of ultrasonography when used to record the passive properties of 
skeletal muscle in vivo. 
 
More definitive information is available in individuals without neurological 
impairment on the passive properties of the tendon where two predominant 
postures have been utilised in the assessment of Achilles tendon stiffness, prone 
(Maganaris and Paul 2002; Muramatsu et al. 2001) and seated (Morrissey et al. 
2011). Morrissey et al. (2011) reported that in 6 physically active adults ranging 
from 18-40 years, tendon stiffness and tendon modulus test-retest assessment 
was reliable (ICC = 0.85 and 0.72, respectively). Comparatively, no study 
assessing tendon properties in the prone position have addressed the reliability of 
the measure. Therefore the seated posture should be utilised in the assessment 
on Achilles tendon stiffness as a result of the lack of data on the reliability of the 
prone posture. Caution should be drawn to the specific set up of the seated 
position as impaired flexibility in SCP cohorts (Alhusaini et al. 2010) may impact 
on the set up of the chair and isokinetic dynamometer in order to maintain 
consistency in the testing procedures of any future assessment. 
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2.10 Summary  
Muscle weakness and reduced flexibility has been reported to influence functional 
tasks and gait performance in individuals with SCP. The paretic muscle has been 
shown to be smaller than the muscle of individuals without neurological 
impairment. The SCP-induced size decrement is counter-intuitively associated 
with a reduction in the flexibility of the paretic joint as measured by the passive 
torque-angle relation. However, the passive properties of the muscle or tendon 
have yet to be established in vivo, for instance through the use of ultrasonography 
during passive stretch trials. Nevertheless, the impaired flexibility of the paretic 
limb is likely to be due to disuse and/or impaired neural communication of the 
paretic muscle, resulting in muscle atrophy. In addition, intrinsic changes within the 
paretic muscle including increased sarcomere stiffness and extracellular matrix 
tissue have been suggested to impact not only on joint ROM, but also strength of 
the paretic muscle of individuals with SCP.  
 
In specific relation to the strength of the paretic muscle, no study has accounted 
for the neural and material determinants associated with strength. Elements of 
muscle weakness have been assessed individually in separate studies with MVC 
torque. However, the calculation of the force generating capacity of the paretic 
muscle of individuals with SCP has yet to be addressed. Lastly, no study has 
examined the properties of the paretic tendon in individuals with SCP. It is not 
understood how the elastic structural and functional properties of the tendon 
contributes, if at all, to the observations related to weakness and flexibility in the 
paretic limib of inividuals with SCP.  
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Thesis aims 
Based upon the presented literature, a number of factors have been associated 
with reduced muscle strength and MTU flexibility in individuals with SCP. The 
determinants include muscle size, neural signalling, muscle morphology and 
intrinsic muscle composition, all of which have been associated with weakness 
and reduced ROM in children with SCP. Although these factors have been brought 
together in the present literature review, very little work has been conducted into 
muscle flexibility and strength whilst accounting for all of the respective 
determining factors. Moreover, in the assessment of flexibility, two predominant 
postures have been utilised, however, very little is understood about how/whether 
testing posture can affect the measurements of passive stiffness. In addition, it is 
unclear from previous data, the degree to which the effects ascribed to SCP are 
mainly owing to sedentary behaviour as opposed to the condition itself. Therefore 
the aims of this thesis were: 
1. To assess whether testing posture has an effect on the measured passive 
flexibility and stiffness measurements of the muscle. 
2. To determine the passive flexibility and stiffness properties of the paretic 
muscle, and examine whether anatomical CSA and/or muscle length influence 
the passive muscle properties.  
3. To ascertain the degree of muscle weakness in adults with SCP, and to 
assess whether muscle size, agonist activation and/or antagonist activation 
can account for the deficits in strength. 
4. To identify whether there is a difference in paretic muscle specific force in vivo. 
36 
 
5. To assess the in vivo structural and mechanical properties of the paretic 
tendon in individuals with SCP. 
 
The objective was also to utilise a habitually physically active hemiplegic SCP 
men, in order to minimise the impact of sedentarism per se, on the descriptive 
magnitude of SCP impairment on the parameters of interest.  
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Chapter 3 
 
The effect of seated and prone testing 
postures on passive stiffness of the 
gastrocnemius muscle 
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3.1 Abstract 
Introduction. The displacement of the myotendinous junction (MTJ) and passive 
stiffness of the human gastrocnemius medialis (GM) are frequently quantified in 
vivo using ultrasonography as they relate to the material properties of the muscle. 
It is however, unclear how body position impacts on the measurements. Thus this 
study compared the impact of seated versus prone testing postures on recorded 
MTJ and GM displacement measurements.  
Methods. Eight men (28 (5) years) completed four randomised passive-stretch 
sessions; two prone, and two seated. During each stretch session, the ankle was 
passively dorsiflexed at 1 deg.s-1 until volitional end range of motion (ROM). 
Throughout each stretch session GM MTJ displacement, passive torque and ankle 
angle were measured. Passive GM MTJ displacement and GM stiffness were 
measured at 22 Nm and end ROM. 
Results. GM stiffness at 22 Nm was 43% stiffer during the prone testing posture 
compared to the seated posture. GM MTJ displacement was 0.69 and 0.65 cm 
greater in the seated position at 22 Nm and end ROM, respectively. Relatively 
lower intra-postural reliability was identified in the prone position across all 
measures at 22 Nm and end ROM, compared with that in the seated position. 
Conclusion. Where multiple repeat assessments are required, the seated posture 
should be employed to reliably and accurately assess the passive properties of the 
GM MTJ displacement and GM stiffness. Conversely the prone posture was 
identified to be an unreliable method to test the passive properties of the GM. 
  
39 
 
3.2 Introduction 
Stretching is a common strategy prescribed to athlete and patient populations to 
increase flexibility (Dadebo et al. 2004) and decrease passive joint stiffness 
(McHugh et al. 1998). Flexibility is classically determined by measuring the 
volitional end range of motion (ROM) around a joint (Halbertsma et al. 1996; 
McHugh et al. 1998), using tests such as touch-toe (Magnusson et al. 1997), sit-
and-reach (Cornbleet and Woolsey 1996) and other related tests (Chapter 2). 
Although such tests are commonly adopted in the assessment of flexibility, the 
reliability of end ROM data has been criticised due to several confounding factors 
influencing the quality of the measurement (McHugh et al. 1998; McNair and 
Stanley 1996). As described in Chapter 2, these limitations are reported to be due 
to several psychological and neural determinants, including; stretch tolerance 
(Magnusson et al. 1996a), pain (Toft et al. 1989), and reflex response of the 
muscle and tendon sensory organs (McNair and Stanley 1996). A more reliable 
method to overcome these limitations is to assess the passive torque-angle 
relationship (Magnusson et al. 1997; Toft et al. 1989). 
 
Muscle-tendon unit stiffness is expressed as the relationship between the change 
in passive torque and joint angle when assessing flexibility throughout a passive 
stretch manoeuvre (Kubo et al. 2001a; Magnusson et al. 1997). However, this 
measurement does not allow the discrimination of elastic properties between the 
individual muscular and tendinous components. Recently, several studies have 
used ultrasonography to measure the in vivo displacement of the gastrocnemius 
medialis (GM) myotendinous junction (MTJ) throughout a passive stretch 
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manoeuvre at pre-determined increments of torque (Kay and Blazevich 2009) or 
ankle angle (Morse et al. 2008a) as a measure of passive muscle stiffness 
(Chapter 2). Such techniques are typically employed to determine and quantify 
whether an intervention affects the passive properties of the muscle and/or tendon 
(Abellaneda et al. 2009; Burgess et al. 2009; Kay and Blazevich 2009; Morse 
2011; Morse et al. 2008a). 
 
During passive dorsiflexion (DF) trials in the prone posture, the average distal GM 
MTJ displacement in healthy male participants was 1.04 cm, when rotating the 
ankle at 1 deg·s-1 to end ROM (Morse et al. 2008a). Such small displacement 
measures require sensitive apparatus and a reliable testing protocol to identify 
genuine differences in elastic properties of the muscle. Recently, Morse (2011) 
suggested that ultrasonography is a valid tool over these small distances by 
reporting a mean error of 0.06 mm, and R2 of 0.999 over 1 mm increments using a 
micrometer calliper. Although the measurement of the GM MTJ displacement 
during passive stretch manoeuvres has not been validated directly, numerous 
studies have consistently shown that ultrasonography is a reliable and valid tool 
for assessing tendon elongation (Maganaris and Paul 1999), muscle fascicle 
length (Narici et al. 1996), muscle cross sectional area (Reeves et al. 2004a) and 
muscle volume (Esformes et al. 2002). However, there are no data regarding the 
validity or reliability of ultrasonography when used to record the passive properties 
of skeletal muscle in vivo. Two testing postures have been utilised within the 
literature to examine the distal GM MTJ displacement under stretch conditions: 
prone (Morse et al. 2008a) and seated (Kay and Blazevich 2009). Though no 
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information exists on whether testing posture affects the bias and reliability within 
the measure of flexibility and passive muscle stiffness. Therefore, the aim of the 
study is to assess whether data from seated and prone postures agree and are 
comparable, and to establish which posture is the most reliable measure of GM 
MTJ displacement, muscular stiffness and ankle angle. 
 
3.3 Methods 
3.3.1 Participants  
Eight healthy males volunteered to participate in the study (age = 27.6 (5.0) years, 
stature = 1.81 (0.07) m, mass = 86.6 (13.3) kg) and provided written informed 
consent. All participants were free from lower extremity injury and were physically 
active. The study conformed to the latest revision of the Declaration of Helsinki 
and the ethics committee at Manchester Metropolitan University. Each participant 
completed one familiarisation session and four testing sessions. Sessions were 
conducted on separate days (two prone and two seated) in a randomised order to 
assess the reliability and validity of each testing procedures. A minimum of 24 
hours separated each testing session and all procedures were performed on the 
left leg. Previous research identified that the effect of leg dominance during 
passive plantarflexor stretch trials was negligible (Moseley et al. 2001). 
Additionally, Guette et al. (2005) reported no difference in maximal voluntary 
isometric contraction (MVIC) torque achieved between the dominant and non-
dominant quadriceps femoris. Equivocal findings have also been found when 
assessing the plantarflexsion (PF) strength of adult males without neurological 
42 
 
impairment (Damholt and Termansen 1978), demonstrating that it is not necessary 
to test both limbs during such simple motor tasks (Guette et al. 2005). 
 
3.3.2 Passive stretch set-up 
Participants were secured to an isokinetic dynamometer (Cybex Norm, Cybex 
International Inc., NY, USA) in the seated and prone posture (Figure 3.1; Kay and 
Blazevich 2009; Morse et al. 2008a). While in the seated posture, three Velcro 
straps were used to limit extraneous movement: one strap was used to secure the 
knee in full extension, and two straps were used to secure the foot to the footplate 
(Figure 3.1). The participant’s hips were secured to the seat which was reclined at 
65 deg to further limit extraneous movement throughout the passive stretch 
manoeuvre. Similarly, whilst in the prone posture, two Velcro straps were used to 
secure the foot to the footplate and the participants’ hips were also secured to the 
bench. Consequently, whilst heel displacement was not visually identifiable, the 
experimenter relied on the participants to report loss of contact between heel and 
the footplate throughout the passive stretch, in which case a new trial would be 
conducted. In both postures, the medial malleolus was visually aligned with the 
dynamometers’ central axis of rotation. Passive end ROM was identified by 
passively DF the participants’ ankle at 1 deg.s-1, from +20 deg plantarflexion, until 
volitional end ROM. Ankle angle was recorded using an electrogoniometer (K100, 
Biometrics Ltd, UK) attached to the distal aspect of the lateral malleolus. Two 
passive stretches were conducted in each testing session, which involved the 
dynamometer passively rotating the individual’s ankle at 1 deg.s-1 through the 
predetermined ROM. Throughout all of the passive procedures, participants were 
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regularly instructed to remain relaxed (i.e. to not resist the movement of the 
footplate).   
 
A multi-channel, analog-digital converter (Biopac Systems Inc., USA) recorded 
ankle angle, torque and GM electromyography (EMG) data at 2 kHz onto a 
Macintosh computer during each passive trial and analysed offline using 
AcqKnowledge software (MP100, Biopac Systems Inc.).  
 
3.3.3 MTJ displacement during passive stretch 
B-Mode ultrasonography (AU5, Esaota, Italy) was used to determine the GM MTJ 
displacement during the two passive stretches. The MTJ was identified as a 
continuous sagittal plane ultrasound image using a 5-cm, 7.5-MHz linear-array 
probe, which was time locked with torque, EMG and goniometer outputs (as 
described previously by Maganaris and Paul 1999; Morse 2011). MTJ 
displacement was measured relative to an acoustically reflective marker secured 
to the skin proximal to the GM MTJ. Images were recorded onto a desktop 
computer at 30 Hz and analysed off line at 2-Nm intervals from 0 Nm to 22 Nm 
(the highest passive torque reached by all participants) and end ROM using 
digitising software (Dartfish, Friburg, Switzerland). Subsequently, muscle stiffness 
was calculated as the instantaneous slope of the relationship between passive DF 
torque and passive distal GM MTJ displacement (Morse 2011).  
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Figure 3.1. Experimental set up of the seated and prone passive stretching 
postures (left). Schematic diagrams of the specific foot positioning in both 
experimental postures (right). 
 
3.3.4 Maximal voluntary contraction 
All participants were allowed 3 min to perform sub-maximal warm-up contractions 
prior to the MVIC testing procedure. After the warm-up, three maximal isometric 
PF MVICs were performed with the ankle at 0 deg. Participants were verbally 
encouraged throughout each isometric contraction, with consecutive efforts 
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separated by a 60-s rest period. The highest MVIC value that was recorded during 
each testing session was used in the analysis of passive muscle activation. 
 
3.3.5 EMG 
The EMG activity of the GM was recorded throughout the passive stretch using 
two pre-gelled, unipolar, 10-mm, Ag-AgCl percutaneous electrodes (Medicotest, 
Denmark). The area where the electrodes were positioned was shaved and 
cleaned with an alcohol swab. The electrodes were placed medially on the upper 
quartile of the GM. Electrodes were placed 25 mm apart and a reference electrode 
placed over the femurs’ medial epicondyle. EMG data were recorded at 2000 Hz, 
with a high and low pass filter set at 500 and 10 Hz respectively, and a notch filter 
at 50 Hz. The integral of the root mean square of the raw signal 0.5 s either side of 
the specific torque values was used to quantify EMG activity. EMG stretch data is 
presented relative to the EMG measured during the MVIC and analysed at 25, 50, 
75 and 100% of peak passive torque.  
 
3.3.6 Statistics 
Inter-postural comparisons were made on the average data from days 1 and 2. 
Ankles angle, GM MTJ displacement and GM stiffness data was determined by 
averaging the data from days 1 and 2 for each participant in the collective group, 
which was presented in the results section of this chapter. The agreement 
between seated and prone GM MTJ displacement stiffness and ankle angle data 
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was assessed using a two-way mixed effects intra-class correlation coefficient 
(ICC), using statistical analysis software (SPSS, version 16.0; Chicago, IL). Intra-
posture reliability (day 1 vs. day 2) was analysed with an ICC, using a one-way 
random effects model. The output from an ICC can range from 0-1 and has been 
discussed by Atkinson and Nevill (1998) where an ICC ranging from 0.7-0.8 is 
suggested to be questionable, whereas values > 0.9 is high. The coefficient of 
variation (CV), systematic bias and 95% limits of agreement (LoA) were reported 
to assess the agreement between postures and the intra-posture reliability of each 
posture (Bland and Altman 1986). The CV was calculated by; (SD x 1.96) / mean x 
100, which covers 95% of the repeated measures (Bishop 1997). It has been 
suggested that the variability of the CV outputs being < 10% is reliable, whereas 
anything over this value is not reliable (Stokes 1985), however this should be used 
with caution and relative to the variable being assessed (Atkinson and Nevill 
1998). In order to calculate the LoA, the systematic bias and random error has to 
be calculated. To calculate systematic bias, the average difference from the tests 
conducted on day 1 and 2 were obtained. This systematic bias indicates a trend in 
the measurement, either in a positive/negative direction between tests, which 
could be due to factors such as learning effects. Whereas random error requires 
the SD for the data collected on day 1 and 2, which is then multiplied by ±1.96. 
The random error indicates the range of biological and/or mechanical variation in 
the measure (Atkinson and Nevill 1998). Differences between GM MTJ 
displacement, stiffness, ankle angle, passive torque and muscle activity were 
assessed by two-tailed paired t-tests. All values are stated as means (SD), unless 
stated otherwise. 
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3.4 Results 
Average inter- and intra-postural measurements of muscle stiffness, GM MTJ 
displacement, passive torque, and ankle angle at 22 Nm are displayed in Table 
3.1 and end ROM in Table 3.2. No difference was detected between inter- or intra-
postural passive torques at end ROM (Table 3.2). Average muscle activity during 
the passive stretch was 0.11 (0.11), 0.12 (0.08), 0.48 (0.50) and 0.91 (1.20)% 
relative to MVIC, in the seated posture at 25, 50, 75% and end ROM, respectively. 
Similarly, muscle activity during the prone posture was 0.38 (0.67), 0.54 (1.09), 
0.21 (0.20) and 0.17 (0.15)% in the prone posture at 25, 50, 75% and end ROM, 
respectively. No differences were identified between postures. 
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Table 3.1. Distal displacement of the GM MTJ and stiffness of the GM muscle and 
ROM of the ankle from 0-22 Nm. 
 Seated Prone Average 
0-22 Nm Day 1 Day 2 Day 1 Day 2 Seated Prone 
GM MTJ 
displacement (cm) 
1.70 
(0.31)* 
1.74 
(0.32) 
1.07 
(0.39) 
0.99 
(0.27) 
1.72 
(0.31)† 
1.03 
(0.23) 
Stiffness (Nm cm-1) 13.4 
(2.7)* 
13.0 
(2.6) 
22.6 
(7.1) 
24.0 
(7.2) 
13.2 
(2.6)† 
23.3 
(4.6) 
Ankle angle (deg) -6.91 
(4.19) 
-7.24 
(4.05) 
-10.3 
(7.0) 
-12.4 
(6.1) 
-7.08 
(3.94)† 
-11.3 
(4.5) 
Gastrocnemius (GM), Range of motion (ROM), Gastrocnemius myotendinous 
junction (GM MTJ). *indicates intra-postural difference (P < 0.01), †denotes inter-
postural difference (P < 0.05). 
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Table 3.2. Distal displacement of the GM MTJ, stiffness of the GM, torque and 
ankle angle at passive end ROM. 
 Seated Prone Average 
end ROM Day 1 Day 2 Day 1 Day 2 Seated Prone 
GM MTJ 
displacement (cm) 
1.70 
(0.31)*  
1.74 
(0.32) 
1.11 
(0.39)  
1.03 
(0.26) 
1.72 
(0.31)† 
1.07 
(0.22) 
Stiffness (Nm cm-1) 20.6 
(5.9)  
19.9 
(6.9) 
32.7 
(7.2)  
38.7 
(15.3) 
20.3 
(5.9)† 
35.7 
(9.7) 
Passive torque (Nm) 34.5 
(9.2) 
33.5 
(8.2) 
34.8 
(9.7) 
37.0 
(7.9) 
34.0 
(8.5) 
35.9 
(8.6) 
Ankle angle (deg) -11.9 
(5.4) 
-11.6 
(2.7) 
-14.7 
(6.8) 
-16.5 
(8.1) 
-11.7 
(3.5)† 
-15.6 
(5.8) 
Volitional end range of motion (end ROM), gastrocnemius myotendinous junction 
(GM MTJ). *indicates intra-postural difference (P < 0.01), †denotes inter-postural 
difference (P < 0.05).  
 
3.4.1 Inter-posture agreement 
At 22 Nm and end ROM, MTJ displacement was 40 and 38% greater in seated 
compared to prone posture (Figures 3.2 and 3.3, P < 0.005), respectively. This 
systematic bias showed that the seated posture was 43% more compliant than the 
prone posture during stiffness measures at 22 Nm and end ROM (Figures 3.2 and 
3.3, P < 0.05). The GM MTJ displacement and GM stiffness produced ICCs of 0.2 
and lower (Tables 3.3 and 3.4), and CV’s ranged between 59% and 76%, at 22 
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Nm and end ROM. The GM MTJ displacement LoA were 0.69 ± 0.82 cm and 0.65 
± 0.86 cm at 22 Nm and end ROM, respectively. At 22 Nm and end ROM, the LoA 
for GM stiffness were -10.1 ± 11.4 Nm cm-1 and -15.4 ± 21.4 Nm cm-1, respectively 
(Bland-Altman plots are displayed in Figures 3.3 and 3.4).  
 
The ankle angle recorded at 22 Nm and end ROM yielded ICCs of 0.409 and 
0.530, respectively (Tables 3.3 and 3.4). At 22 Nm and end ROM, CV’s were over 
70%, with the ankle angle in the prone position being 37% greater (P < 0.05) than 
the seated angle at 22 Nm (Table 3.1). Large differences were identified between 
testing postures at end ROM (Table 3.2). LoA were 4.25 ± 9.27 deg and 3.93 ± 
9.77 deg at 22 Nm and end ROM, respectively.  
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Figure 3.2. Distal displacement of the GM MTJ at 2 Nm intervals during continuous 
passive dorsiflexion stretch in seated (circles) and prone (squares) testing 
postures. Continuous and broken lines represent test day 1 and day 2, 
respectively. Error bars indicate SEM. 
 
3.4.2 Prone intra-posture comparison 
The prone testing posture yielded ICCs of -0.111 to 0.464, and CV’s over 75% for 
GM MTJ displacement and muscle stiffness, at 22 Nm and end ROM (Tables 3.3 
and 3.4). The GM MTJ displacement LoA were -0.09 ± 0.94 cm and -0.08 ± 0.98 
cm at 22 Nm and end ROM, respectively. At 22 Nm and end ROM, the LoA for GM 
stiffness were 1.39 ± 21.6 Nm cm-1 and 5.98 ± 27.1 Nm cm-1, respectively. The 
Bland-Altman plots (Figures 3.3 and 3.4) display the range in error between day 1 
and day 2 displacement and stiffness measures. There were no differences 
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between day 1 and day 2 in GM displacement and stiffness data, at 22 Nm (Table 
3.1) or end ROM (Table 3.2).  
Ankle angle at 22 Nm (Table 3.3) and end ROM (Table 3.4) during the prone 
posture produced ICCs below 0.400, and CV’s over 100%. The LoA at 22 Nm 
were -2.09 ± 18.8 deg, and -1.60 ± 18.6 deg at end ROM. No systematic bias was 
detected at 22 Nm or end ROM (Tables 3.1 and 3.2). 
 
Table 3.3. ICC for all inter- and intra-postural assessments from 0-22 Nm.  
0-22 Nm Seated posture 
(day 1 vs. day 2) 
Prone posture 
(day 1 vs. day 2) 
Seated vs. 
Prone postures 
GM MTJ 
displacement (cm) 
0.992 0.038 -0.072 
Stiffness (Nm cm-1) 0.993 -0.309 -0.057 
Ankle angle (deg) 0.914 -0.067 0.409 
Intraclass correlation coefficient (ICC), gastrocnemius myotendinous junction (GM 
MTJ). 
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Table 3.4. ICC for all inter- and intra-postural assessments at end ROM.  
end ROM Seated posture 
(day 1 vs. day 2) 
Prone posture 
(day 1 vs. day 2) 
Seated vs. 
Prone postures 
GM MTJ 
displacement (cm) 
0.993 -0.111 -0.181 
Stiffness (Nm cm-1) 0.830 0.464 0.570 
Ankle angle (deg) 0.594 0.390 0.530 
Intraclass correlation coefficient (ICC), gastrocnemius myotendinous junction (GM 
MTJ), volitional end range of motion (end ROM). 
 
3.4.3 Seated intra-posture comparison  
The seated testing posture produced ICCs of 0.992 and 0.993 at 22 Nm (Table 
3.3), and 0.993 and 0.830 at end ROM (Table 3.4) for GM MTJ displacement and 
GM stiffness, respectively. The CV’s of displacement and stiffness data were 4% 
for the two measures at 22 Nm. The CV’s at end ROM were 4% and 50% for GM 
MTJ displacement and GM muscle stiffness, respectively. The GM MTJ 
displacement LoA were 0.05 ± 0.06 cm and 0.04 ± 0.07 cm at 22 Nm and end 
ROM, respectively. At 22 Nm and end ROM, the LoA for GM stiffness were -0.37 ± 
0.50 Nm cm-1 and -0.68 ± 10.1 Nm cm-1, respectively. Bland-Altman plots illustrate 
the systematic bias and random error, between the day 1 and 2 trials in the seated 
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testing posture at 22 Nm (Figure 3.3) and end ROM (Figure 3.4). There was a 7% 
increase in GM MTJ displacement (P < 0.01) at 22 Nm and end ROM, indicating 
systematic bias. Systematic bias was also recorded at 22 Nm, showing a 3% 
decrease in GM stiffness (P < 0.01) when day 1 was compared to day 2. 
 
The ankle angle in the seated posture produced ICCs of 0.914 and 0.594 at 22 
Nm (Table 3.3) and end ROM (Table 3.4), respectively. In addition, CV’s at 22 Nm 
and end ROM were 68% and 80%, respectively. The LoA were -0.33 ± 4.80 at 22 
Nm and 0.34 ± 9.36 at end ROM. No statistical difference was found between 
seated trials at 22 Nm and end ROM (Table 3.1 and 3.2). 
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Figure 3.3. Bland-Altman plots from 0-22 Nm displaying seated (A) and prone (B) intra-posture 
agreement, and inter-posture (C) agreement. 
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Figure 3.4. Bland-Altman plots at end ROM displaying seated (A) and prone (B) intra-posture 
agreement, and inter-posture (C) agreement. 
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3.5 Discussion 
The aim of the present study was to assess the level of agreement between the 
seated and prone postures, and to establish which posture is the most reliable 
measure of GM MTJ displacement, muscle stiffness and ankle flexibility. The main 
findings show that the seated posture was the most reliable method of measuring 
GM MTJ displacement, GM stiffness and ankle angle, compared to the prone 
posture. Furthermore, the seated and prone postures yielded poor inter-postural 
agreement when measuring distal GM MTJ displacement, GM stiffness and ankle 
angle at 22 Nm and end ROM. 
 
The present results confirm that the seated posture is a reliable protocol when 
measuring GM MTJ displacement and GM stiffness at 22 Nm during a passive 
stretch to DF end ROM. At end ROM, distal GM MTJ displacement was the only 
reliable measure recorded. From the ICC analysis, the displacement assessment 
to compute GM stiffness and ankle angle were repeatable, however the CV and 
LoA revealed poor reliability and agreement between the two measures. These 
findings confirm the importance of using a triangulated approach (the use of three 
or more reliability tests to ascertain the repeatability and accuracy of a method) to 
obtain a more accurate interpretation of the reliability and agreement of measures 
(Atkinson and Nevill 1998). By using such an approach to test reliability, this also 
facilitates researchers to assess specific statistical reliability tests they are most 
familiar with implementing. Additionally, during passive stretch of the GM, it is 
more reliable to monitor GM MTJ distal displacement as opposed to other 
methods of assessing flexibility to end ROM. 
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GM stiffness in the present study was calculated using GM MTJ displacement and 
passive toque (Morse 2011; Morse et al. 2008a). At 22 Nm GM stiffness was 
reliable across all statistical analyses in the seated posture, though measurements 
at end ROM such should be used with caution as the random error and CV 
indicated that the measure was less reliable. Nevertheless, the systematic bias 
was only found to be 0.18 Nm cm-1 higher than that measured at 22 Nm and also 
the ICC rated as a reliable test. This difference in findings between end ROM and 
22 Nm may be due to variability in the torque and GM MTJ displacement, as 
measures at end ROM are likely to be confounded by psychological factors 
(Magnusson et al. 1996a; Toft et al. 1989; McNair and Stanley 1996). Thus, GM 
MTJ displacement is a more reliable method of assessing the passive properties 
particularly at end ROM, however, as the measurement of GM stiffness accounts 
for passive torque and GM MTJ displacement, it would be expected that the level 
of variability would increase in the measure.    
 
Of the two postures tested, the seated posture was the most reliable, but 
demonstrated a systematic bias from day 1 to day 2, with GM MTJ displacement 
increasing by 7% at 22 Nm and end ROM, respectively. It is questionable whether 
this systematic bias of 0.04 cm at end ROM would have a meaningful impact on 
identifying differences in the passive properties of the GM as comparatively, acute 
stretch intervention studies have reported GM MTJ displacement in excess of 0.3 
cm at end ROM (Morse et al. 2008a). This day to day bias may also be associated 
with the mathematical limitations involved with the calculation of systematic bias, 
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such as the magnitude of variation observed (Atkinson and Nevill 1998). 
Alternatively, these findings may simply be due to the relatively small number of 
participants tested and/or the cohort being too homogenous. As displayed in figure 
3.3 and 3.4, the level of variation is far smaller in the seated posture compared to 
the prone posture. Furthermore, the inter-postural difference in GM MTJ 
displacement ranged from 38-40% and showed a large variability in the relation to 
the LoA confidence intervals throughout the torque range. Such large variations 
between the seated and prone positions demonstrate that any direct comparison 
between the two postures would be erroneous. 
 
Although the prone posture was unreliable it is similar to previous data; Morse et 
al. (2008a) reported a 1.04 cm displacement of the GM MTJ and 38.8 Nm cm-1 GM 
stiffness, whereas the present study GM MTJ displacement was 1.07 cm and GM 
stiffness was 35.7 Nm cm-1. All of these comparisons were made at end ROM as 
submaximal measurements were made relative to ankle angle and not torque. 
Although similar to previous data, all of the prone reliability tests in the present 
study reported that: GM MTJ displacement, GM stiffness and ankle angle were 
unreliable measures at 22 Nm and end ROM. These findings could be due to 
several confounding factors including: heel displacement, segmental translation 
and neural reflexes at end ROM (Magnusson et al. 1996a; McNair and Stanley 
1996). 
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The potential effect of heel displacement on passive torque values would result in 
isokinetic dynamometer moment arm assumptions being violated due to the 
translation of the lateral malleolus away from the axis of rotation. This excess 
movement of the heel could also lead to segmental translation. Indeed this 
translation in seated position would be minimal due to the seat being inclined, 
restricting the movement of the hip, whereas the prone posture had no structure 
limiting this extraneous movement. In contrast, neural activation was measured in 
the present study through EMG and expressed relative to PF MVIC. The GM was 
near electrical silence with prone and seated postures recording signals < 1% 
activity relative to GM MVIC throughout the passive stretch (at 25, 50, 75% and 
end ROM); confirming that the torque measured was indeed passive and that data 
were not confounded by voluntary or reflex contractions.  
 
Although there are inter-postural similarities in GM activity and torque, low levels 
of agreement were demonstrated in GM MTJ displacement, GM stiffness and 
ankle angle measurements between postures. The GM at 22 Nm was 43% more 
compliant in the seated posture when compared to the prone position. GM MTJ 
displacement was also 0.69 and 0.65 cm greater in the seated position at 22 Nm 
and end ROM, respectively. At end ROM the average angles achieved by the 
seated and prone positions were 11.7 and 15.6 deg, respectively. Previous studies 
show a linear relationship between GM MTJ displacement and ankle angle (Morse 
et al. 2008a). The present study showed that lower GM MTJ displacement values 
are achieved in the prone posture than the seated position. This data provides 
indirect evidence that suggests heel displacement may have occurred during the 
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prone position – assuming that no heel displacement occurred during the seated 
posture. However, the degree of heel displacement could not be quantified in the 
present study, due to the structure of the footplate obstructing the recording of the 
foot during the testing procedure. Consequences resulting from any potential heel 
displacement during the prone position may have resulted in the translation of the 
participant away from the dynamometer, as no opposite force was applied to the 
resting participant during the experimental procedure to counteract the horizontal 
force applied during the passive procedure. 
 
3.6 Conclusion 
There are several factors that affect the measurement of ROM and the 
assessment of muscle elastic properties during passive stretch conditions at 22 
Nm and end ROM. The present findings suggest that the inter-postural agreement 
between the seated and prone postures is too low to make any comparison 
between the two measures. The intra-postural reproducibility was highest for the 
seated position for GM MTJ displacement, GM stiffness and ankle angle, 
compared to the unreliable results obtained for the prone posture. Although the 
results at end ROM were subject to several confounding variables impacting on 
the reliability of GM MTJ displacement and GM stiffness measures, presenting 
these variables should be done with an understanding of the increased level of 
error. Thus, future studies assessing the passive elastic properties of the GM 
should use the seated posture at a common torque reached by all participants.   
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Chapter 4 
 
Passive stiffness of the gastrocnemius 
muscle in active adults with spastic 
hemiplegic cerebral palsy 
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4.1 Abstract 
Introduction. The passive properties of the muscle-tendon unit are regularly 
assessed in children with spastic cerebral palsy (SCP). However, no information is 
available on the passive properties of SCP adult muscle and whether any 
differences exist between the paretic and control muscles.  
Methods. Eleven physically active ambulant men with hemiplegic SCP (21.2 (3.0) 
years) and controls without neurological impairment completed two and one 
passive stretch session, respectively. During each session, the ankle was 
passively dorsiflexed until end range of motion (ROM), whilst recording passive 
ankle angle, torque and gastrocnemius medialis (GM) myotendinous junction 
(MTJ) displacement. Additionally, GM cross sectional area (CSA) and length were 
measured. Subsequently, in vivo stress and strain were determined to calculate 
elastic modulus. 
Results. Passive stiffness, MTJ displacement and ROM of the paretic GM were 
not different from the control muscles. However, the elastic modulus of the paretic 
GM was two times higher than the control GM muscles.  
Conclusion. Physically active adults with SCP exhibit absolute passive muscle 
stiffness similar to the controls; however the elastic modulus of the SCP muscle 
was significantly greater. Therefore, throughout the same ROM a smaller GM CSA 
in physically active adults with SCP have to dissipate larger relative torque 
compared to the control muscles, consequently causing the muscle to elongate to 
the same extent as the non-paretic muscle under stretch. 
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4.2 Introduction 
The range of motion (ROM) available to individuals with spastic cerebral palsy 
(SCP) around a paretic joint is often reported to be limited (Alhusaini et al. 2010; 
Barber et al. 2011a), consequently impacting on locomotion (Gage et al. 1995). As 
a result of such limitations in ROM around the paretic joint, many studies have 
quantified the magnitude of difference by passively lengthening the muscle-tendon 
unit (MTU) until volitional end ROM (Alhusaini et al. 2010; Barber et al. 2011a; Kay 
and Blazevich 2009; Morse 2011; Morse et al. 2008a). As discussed in Chapter 2 
and 3, this method of assessing flexibility is simple to perform and often adopted in 
field-based testing, however several limitations have been reported to confound 
such data, including psychological (Magnusson et al. 1996a; Toft et al. 1989) and 
neural factors (McNair and Stanley 1996). Furthermore measuring end ROM 
around the joint does not provide information on the constituents of the MTU that 
contribute to resistance to stretch.  
 
In contrast to flexibility testing which is influenced by stretch tolerance and reflex 
activation of the muscle under stretch (McNair and Stanley 1996), the passive 
torque-angle relation has been shown to eliminate these neural shortcomings by 
monitoring electromyography of the muscle in order to quantify whether the stretch 
was passive (Magnusson et al. 1997). In individuals with hemiplegic CP, it is 
consistently reported that the relaxed MTU of the paretic limb is stiffer than 
controls without neurological impairment (Alhusaini et al. 2010; Vaz et al. 2006). 
This has been speculated to be due to ‘spasticity’, which describes a velocity-
dependent resistance of the muscle to stretch, as a result of a lesion to the central 
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nervous system causing hyperexcitability of the stretch reflex (Sanger et al. 2003). 
Thus, in order to minimise muscle activation in individuals with SCP, a low velocity 
passive stretch is required to inhibit involuntary reflexes.  
 
Such an increase in neural activity was previously thought to be the primary factor 
resisting passive movement (O'Dwyer et al. 1996). However, a number of 
structural factors have been suggested as determinants of passive properties of 
the muscle in a number of different population groups. These have included; 
fascicle length (Friden and Lieber 2003), fascicle stiffness (Barber et al. 2011a), 
muscle cross sectional area (CSA) (Magnusson et al. 1997), pennation angle 
(Moreau et al. 2009), extracellular connective tissue (Lieber et al. 2003), type 1 
muscle fibres (Ito et al. 1996) and variation in fibre size (Marbini et al. 2002). Such 
information on the passive properties of the MTU in individuals with SCP has 
predominantly been reported in children. Where previous data is reported in 
adults, it does not discriminate between male and female participants and includes 
a range of ages (15-21 yrs) where individuals may not be fully mature (Barber et 
al. 2011a). 
 
Such data may not apply to physically active adults with SCP as the brain lesion is 
typically non-progressive, but the resultant movement disorders may become 
more pronounced and progressive over time (Hanna et al. 2009). As the MTU is 
highly plastic, the environment the tissue is subjected to may be a key factor in 
how these progressions affect the passive properties of the contractile and elastic 
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components. In order to discriminate between the muscle and tendon structures, 
ultrasonography has previously been used to track the movement of the 
myotendinous junction (MTJ) in vivo throughout a passive stretch manoeuvre 
(Abellaneda et al. 2009; Kay and Blazevich 2009; Morse 2011; Morse et al. 
2008a). By utilising a similar technique, Barber et al. (2011a) reported that the 
stiffness of the  paretic MTU of individuals with SCP was higher when compared to 
age-matched controls without neurological impairment.  
 
As stated in Chapter 2, individuals with CP are documented to typically live a 
sedentary lifestyle (Longmuir and Bar-Or 2000). It is well established in individuals 
without neurological impairment that a reduction in physical activity results in 
muscle atrophy, weakness and muscle shortening (de Boer et al. 2007). Physically 
active adults with SCP may comparatively experience relative preservation in 
muscle function associated with increased physical activity. Indeed, previous data 
assessing the MTU properties of individuals with SCP compared to those without 
neurological impairment have focused on sedentary populations; there is however, 
no information on the impact of relatively elevated habitual physical activity of 
individuals with SCP compared to age-matched counterparts without neurological 
impairment on the passive properties of the muscle. Therefore the primary aim of 
the study was to assess the passive stiffness of the paretic GM in physically active 
adults with SCP compared to the non-paretic contralateral limb of the individuals 
with SCP and age-matched controls. The secondary aim was to assess whether 
muscle length and/or CSA have any influence on passive muscle stiffness 
properties. Based on previous data assessing MTU and GM stiffness in individuals 
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with SCP, we hypothesised that the passive stiffness of the paretic GM in 
physically active adults with SCP would be higher compared to the non-paretic 
muscle and the age match controls without neurological impairment. 
 
4.3 Methods 
4.3.1 Participants  
Eleven physically active adult men with hemiplegic SCP (age = 21.2 (3.0) years, 
stature = 1.79 (0.10) m, mass = 70.0 (12.5) kg) and eleven males without 
neurological impairment (age = 21.8 (2.2) years, stature = 1.81 (0.04) cm, mass = 
79.0 ± 8.4 kg) volunteered to participate in the study after written informed consent 
was obtained. Each participant with SCP rated between II and III on the modified 
Ashworth scale and had been formally classified independently by individuals from 
the Cerebral Palsy International Sports and Recreation Association (CPISRA). All 
participants with SCP completed football-specific training and stretched at least 3 
times per week. All participants without neurological impairment played and 
trained regularly for a university soccer team. All participants were free from lower 
limb injury and had not received any form of medication to reduce the effects of 
spasticity within the last year. Both the paretic and non-paretic legs were tested in 
each participant with SCP, whereas the dominant limb was assessed in all 
individuals without neurological impairment. Informed consent was obtained from 
all participants involved in the study prior to the commencement of testing and 
approval was obtained from the local ethics committee at Manchester Metropolitan 
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University. Furthermore, the study conformed to the principles set out in the 
Decleration of Helsinki.  
 
4.3.2 Further testing and participant recruitment information 
The recruitment of healthy men without neurological impairment was completed by 
inviting individuals that regularly engaged in football training at Manchester 
Metropolitan University. Men with hemiplegic SCP were recruited from a database 
that The Football Association provided. The database consisted of 159 players 
from England and Wales that could be approached to take part in the series of 
studies. Due to the aims and objectives of the present thesis, the majority of the 
individuals on the database were unsuitable to be invited to partake in the series of 
studies due to their specific impairment, habitual training status and/or age. As a 
result of the criteria, this left 14 possible individuals that could have been recruited 
to partake in the series of tests. Of these 14 individuals, 11 were successfully 
recruited. 
 
All of the participants that volunteered to take part in the testing protocol for the 
present chapter were tested on all of the parameters outlined in chapter 4-7 on the 
same day. Initially participants attended a familiarisation session individually where 
each person sampled all of the testing procedures outlined in experimental 
chapters 4-7. There was a period of at least 24 hours between the familiarisation 
session and experimental testing session where the participants completed the full 
testing protocol that is outlined in Figure 4.1.  
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Figure 4.1. Chronological order of the testing procedures completed on all 
participants. 
 
4.3.3 Passive stretch set-up 
As the seated posture was found to be the most accurate and reliable test in 
addressing the passive properties of the muscle (Chapter 3), all tests were carried 
out in a seated position (for further details see Kay and Blazevich 2009; Morse 
2011), using a isokinetic Cybex dynamometer (Cybex Norm, Cybex International 
Inc., NY, USA). The medial malleolus was visually aligned with the dynamometer’s 
central axis of rotation. Three Velcro straps were used to limit extraneous 
movement: one strap was used to secure the knee in full extension, and two 
straps were used to secure the foot to the footplate. The participant’s hips were 
secured to the seat to further limit extraneous movement throughout the passive 
stretch manoeuvre. Consequently, whilst heel displacement was not visually 
identifiable, the experimenter relied on the participants to report loss of contact 
between heel and the footplate throughout the passive stretch, in which case a 
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new trial would be conducted. Passive dorsiflexion (DF) end ROM was identified 
by the experimenter rotating the ankle at 1 deg.s-1, starting from +20 deg 
plantarflexion (PF), until discomfort caused the participants to cease the stretch. 
This velocity was chosen in relation to previous findings which elicited minimal 
neural activity throughout passive stretch trials in individuals without neurological 
impairment (Morse 2011; Morse et al. 2008a). Ankle angle was recorded by an 
electrogoniometer (K100, Biometrics Ltd, UK), which was attached to the distal 
aspect of the lateral malleolus, about the coronal axis of the ankle. Similar to 
Morse et al. (2008a), all angle data refer to the angle of the goniometer as 
opposed to the dynamometer angle. Two passive stretches were conducted in 
each testing session, throughout all passive procedures; participants were 
regularly instructed to remain relaxed and not to resist the movement of the 
footplate. The first passive stretch was used to identify participant end ROM, the 
second was used for data collection. Throughout the passive stretch used for data 
collection, a multi-channel, analog-digital converter (Biopac Systems Inc., USA) 
recorded ankle angle, torque and GM electromyogram (EMG) data at a 2-kHz 
sampling frequency onto a Macintosh computer. All data were analysed offline 
using AcqKnowledge software (MP100, Biopac Systems Inc. USA).  
 
4.3.4 MTJ displacement during passive stretch 
B-Mode ultrasonography (AU5, Esaota, Italy) was used to determine the 
displacement of the GM MTJ throughout the passive stretch (Chapter 3). The MTJ 
was identified as a continuous sagittal plane ultrasound image using a 5-cm, 7.5-
MHz linear-array probe, which was time locked with the torque, EMG and 
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goniometer outputs as described previously (Maganaris and Paul 1999; Morse 
2011). MTJ displacement was measured relative to an acoustically reflective 
marker (a thin strip of Micropore tape) secured to the skin proximal to the GM 
MTJ, as previously validated by Morse et al. (Morse et al. 2008a). Images were 
recorded onto a desktop computer at 30 Hz and analysed off line at 2-Nm intervals 
from 0 Nm to 14 Nm (the highest passive torque reached by all participants) and 
end ROM using digitizing software (Dartfish, Friburg, Switzerland).  
 
Subsequent to this analysis, muscle stiffness was calculated as the ratio of 
passive DF torque to the passive distal displacement of the GM MTJ (Morse 
2011). It should be noted, as with previous investigations into the passive 
properties of the GM, that it is not possible to account for elongation of the 
proximal tendon or the contribution of other structures to passive torque, such as 
the joint capsule. It has been reported in rats that after a period of 14 days hind 
limb suspension, that 25% of the passive ankle joint tension was due to joint 
structures, whereas the remaining 75% was due to muscle-tendon properties 
(Gillette and Fell 1996), though whether this is representative of joint stiffness in 
humans has yet to be determined. Therefore with these caveats in mind, nominal 
passive muscle stiffness is defined as the distal displacement of the GM MTJ 
relative to passive PF joint torque (Nm.cm-1). 
 
 4.3.5 Maximal voluntary contractions 
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Following passive stiffness measurements, participants performed maximal 
voluntary isometric PF and DF contractions. All participants were given a 3 min 
period of time to perform sub-maximal warm up contractions prior to the maximal 
voluntary isometric contraction (MVIC) testing procedure. After the warm-up, three 
PF and DF MVICs with the ankle at 0 deg were performed. Each participant was 
verbally encouraged throughout each isometric contraction and each trial was 
separated by a 60-s rest period, which has previously been demonstrated to 
negate the effects of fatigue during maximal isometric testing (Binder-Macleod and 
McDermond 1992). The highest MVIC value was recorded, which was defined as 
the average torque 0.5 s either side of the instantaneous peak torque. The MVIC 
torque data was subsequently used to normalise EMG data during the passive 
stretch procedure. 
 
4.3.6 Electromyography 
The activity of both the GM and tibialis anterior (TA) muscles was recorded 
throughout the passive stretch using four (two each for the GM and TA) pre-gelled, 
unipolar, 10-mm, Ag-AgCl percutaneous electrodes (Medicotest, Denmark). The 
area where the electrodes were positioned was shaved, and cleaned with an 
alcohol swab to remove residual skin cells and oils, as well as reduce skin 
impedance. The electrodes were placed medially at two thirds and proximally of 
GM length and TA length, having first defined the boundaries of the respective 
muscles using ultrasonography. The upper two thirds were used for electrode 
placement to avoid the innervation zone (Saitou et al. 2000), and to allow 
ultrasound placement over the proximal MTJ. Electrodes were placed with 25 mm 
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distance between the centres; reference electrodes were placed over the medial 
and lateral epicondyle of the femur for the GM and TA, respectively. EMG data 
were recorded at 2000 Hz, with a low and high-pass filter set at 500 and 10 Hz 
respectively, and a notch set at 50 Hz. The integral of the root mean square of the 
raw signal 0.5 s either side of the specific torque values was used to quantify 
muscle activity. Integrated EMG from the stretch trials is presented relative to the 
integrated EMG measured during the MVIC. This allowed the quantification of 
muscular activity during the passive stretch, which was analysed at 25, 50, 75 and 
100% of the maximum passive torque value.  
 
 4.3.7 Gastrocnemius medialis and tendon length 
Although it was stated in Chapter 3 that the prone posture was an unreliable 
position to obtain passive data from, all measurements obtained in this posture did 
not required the participant or isokinetic dynamometer to move once the 
participant was secured into position and the participant was requested to stay as 
still as possible. Furthermore, whilst in the seated position, a portion of the 
proximal gastrocnemius was obstructed by the seat, making the accurate 
assessment of GM length an impossible task. 
 
B-Mode ultrasonography was used to determine the length of the GM and the 
muscle tendon unit, whilst the participant lay prone. Ankle angle was fixed at 0 
deg, for all individuals that stood with their heels in contact with the ground. 
Corrections in the fixed ankle position were made for two of the participants with 
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SCP, as their paretic heel did not make contact with the floor. This was completed 
by aligning a goniometer with the tibia, the lateral malleolus of the ankle and the 
fifth metatarsal until the foot made contact with the floor; using this adjusted ankle 
angle as 0 deg. 
 
Whilst the participant lay relaxed in the prone position, the insertion of the GM into 
the medial condyle of the femur and the MTJ were marked on the skin and used to 
calculate GM length. Additionally the GM MTJ to the insertion of the Achilles 
tendon into the calcaneus (which was determined using ultrasonography) was 
measured using an inextensible tape to determine the length of the tendon, a 
method which has been previously validated (Barber et al. 2011b). 
 
4.3.8 Gastrocnemius medialis cross-sectional area 
Several axial-plane images of the GM were obtained using B-mode 
ultrasonography to estimate CSA (Reeves et al. 2004a). The distance between the 
proximal insertion and the MTJ was marked along the width of the GM at 
approximately 3.5 cm intervals with Micropore tape. With the probe in an axial-
plane, a video recording of the probe moving from the medial to the lateral border 
of the GM was obtained. Individual images were extracted from the recording 
offline and used to construct the muscle by overlapping anatomical landmarks and 
external markers. Image J software (version 1.34; National Institutes of Health) 
was subsequently used to measure the cross-sectional area of the reconstructed 
GM image.  
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4.3.9 Elastic modulus 
The GM elastic modulus, Em, was calculated as the in vivo muscle stress-strain 
relation from 0 Nm to 14 Nm and end ROM: 
 
   
   
   
  
(            )
(           )
  
 
Where εmax and εmin represent the maximum and minimum calculated strain (GM 
MTJ displacement/muscle length), σmax and σmin represent the maximum and 
minimum calculated stresses (torque/GM CSA) placed upon the GM during the in 
vivo passive stretch trial. The in vivo change in the muscle stress and strain (as 
presented in Figure 4.3) is represented by Δσm and Δεm, respectively. 
 
4.3.10 Statistics 
All statistical analyses were performed using SPSS software (Version 18, SPSS 
Inc., Chicago Illinois). Regressions were conducted to assess whether muscle 
CSA and/or length were covariates of passive muscle displacement. As a result of 
the regression analysis, a repeated measures ANOVA was used to distinguish 
differences between group (3 levels; paretic, non-paretic and individuals without 
neurological impairment) and within-subject differences in passive muscle 
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displacement at each passive torque increment (7 levels; 2, 4, 6, 8 10, 12 and 14 
Nm). If a significant interaction was found, independent t-tests were used to 
determine group differences. As assumptions of sphericity were violated, 
Greenhouse-Geisser correction was used to identify differences in the data. 
 
A MANOVA was used to determine the differences between the paretic, non-
paretic and individuals without neurological impairment in muscle length, CSA, 
ROM, MVIC and muscle activity. Independent t-tests were used to assess 
baseline anthropometric data between SCP and individuals without neurological 
impairment. All subsequent data are reported as the mean (standard deviation 
(SD)) and exact alpha levels are reported as published by the American 
Physiological Society guidelines (Curran-Everett and Benos 2004) unless P < 
0.0005. 
 
4.4 Results 
Participant age (P = 0.575), stature (P = 0.604) and body mass (P = 0.061) were 
not different between individuals with SCP and those without neurological 
impairment. Table 4.1 shows that whilst the ankle was secured at 0 deg, the GM 
muscle and tendon lengths were not different between the paretic limb, the non-
paretic limb and individuals without neurological impairment (P = 0.222 and P = 
0.698, respectively). At 50% of GM muscle length, CSA of the paretic muscle was 
25% and 35% smaller than the non-paretic muscle (P = 0.029) and the muscle of 
individuals without neurological impairment (P = 0.001), respectively. However no 
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difference was identified between the non-paretic muscle and that of individuals 
without neurological impairment (P = 0.601, Table 4.1). DF MVIC torque was not 
different between the paretic limb, the non-paretic limb and individuals without 
neurological impairment (P = 0.653, Table 4.1). PF MVIC torque in the paretic limb 
was less than that of the non-paretic limb (P = 0.037) and individuals without 
neurological impairment (P = 0.001, Table 4.1), respectively. 
 
Table 4.1. Group comparisons of PF and DF MVIC, GM muscle and tendon 
lengths, and GM CSA. 
 Paretic Limb Non-paretic Limb Control 
PF MVIC (Nm) 100 (57.2)*† 152 (49.9) 187 (26.9) 
DF MVIC (Nm) 17.5 (8.58) 21.3 (11.9) 20.8 (10.6) 
Resting GM length (cm) 24.5 (3.75) 26.8 (3.23) 25.7 (2.00) 
Resting tendon length (cm) 23.5 (2.67) 22.9 (2.29) 23.8 (2.50) 
Resting GM CSA (cm2) 12.0 (2.62)*† 15.0 (2.23) 16.2 (2.90) 
Control refers to individuals without neurological impairment. *Significant 
difference from non-paretic group (P < 0.05). †Significant difference from control 
group (P < 0.001). Data are expressed as mean (SD) 
 
4.4.1 Muscle properties 0-14 Nm 
Ankle angle at 14 Nm did not show a difference between any of the groups (P = 
0.602, Table 4.2) The passive displacement of the GM MTJ exhibited a curvilinear 
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relationship with torque, but no interaction was identified between torque and 
group in terms of displacement between 0-14 Nm (P = 0.863, Figure 4.2). This 
was confirmed as GM muscle stiffness was not different between any of the 
groups (P = 0.169, Table 4.2). When passive displacement of the MTJ was made 
relative to GM muscle length, there was no group-by-torque interaction throughout 
the passive stretch (P = 0.965, Table 4.2). However, when passive torque was 
made relative to the GM CSA, a torque-by-group interaction was detected (P < 
0.0005, Table 4.2). Pairwise comparisons showed no difference between the non-
paretic limb and individuals without neurological impairment (P = 1.000). The 
passive torque relative to the paretic GM CSA was greater than the non-paretic 
limb (P < 0.0005) and the GM of individuals without neurological impairment (P < 
0.0005) at each 2 Nm torque increment from 2-14 Nm. The elastic modulus of the 
paretic muscle was over 2-fold greater than the non-paretic muscle (P = 0.002) 
and muscle of individuals without neurological impairment (P = 0.002, Figure 4.3). 
However, there was no difference between non-paretic limb and individuals 
without neurological impairment (P = 1.000, Figure 4.3).   
 
79 
 
 
Figure 4.2. Passive torque displacement relationship in paretic (open squares) and 
non-paretic (closed squares) limbs and in the control group (closed triangles). 
Data are expressed as mean (SD). 
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Table 4.2. Passive properties of the GM during a passive stretch from 0-14 Nm. 
 Paretic Limb Non-paretic Limb Control 
GM muscle stiffness (Nm.cm-1) 13.5 (7.09) 9.98 (2.48) 10.7 (2.12) 
GM MTJ displacement (cm) 1.22 (0.38) 1.47 (0.25) 1.37 (0.30) 
Ankle angle (deg) -1.84 (4.27) -3.40 (4.02) -1.84 (4.21) 
GM MTJ displacement/Lm (%) 5.19 (1.97) 5.57 (1.23) 5.38 (1.37) 
Torque/GM CSA (Nm.cm-1) 1.66 (0.27)*† 0.96 (0.14) 0.88 (0.16) 
Elastic modulus (Nm.cm-2) 0.39 (0.21)‡§ 0.18 (0.05) 0.17 (0.06) 
Control refers to individuals without neurological impairment and Lm = muscle 
length. *Significant difference from non-paretic group (P < 0.001). †Significant 
difference from control group (P < 0.001). ‡Significant difference from non-paretic 
group (P < 0.005). §Significant difference from control group (P < 0.005). Data are 
expressed as mean (SD). 
 
4.4.2 Muscle properties at end ROM 
No group differences in ankle angle at end ROM (P = 0.527) and passive torque 
(P = 0.874, Table 4.3). Passive GM displacement and stiffness were not different 
between groups (P = 0.385 and P = 0.462, respectively, Table 4.3). No difference 
was identified for in vivo strain between paretic limb, non-paretic limb and 
individuals without neurological impairment (P = 0.973), though in vivo stress was 
different between the groups (P = 0.006, Table 4.3). Subsequently, no differences 
in stress were identified between the non-paretic limb and individuals without 
neurological impairment (P = 1.000). However, the stress to which the paretic 
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muscle was subjected was 46% larger than the non-paretic muscle (P = 0.015) 
and muscle of individuals without neurological impairment (P = 0.015), 
respectively. The elastic modulus of the paretic muscle was 47% and 48% greater 
than the non-paretic muscle (P = 0.006) and that of individuals without 
neurological impairment (P = 0.003), respectively. No difference in elastic modulus 
was identified between paretic muscle and individuals without neurological 
impairment (P = 1.000).   
  
Throughout the passive stretch, no EMG recording from GM or the TA exceeded 
3% maximal activity across all groups. The average activity calculated at 25, 50, 
75 and 100% of the passive stretch were below 2% with no between-group effect 
identified (GM activity; P = 0.549 and TA; P = 0.746), indicating that the stretch 
trials were passive and not influenced by reflex contractions (Table 4.3).  
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Figure 4.3. GM MTJ displacement relative to resting muscle length (strain) at 0 
deg and passive torque relative to GM CSA (stress) in paretic (open squares) and 
non-paretic (closed squares) limbs, and in the control group (closed triangles). 
Data are expressed as mean (SD). 
 
  
83 
 
Table 4.3. Passive properties of the GM at end ROM and average muscular 
activity of the agonist and antagonist throughout the passive stretch. 
 Paretic Limb Non-paretic Limb Control 
GM muscle stiffness (Nm.cm-1) 20.2 (8.70) 16.9 (5.67) 18.8 (5.50) 
GM MTJ displacement (cm) 1.73 (0.50) 1.96 (0.33) 1.94 (0.56) 
Ankle angle (deg) -8.34 (5.70) -11.9 (4.49) -11.6 (7.59) 
Passive torque (Nm) 35.6 (16.6) 33.5 (12.5) 37.0 (18.4) 
Average GM EMG (%) 0.48 (1.18) 0.09 (1.54) 0.62 (0.53) 
Average TA EMG (%) 0.69 (2.53) 1.16 (1.92) 0.59 (0.56) 
GM MTJ displacement/Lm (%) 7.41 (2.98) 7.42 (1.62) 7.63 (2.50) 
Torque/GM CSA (Nm.cm-1)  4.26 (2.28)*† 2.29 (0.94) 2.28 (0.95) 
Elastic modulus (Nm.cm-2) 0.58 (0.21)‡§ 0.31 (0.05) 0.30 (0.06) 
Control refers to individuals without neurological impairment and Lm = muscle 
length. *Significant difference from non-paretic group (P < 0.05). †Significant 
difference from control group (P < 0.05). ‡Significant difference from non-paretic 
group (P < 0.01). §Significant difference from control group (P < 0.005). Data are 
expressed as mean (SD) 
 
4.5 Discussion 
The main findings of the present study show that ankle ROM, passive stiffness 
and MTJ displacement values of the paretic GM were not different from the 
contralateral non-paretic limb or the limb of individuals without neurological 
impairment. When these passive properties were expressed relative to structural 
84 
 
measurements of the GM muscle (i.e. GM CSA and muscle length), stress was 
found to be significantly higher at 14 Nm and end ROM. Additionally, the elastic 
properties of the paretic GM muscle, as measured by elastic modulus, were 
approximately double that of the non-paretic and control GM muscles at 14 Nm 
and end ROM. We also observed that there was minimal EMG activity throughout 
all passive trials (consistent with others at these velocities (Gajdosik et al. 2005; 
Morse 2011; Morse et al. 2008a)), therefore the data obtained from the GM is 
primarily due to the elastic properties of the muscle rather than additional neural 
influences. 
 
The limited ROM around a joint or group of joints is a defining clinical 
characteristic of CP (Alhusaini et al. 2010; Vaz et al. 2006) and ROM is a common 
indicator of flexibility in athletes (Dadebo et al. 2004). In contrast to previous 
reports (Alhusaini et al. 2010; Barber et al. 2011a; Vaz et al. 2006), no differences 
were observed between the paretic limb and individuals without neurological 
impairment in the present study. Furthermore, no difference in ROM between the 
paretic and non-paretic ankle of physically active adults with SCP was observed. 
In the paretic limb and that of individuals without neurological impairment, it is 
likely that this is due to the active nature of the participants. However, a single 
measure of ROM does not provide information on the passive properties of the 
MTU due to subjective influences such as stretch tolerance (Magnusson et al. 
1996a; Toft et al. 1989). Therefore, in order to understand how the elastic and 
contractile components behave individually, ultrasonography should be used 
throughout a passive stretch protocol to assess the angle/torque-displacement 
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relation as conducted previously in individuals without neurological impairment 
(Kay and Blazevich 2009; Morse 2011; Morse et al. 2008a). 
 
By assessing the torque-displacement relation it is possible to monitor not only the 
displacement of the GM MTJ or passive torque throughout a passive stretch, but 
also calculate passive muscle stiffness (Kay and Blazevich 2009; Morse 2011; 
Morse et al. 2008a). Muscular stiffness provides information on the elastic 
properties of the muscle in vivo and could be used as a monitoring tool by coaches 
and clinicians throughout training cycles to assess how the muscle responds to 
various interventions. Contrary to the hypothesis, no difference in GM MTJ 
displacement, passive torque or GM stiffness was identified between the paretic, 
non-paretic and the muscle of individuals without neurological impairment at 14 
Nm and end ROM; indicating similar passive muscle properties when compared to 
the individuals without neurological impairment in the present study. It should be 
noted, however that GM stiffness at end ROM may be highly variable measure as 
reported in Chapter 3. Nevertheless, previous data on the torque-angle relation in 
children with CP reported by Vaz et al. (2006) and Alhusaini et al. (2010) found 
that MTU stiffness was significantly higher than aged matched controls without 
neurological impairment. Although MTU stiffness was not directly examined in the 
present study, no difference was found between torque or ankle ROM at 14 Nm 
and end ROM in the paretic and non-paretic limbs, and individuals without 
neurological impairment. As muscle activity was not reported in the 
aforementioned studies, the subsequent contrast in findings between the present 
study may be due to the increased passive velocity at which the participants were 
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passively stretched, which in turn may heighten neuromuscular stretch reflex 
responses in individuals with spasticity (Sheean 2002).  
 
Whilst using ultrasonography and contrary to the present findings, Barber et al. 
(2011a) found that MTU stiffness was higher in a group of young adults with SCP 
as a result of an inability of the fascicles to elongate throughout a passive stretch 
trial when compared to age-matched controls without neurological impairment. It is 
likely, however, that the heterogeneous nature of the age and gender of the 
participants reported by Barber et al. (2011a) can account for some of the 
difference in the observed results from the present study. For example, it is known 
that gender influences the passive properties of the MTU, with stiffer MTU in 
males compared to females (Morse 2011). Furthermore maturation has been 
shown to influence the elastic properties of the MTU (O'Brien et al. 2010b). 
Additionally, these differences between the present study and previous findings in 
passive muscle extension and MTU properties may be due to the regular 
engagement in physical activity and flexibility training completed by the present 
cohort of adults with SCP as part of their training regime. It is well documented 
that various stretch interventions facilitate improvements in joint end ROM and 
passive muscle/MTU stiffness in individuals without neurological impairment 
(Bressel and McNair 2002; Brouwer et al. 2000; Kay and Blazevich 2009; Morse et 
al. 2008a). Physically active adults with SCP regularly partake in such stretch 
activities as an integral part of their training regime. Indeed stretching in individuals 
with SCP not only make the passive properties of the muscle similar to individuals 
without neurological impairment, but increasing passive MTU compliance has 
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been associated with improved gait in individuals with spasticity (Dietz et al. 1981). 
As no difference in ROM was observed between the paretic limb, non-paretic limb 
and that of individuals without neurological impairment in the present study, the 
training interventions that they regularly complete may have a facilitative effect on 
the passive muscle properties. 
 
Although muscle stiffness, in absolute terms was not found to be different between 
the groups, when the dimensions of the GM were used to calculate in vivo stress 
and strain; the elastic modulus of the paretic muscle demonstrated stiffer passive 
properties than the non-paretic muscle and muscle of individuals without 
neurological impairment at 14 Nm and end ROM. As no difference in strain was 
identified, the observed increase in elastic modulus must be due to the increased 
stress the GM is subjected to during the passive stretch. Moreover, this increased 
in vivo stress in the paretic muscle results from the smaller GM CSA, as there 
were no differences between passive torque at end ROM. As the smaller CSA of 
the paretic muscle is required to dissipate the same amount of torque as that of 
the non-paretic muscle and that of individuals without neurological impairment; this 
could perhaps increase the risk of injury to the MTU, though no published 
information is currently available which assess the prevalence of injury in 
individuals with SCP. 
 
It is evident from the present findings that the dimensions of the GM have an effect 
on the elastic modulus properties. Magnusson et al. (1997) found that larger CSAs 
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correlated with increases in passive muscle stiffness in individuals without 
neurological impairment. However, the present findings show that when calculated 
relative to CSA, paretic muscle is significantly less elastic than the non-paretic 
muscle and that of individuals without neurological impairment. The fact that a 
difference in elastic properties remains when CSA is accounted for, may reside at 
the single fibre level. Based on single fibre data, it is possible that shorter and 
stiffer sarcomeres (Friden and Lieber 2003), and a larger proportion of 
extracellular matrix tissue (Lieber et al. 2003), contributed to the increased elastic 
modulus observed in the current SCP population. However, further research is 
required to identify whether the previously reported differences in single muscle 
fibre stiffness and extracellular matrix tissue influence the elastic properties 
specifically in the paretic GM of physically active individuals with SCP. 
 
In order to assess the passive properties of the muscle, neural (McNair and 
Stanley 1996; O'Dwyer et al. 1996) and mechanical factors (Friden and Lieber 
2003; Morse 2011; Morse et al. 2008a) have been suggested to affect the 
contractile component under passive stretch conditions. As the activity of the GM 
and TA muscles were 2 and 3%, respectively in the present study, it is unlikely that 
neural activation of the agonist or coactivation of the antagonist muscles 
confounded the passive properties of the muscle whilst the GM was passively 
stretched at 1 deg.s-1. Gajdosik et al. (2005) defined that if the muscle activity 
levels during the passive stretch did not exceed 5%, the neural responses of the 
stretch were deemed negligible, in which the data presented in the present study 
conforms to. As a result of neuromuscular activity being minimal, it can be 
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assumed that the stretch was passive and not confounded by spasticity or stretch 
reflexes. Thus, one may argue that the results in the present study are due to 
mechanical factors intrinsic to the GM.  
 
4.6 Conclusion 
Individuals with SCP are commonly defined by their limitations in joint ROM, 
whereas in the present physically active population no such impairment in ROM 
was observed, providing additional in vivo data to the clinical definition of the SCP. 
However, when the smaller CSA of individuals with SCP was accounted for, the 
passive stress of the muscle was significantly higher than the contralateral non-
paretic muscle and the muscle of individuals without neurological impairment. In 
this particular physically active SCP population it is possible that their regular 
training may have facilitated these observed findings.  
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Chapter 5 
 
Muscle size, activation and coactivation in 
adults with spastic cerebral palsy 
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5.1 Abstract 
Introduction. Muscle weakness is present in the paretic limbs of individuals with 
spastic cerebral palsy (SCP). This study aims to determine what neuromuscular 
factors contribute to weakness in adults with SCP during maximal voluntary 
isometric contractions (MVIC).  
Methods. Gastrocnemius anatomical cross-sectional area (ACSA), agonist and 
antagonist activation were measured in 11 SCP and 11 control adult males during 
plantarflexion MVIC.  
Results. Plantarflexion MVIC torque of the paretic leg was 42% and 52% less 
than the non-paretic and control limbs, respectively. The paretic gastrocnemius 
ACSA was smaller than the control group only. Paretic agonist activation was less 
than the non-paretic and control groups, whereas antagonist coactivation was 
higher. Multiple regression analysis revealed muscle activation accounted for 57% 
of variation in paretic plantarflexion MVIC torque.  
Conclusion. This demonstrates that in individuals with SCP, muscle weakness in 
the paretic limb is primarily attributed to impaired neural activation, and to a lesser 
degree ACSA. 
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5.2 Introduction 
Individuals with spastic cerebral palsy (SCP) often suffer with a number of 
impairments including impaired and muscle weakness, particularly in the paretic 
muscles (Chapter 4). The maximum voluntary isometric contraction (MVIC) torque 
generated in this population has regularly been reported to be less in the paretic 
muscle when compared to controls without neurological impairment (Elder et al. 
2003; Stackhouse et al. 2005) or the non-paretic leg of hemiplegic children (Elder 
et al. 2003). Muscle weakness in individuals with SCP occurs primarily as a result 
of a non-progressive lesion to the brain, impairing cortical input into the 
descending neural signalling pathways to the muscle, resulting in secondary 
adaptations in the muscle (Ito et al. 1996; Koman et al. 2004; Lieber et al. 2003; 
Malaiya et al. 2007; McNee et al. 2009; Mohagheghi et al. 2007). These 
secondary adaptations which could contribute to weakness in SCP include smaller 
muscle size, reduced agonist muscle activation and/or changes in patterns of 
coactivation (Chapter 2).  
 
The size of the muscle in the paretic limb of children with SCP has consistently 
been shown to be smaller when compared to the muscles of the non-paretic limb 
(Mohagheghi et al. 2007) and that of individuals without neurological impairment 
(Malaiya et al. 2007). Smaller muscle sizes have previously been correlated with 
decreased strength in elderly populations without neurological impairment and 
children with SCP (Elder et al. 2003; Morse et al. 2004), however no such 
relationship has been identified specifically in adults with SCP. Increases in 
muscle strength with resistance training have been attributed to a corresponding 
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increase in size in the paretic muscle (McNee et al. 2009), with subsequent 
improvements being identified in functional performance in children (Blundell et al. 
2003; Damiano and Abel 1998; Dodd et al. 2003) and adults with SCP (Andersson 
et al. 2003). Although understanding the force generation capabilities of children 
with SCP is fundamental to addressing clinical manifestations such as muscle 
weakness, its applicability to adult cohorts may be considered limited. Previous 
findings in individuals without neurological impairment have shown that adult 
males have a larger muscle size, accounting for 75% of MVC torque, when 
compared to prepubescent boys (O'Brien et al. 2010a). Additionally, the ability of 
prepubescent children with SCP to exert maximal force reliably has been 
questioned (Sanger et al. 2003; Verschuren et al. 2008; Ayalon et al. 2000; Allen 
et al. 1995; Taylor et al. 2004). This may be due to their level of maturation, lack of 
understanding of the requested instruction and/or inability to recruit the required 
motor units to exert a MVC (Stackhouse et al. 2005). Nevertheless, a recent study 
assessing the torque-length relationship of the plantarflexion (PF) muscles in an 
older SCP population ranging from 15-21 years reported lower torque values 
across the available range of motion in the paretic limb when compared to 
individuals without neurological impairment (Barber et al. 2012), These findings 
are consistent with those studies completed in children populations (Elder et al. 
2003; Stackhouse et al. 2005), though the reasons for these differences have yet 
to be assessed in adult SCP populations. 
 
In addition to muscle size being a determinant of strength, the neural factors 
including activation and coactivation may also have an effect. During maturation of 
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children with SCP there are no reported alterations to the brain lesion (Koman et 
al. 2004). However, clinical manifestations, such as motor function that was 
assessed by the Gross Motor Function Classification System, are reported to 
change throughout maturation, depending on the individuals gross motor function 
classification (Hanna et al. 2009). This may suggest that adaptations in the 
muscle-tendon unit may occur or even change in response to the altered neural 
signalling pathways. In order to assess whether individuals are able to fully 
activate all of their motor units in vivo, an electrical stimulation is superimposed 
onto the muscle during an MVC (Bampouras et al. 2006; Stackhouse et al. 2000). 
Such studies have previously been performed in children with SCP, which 
identified that there was approximately 50% less activation in the paretic 
gastrocnemius when compared to individuals without neurological impairment 
(Elder et al. 2003; Stackhouse et al. 2005), but no difference was identified when 
compared to the non-paretic gastrocnemius (Elder et al. 2003). Another factor that 
has been associated with muscle weakness is the increased coactivation of the 
paretic antagonist muscles (Ikeda et al. 1998), which has regularly been 
demonstrated to contribute to muscle weakness of the gastrocnemius in 
individuals with SCP (Elder et al. 2003; Stackhouse et al. 2005). As children with 
CP are suggested to typically live a sedentary lifestyle (Longmuir and Bar-Or 
2000), the data presented in these previous studies may not apply to physically 
active adults with SCP who as a consequence may have lower levels of antagonist 
coactivation. 
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In children with SCP, it is evident that neural and muscular factors contribute 
towards the force generation limitations of the paretic muscle. Although chapter 4 
highlighted that the paretic maximal gastrocnemius torque was lower than the non-
paretic limb and control individuals without neurological impairment, no such 
information currently addresses whether similar neuromuscular limitations exist in 
adults with SCP, particularly where issues of sedentary lifestyle are controlled. 
Therefore, the aim of present study was to identify the magnitude of weakness and 
to assess whether muscle size, agonist activation and/or antagonist activation are 
responsible for these deficits in physically active adults with SCP. We 
hypothesised, that, even with elevated habitual physical activity, the size of the 
paretic muscle would be lower in relation to individuals without neurological 
impairment. Additionally it was also hypothesised lower agonist activation and 
higher antagonist coactivation during PF MVIC in the paretic limb of adults with 
SCP.  
 
5.3 Methods 
5.3.1 Subjects 
Eleven ambulant males with hemiplegic SCP (age = 21.2 (3.0) years, stature = 
1.79 (0.10) m, mass = 70.0 (12.5) kg) and 11 males without neurological 
impairment (age = 21.8 (2.2) years, stature = 1.81 (0.04) cm, mass = 79.0 (8.4) kg) 
volunteered to participate in the study after written informed consent was obtained. 
All participants with SCP had been classified by physical therapists from the 
Cerebral Palsy International Sports and Recreation Association (CPISRA). All 
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participants, SCP and individuals without neurological impairment self-reported as 
undertaking 3-5 hours of sport-based exercise per week and did not partake in any 
structured resistance training regime. The entire cohort involved in the study was 
free from lower limb injury and had not received any form of medication to reduce 
the effects of spasticity within the last year. The study conformed to the standards 
set by the latest revision of the Declaration of Helsinki and the local ethics 
committee at Manchester Metropolitan University. Both the paretic and non-paretic 
legs were tested in each participant with SCP, whereas the dominant limb was 
assessed in the control participants. 
 
5.3.2 Protocol   
Participants attended the laboratory on two occasions. During the first visit, 
familiarisation was carried out which included a series of six PF MVIC followed by 
a series of submaximal percutaneous electrical stimulations. During the second 
visit, participants were assessed for resting measures of muscle size, which were 
then followed by the MVIC testing procedures. 
 
5.3.3 Strength measurements   
Participants were secured to an isokinetic dynamometer (Cybex Norm, Cybex 
International Inc., NY, USA) in a seated position with the back angle reclined at 65 
deg (Chapter 3 and 4), prior to the commencement of MVC trials. The participant’s 
knee was secured in full extension with Velcro straps, which were positioned 
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proximal to the knee. The medial malleolus was visually aligned with the 
dynamometer’s central axis of rotation and two Velcro straps were used to secure 
the foot to the footplate in order to minimise heel displacement. The participant’s 
hips were also secured to the seat to limit extraneous movement during PF MVIC 
trials. All participants warmed up by performing three submaximal isometric 
contractions at 0 deg (the individual’s anatomical zero), each of which were 
separated by a 1 min rest period. In this instance, 0 deg was defined as the foot at 
a 90 deg to the tibia. Two out of the 11 participants with SCP could not achieve the 
described 0 deg in the paretic leg as their heel did not rest on the ground during 
anatomical stance. In these two cases, 0 deg was calculated by using a 
goniometer to quantify how much their resting ankle angle differed and an 
appropriate correction was measured on the isokinetic dynamometer. Ankle angle 
was corrected by 10 and 7 deg in the two participants. According to Narici et al. 
(1996), fascicle length would have been underestimated by 4 and 3 mm, 
respectively, in each of these individuals based on changes in GM fascicle length 
relative to ankle angle in individuals without neurological impairment. Although it is 
not clear whether the length changes are different between individuals with SCP 
equinus gait and those without, it is impossible to add a correction factor to two 
individuals. Furthermore, the error in the estimation in fascicle length change 
between the two angles is so small that it is not likely to make a difference to the 
mean data obtained.  After the warm up, the participant’s ankle remained fixed at 0 
deg where two PF MVICs were obtained, separated by a 1 min rest period. 
Dorsiflexion (DF) MVIC was completed using the same testing posture and 
protocol to assess PF MVIC in order to calculate coactivation of the tibialis anterior 
(TA).  
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5.3.4 Voluntary muscle activation 
To quantify the participants’ ability to voluntary activate the PF muscles during 
MVIC, percutaneous stimuli (DSVDigitimer Stimulator; Digitimer, Herts., UK) were 
applied to the gastrocnemius using rubber stimulation pads (size ranging from 38 
mm x 89 mm to 76 mm x 127 mm; Versastim; Conmed, NY, USA). The two 
stimulation pads were placed transversely distal to the popliteal crease and 
proximal to the myotendinous junction of the soleus. The amplitude of the stimuli 
was determined prior to interpolation whilst the participant was in a relaxed state; 
administering twitches starting from 50 mA and increasing in increments of 50-100 
mA, until no further increase in twitch torque was elicited. Two supramaximal 
stimuli were applied to assess the activation capacity of the gastrocnemius. The 
first twitch was applied once a plateau in maximal torque had been reached and 
the second twitch was initiated approximately 2 s after the first twitch, once resting 
torque values (0 Nm) were attained. All participants were instructed to relax 
immediately after the first twitch. Throughout all MVC trials, participants were 
verbally encouraged to exert as much force as possible. The voluntary activation 
level of each participant was assessed using the trial that produced the highest 
contractile torque and was calculated using the following equation: percentage 
activation = [1 – (superimposed stimulus torque / post MVC stimulus torque)] x 100 
(Allen et al. 1995; Bampouras et al. 2006; Harridge et al. 1999; Morse et al. 2004).  
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It is well reported that an increased number of twitches superimposed decreases 
the variability of the data obtained when assessing muscle activation in healthy 
individuals (Bampouras et al. 2006; Suter and Herzog 2001), though this finding is 
not always consistent (Behm et al. 1996). Nevertheless, during the familiarisation 
sessions, the participants with SCP were blind tested on their reaction to 
superimposed twitches and doublets and the majority of the participants 
commented that the doublet stimuli were ‘unbearable’ compared to the twitch 
procedure. Resultantly, in order to obtain agonist activation data from the 
participants with SCP twitches stimuli were used. 
 
5.3.5 Coactivation 
During MVIC trials, TA electromyography (EMG) activity was recorded using two 
pre-gelled, unipolar, 10-mm, Ag-AgCl percutaneous electrodes (Medicotest, 
Denmark). Boundaries of the TA were determined using ultrasonography to 
ensure the accurate placement of each electrode along the mid sagittal axis of the 
muscle and to reduce cross-talk. Two electrodes were placed at two thirds of the 
TA length and one reference electrode was placed over the lateral epicondyle of 
the femur. The area where the electrodes were positioned was shaved and 
cleaned with an alcohol swab to remove residual skin cells and oils, as well as 
reduce skin impedance. Raw EMG data were recorded at 2000 Hz, with band 
pass filter set at 10-500 Hz, and a notch at 50 Hz. The integral of the root mean 
square of the raw signal 0.5 s either side of the MVC PF torque was used to 
quantify the level of muscle coactivation. Coactivation was calculated as: 
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percentage coactivation = (TA activity during PF MVC / TA activity during DF 
MVC) x 100 (Klein et al. 2001; Morse et al. 2004).  
 
5.3.6 Anatomical cross sectional area 
Several axial-plane images of the gastrocnemius medialis and lateralis were 
obtained using B-mode ultrasonography to estimate gastrocnemius anatomical 
cross-sectional area (ACSA; Reeves et al. 2004a), across the greatest width of the 
muscle. The gastrocnemius medialis and lateralis proximal insertion and the 
myotendinous junction were marked. An axial line was then marked from the 
medial to lateral border of the gastrocnemius, perpendicular to the insertion and 
the myotendinous junction, which marked the path where the axial images would 
be obtained. Strips of Micropore tape were placed axially across the line of the 
gastrocnemius at approximately 3.5 cm intervals. These strips of tape were used 
as echo-absorptive markers that project a shadow onto the ultrasound image to 
provide a positional reference into the scanned structures. With the probe in an 
axial-plane, a recording of the probe moving from the lateral border of the 
gastrocnemius lateralis to the gastrocnemius medialis medial border was obtained. 
Individual images were extracted from the recording offline and used to construct 
the muscle by overlapping anatomical landmarks and external markers. Image J 
software (version 1.34; National Institutes of Health) was used to measure the 
CSA of the constructed gastrocnemius medialis and lateralis to determine 
gastrocnemius ACSA.  
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5.3.7 Statistics 
All statistical analyses were performed using SPSS software (Version 18, SPSS 
Inc., Chicago Illinois). The Shapiro-Wilk and Levene’s tests were utilised to assess 
the normality and variance of the data. As there were no breaches of these 
statistical assumptions, and to avoid a type I error (as could occur with repeated 
ANOVA tests), a MANOVA was used to compare the differences in: PF MVIC 
torque, agonist activation, gastrocnemius ACSA, antagonist coactivation, PF MVIC 
torque relative to body mass and PF MVIC torque relative to gastrocnemius ACSA 
variables of the paretic vs. non-paretic limbs vs. the dominant limb of individuals 
without neurological impairment (the latter which will be referred to as the control 
group herein). Pearson correlations were used to examine the level of association 
between all of the assessed variables, with corrections for multiple associations. A 
stepwise multiple regression was used to predict paretic limb PF MVIC torque from 
gastrocnemius ACSA, agonist activation and antagonist coactivation. In addition, a 
second multiple linear regression to predict PF MVIC torque, where data across all 
groups were pooled, was used to determine whether an equation that incorporates 
gastrocnemius ACSA, experimental group, agonist activation and antagonist 
coactivation, would realise a stable regression model. In addition, independent t-
tests were used to assess baseline anthropometric data between SCP and control 
groups. Statistical significance was accepted at the P < 0.05 level, moreover, 
exact P-values are reported unless P < 0.001. Effect size is reported as partial eta 
squared (pε2) and data are presented as the mean (SD). It has been suggested 
that pε2 effect sizes for an ANOVA range from; small effects < 0.1, medium effects 
ranging from 0.1-0.25; and large effects > 0.4 (Portney and Watkins 1997). 
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5.4 Results 
Adults with SCP and matched controls without neurological impairment were of 
similar age (P = 0.575), stature (P = 0.604) and body mass (P = 0.061).  
 
5.4.1 MVC torque and gastrocnemius ACSA 
The PF MVIC differed between groups (P < 0.001, pε2 = 0.461). Post-hoc pairwise 
comparisons (Figure 5.1) showed that the paretic limb PF MVIC torque was 52% 
less than the controls (P < 0.001) and 42% less than the non-paretic limb (P = 
0.007). No difference in PF MVIC torque was identified between the control group 
and non-paretic limb (P = 0.334, Figure 5.1). Furthermore, no differences were 
identified in DF MVIC torque between groups (P = 0.653, pε2 = 0.028, Figure 5.1). 
 
Gastrocnemius ACSA differed between groups (P = 0.004, pε2 = 0.306). Post-hoc 
pairwise comparisons showed that the paretic muscle was 20% smaller than that 
of the control group (P = 0.004, Table 5.1). There were no differences between the 
paretic and non-paretic muscle (P = 0.054, Table 5.1), or between the control 
group and non-paretic muscle (P = 0.925). 
 
When MVIC PF torque was considered relative to the ACSA of the gastrocnemius 
muscle, differences existed between groups (P = 0.001, pε2 = 0.376). Post-hoc 
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pairwise comparisons (Table 5.1) revealed that PF MVC torque relative to ACSA 
in the paretic limb was 44% less than the control group (P = 0.001) and 34% lower 
than the non-paretic limb (P = 0.027). There was no difference between the control 
group and non-paretic limb (P = 1.000). Similarly, when PF MVIC torque was 
considered relative to body mass, there were again between-group differences (P 
= 0.001, pε2 = 0.396). Post-hoc comparisons (Table 5.1) showed that PF MVIC 
torque relative to body mass in the paretic limb was 46% and 42% less than the 
control group (P = 0.001) and non-paretic limb (P = 0.005), respectively. There 
was no difference between the control group and non-paretic limb (P = 1.000).  
 
 
Figure 5.1. Gastrocnemius PF and TA DF MVIC torque. *Difference between 
paretic and control groups (P < 0.001). †Difference between paretic and non-
paretic groups (P = 0.007). 
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Table 5.1. ACSA of the gastrocnemius, PF MVIC torque relative to gastrocnemius 
ACSA and PF MVIC torque relative to body mass in the paretic, non-paretic and 
control groups. 
*Difference between paretic and control groups (P = 0.004). †Difference between 
paretic and control groups (P < 0.001). ‡Difference between paretic and non-
paretic groups (P = 0.027). §Difference between paretic and non-paretic groups (P 
= 0.005). 
 
5.4.2 Voluntary muscle activation and coactivation 
There were differences between groups in terms of voluntary activation of the 
gastrocnemius muscle during the PF MVIC (P < 0.001, pε2 = 0.496). Post-hoc 
pairwise comparisons (Figure 5.2A) revealed that the paretic limb was 36% and 
39% less activated during an MVIC than the non-paretic limb (P < 0.001) and 
control group (P < 0.001), respectively. There was no difference between the 
control group and activation properties of the muscle in the non-paretic limb (P = 
1.000). 
 
Group Control  Paretic  Non-paretic  
Gastrocnemius ACSA (cm2) 25.9 (3.99) 20.7 (3.48)* 24.3 (2.75) 
MVC torque/Gastrocnemius ACSA 
(Nm.cm-2) 
6.65 (1.56) 3.71 (1.85)†‡ 5.62 (1.37) 
MVC torque/Body mass (Nm.kg-1) 2.13 (0.45) 1.14 (0.66)†§ 1.97 (0.54) 
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The coactivation of the TA muscle during PF MVIC also differed between groups 
(P < 0.001, pε2 = 0.741). Post-hoc pairwise comparisons (Figure 5.2B) revealed 
that antagonist coactivation of the paretic muscle was over 3-fold greater when 
compared to the non-paretic limb (P < 0.001) and control group (P < 0.001). There 
was no difference between the control group and non-paretic limb (P = 1.000). 
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Figure 5.2. (A) Voluntary activation of the gastrocnemius during an isometric PF 
MVC. (B) Coactivation of the TA during an isometric PF MVC. *Difference between 
paretic and control groups (P < 0.001). †Difference between paretic and non-
paretic groups (P < 0.001). 
 
5.4.3 Correlations 
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The levels of associations between PF MVIC torque and the three candidate 
predictor variables (gastrocnemius ACSA, agonist activation and antagonist 
coactivation) in the paretic limb, non-paretic limb, control group and entire 
participant population are shown in Table 5.2. Gastrocnemius ACSA was 
positively associated with PF MVIC torque in the paretic limb (r = 0.650), non-
paretic limb (r = 0.702) and entire participant population (r = 0.688). Additionally, 
agonist activation was positively associated with PF MVIC torque in the paretic 
limb (r = 0.753), non-paretic limb (r = 0.631) and entire participant population (r = 
0.750). Neither gastrocnemius ACSA nor agonist activation were significantly 
associated with PF MVIC torque in the control group. Coactivation of the 
antagonist muscle was not associated with PF MVIC torque in either the paretic 
limb, non-paretic limb or control group. However a negative association was 
established between coactivation and PF MVIC torque in the entire participant 
population (r = -0.706). 
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Table 5.2. Level of association between gastrocnemius ACSA, agonist activation 
and antagonist coactivation in relation to PF MVIC torque.  
Group Control Paretic 
Non-
paretic 
Entire 
population 
Gastrocnemius ACSA (cm2) 0.224  0.650‖ 0.702‡ 0.688* 
Activation (%) 0.431  0.753† 0.631§ 0.750* 
Coactivation (%) -0.167  -0.568 -0.176  -0.706* 
Correlation with PF MVIC torque; *(P < 0.001), †(P = 0.007), ‡(P = 0.030), §(P = 
0.037), ‖(P = 0.016). 
 
5.4.4 Multiple regressions 
A multiple regression analysis was conducted to identify which variables are 
determinants of paretic PF MVIC torque. Gastrocnemius ACSA, agonist activation 
and antagonist coactivation in the regression model predicted torque (P = 0.020, r 
= 0.858, r2 = 0.736), but only agonist activation was a significant predictor variable 
(P = 0.043). When the regression was repeated in a stepwise manner, agonist 
activation was indeed the only predictor variable identified, explaining 57% of PF 
MVC torque in the paretic limb (P = 0.007, r = 0.753, as previously presented in 
Table 5.2). 
 
When all PF MVIC torque data were pooled together (from paretic limb, non-
paretic limb and control group), a regression model including all potential variables 
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was produced (P < 0.001, r = 0.848, r2 = 0.719), with agonist activation (P = 0.005) 
and gastrocnemius ACSA (P = 0.012) being determinants of PF MVIC torque. 
However, participant group (P = 0.143) and antagonist coactivation (P = 0.433) 
were not determinants of PF MVIC torque. When the analysis was repeated in a 
stepwise manner, only agonist activation (P < 0.001) and gastrocnemius ACSA (P 
= 0.001) were included in the model, explaining 69% of PF MVIC torque variation 
in the entire participant population (P < 0.001, r = 0.831). 
 
5.5 Discussion 
This is the first study to assess the neuromuscular properties of ambulant adults 
with SCP. The purpose of this study was to identify whether muscle ACSA, agonist 
activation and antagonist coactivation are different in the paretic limb, when 
compared to the non-paretic limb and control group when assessing PF MVIC 
torque. The main findings are that differences in PF MVIC torque, agonist 
activation and antagonist coactivation exist between the paretic limb when 
compared to the non-paretic limb and control group. The paretic gastrocnemius 
ACSA was smaller than the control group muscle, though no difference in size was 
observed between the paretic and non-paretic muscle. Gastrocnemius ACSA and 
agonist activation were found to be determinants of isometric PF MVIC torque 
across the entire participant population, whereas agonist activation was the only 
predictor of paretic limb PF MVIC torque.  
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The PF MVIC torque of the paretic limb generated 42% and 52% less torque than 
the non-paretic limb and control group, respectively; however no difference 
between the groups was identified when assessing DF MVIC torque. The average 
findings in DF MVIC torque in the present study is consistent with data reported in 
males aged 20-40 years at 0 deg, with torque measures ranging between 17 Nm 
to 26 Nm (van Schaik et al. 1994). This suggests that based on the DF MVIC 
torque in the paretic limb of individuals with SCP alone, it can be assumed that 
impairment in the TA is limited or negligible. However, it should be noted that van 
Schaik and colleagues (1994) reported that the optimal ankle angle for testing DF 
peak torque in relation to the force length relation is at 20 deg PF. Whether this 
data from individuals without neurological impairment applies to individuals with 
SCP has yet to be determined. Therefore, further research is required to address 
whether this is the optimal angle to assess DF strength in the paretic limb of men 
with hemiplegic SCP. In relation to PF MVIC torque in the present study, this data 
is consistent with previous findings assessing muscle weakness in the PF and 
quadriceps of children with SCP in comparison to the non-paretic limb and age 
matched controls without neurological impairment (Elder et al. 2003; Damiano et 
al. 2001; Stackhouse et al. 2005). This difference in findings may be due to 
individuals with SCP employing an avoidance strategy by becoming more 
dependent on their dominant side, perpetuating weakness in the paretic limb 
(Gage et al. 1995). Additionally, as the adults in the present study are active 
individuals, the difference in muscle strength between both limbs may be further 
exacerbated as a result of non-paretic limb dominance during exercise. 
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In the present study, the paretic limb was weaker than both the non-paretic limb 
and control group. Previous findings have reported 62% of the variability in PF 
MVIC torque to be due to differences in the gastrocnemius ACSA (Fukunaga et al. 
1996). Here a similar association between the gastrocnemius ACSA and PF MVIC 
torque in the paretic, non-paretic limbs and the entire participant population was 
identified. In agreement with the hypothesis, the paretic muscle of adults with SCP 
was 20% smaller than that of the control group. This finding is similar to that 
reported by Elder and colleagues (Elder et al. 2003), who showed that the paretic 
triceps surae ACSA in children with SCP was approximately 27% smaller than the 
control muscle of aged matched controls without neuromuscular impairment. They 
also reported no difference between paretic and non-paretic muscle ACSA, which 
is consistent with the findings from the present study. As there was a positive 
correlation between gastrocnemius ACSA and PF MVIC torque in the present 
study, it was expected that as PF MVIC torque was significantly different between 
the paretic and non-paretic limbs, gastrocnemius ACSA would also differ. 
However, this was not the case, suggesting that internal mechanical factors of the 
muscles may be different between the paretic and non-paretic limbs. This is 
reflected in the present data when the strength/size relationship is considered.  
 
When PF MVIC torque is considered relative to the ACSA of the gastrocnemius, 
the paretic limb torque was 56% and 66% less than the non-paretic limb and 
control group torque, respectively. This finding is consistent with previous data on 
children with SCP, where the paretic limb was approximately 56% of the non-
paretic limb and 60% of the control group (Elder et al. 2003). This decline in PF 
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MVIC torque relative to ACSA in the paretic limb is likely to be due to an 
overestimation of contractile material (Lieber et al. 2003; Urbanchek et al. 2001), 
or neural factors such as a reduction in agonist motor unit recruitment and/or an 
increase in antagonist muscle coactivation (Elder et al. 2003; Lieber et al. 2004; 
Stackhouse et al. 2005).  
 
Lieber et al., (2003) reported that paretic muscle biopsy samples contained 40% 
contractile tissue and the remaining tissue was composed of extracellular matrix. 
In contrast, in control children 95% was contractile tissue and only 5% extracellular 
matrix. Although these data were obtained from children with SCP, the present 
study concerns active adults with SCP who may have a more ‘normal’ muscle 
composition due to the regular physical exercise they undertake, and perhaps an 
increased muscle mass through hypertrophic adaptations too.  
 
The neural capabilities of the paretic triceps surae to fully activate motor units 
during a MVC is approximately 40% less in children with SCP when compared to 
control populations (Elder et al. 2003; Stackhouse et al. 2005). The present study 
reports similar observations with activation approximately 37% less in the paretic 
limb, when compared to the non-paretic limb and control group, which is in 
accordance with the hypothesis. This is likely to be due to the insult sustained to 
the brain, resulting in impaired efferent neurological signalling (Koman et al. 2004; 
Lieber et al. 2004), and sensory deficits within the paretic muscle which may 
impact on muscular weakness (Graham and Selber 2003). Although these 
113 
 
differences exist between the different groups, this study is the first to identify an 
association between PF MVIC torque and agonist activation in the paretic, non-
paretic limbs and the entire participant population. This association between PF 
MVIC torque and agonist activation in the paretic limb demonstrates that muscle 
weakness in SCP is linked with lower levels of voluntary motor unit recruitment 
during PF MVIC. 
 
The present study also identified that gastrocnemius ACSA was not associated 
with MVIC torque in the control group, which is contrary to previous research 
(Morse et al. 2004). It is apparent that the control group (torque = 167 (33.3) Nm) 
was more homogenous than the paretic (torque = 79.5 (46.6) Nm) and non-paretic 
(torque = 138 (42.9) Nm) limbs, which may provide some explanation to the non-
significant findings in the present study. In addition, the small participant cohort 
may also be a factor affecting the outcome, particularly when considered in 
conjunction with the relatively lower variation in data in the control group. Indeed 
when the entire testing cohort was assessed, a correlation was identified between 
gastrocnemius ACSA and MVIC torque.  
 
In support of the hypothesis, antagonist coactivation properties of the TA in the 
present study were approximately 3-fold higher in the paretic limb of adults, when 
compared to the non-paretic limb and control group. Previous reports in children 
with SCP showed that coactivation of the triceps surae was approximately 2-fold 
higher when compared to control populations (Elder et al. 2003; Stackhouse et al. 
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2005). The present study also identified an inverse association between PF MVIC 
torque and antagonist coactivation in the paretic limb and entire participant 
population. Such increases in coactivation have been previously suggested to act 
as a safety mechanism to increase joint stabilization and limit the degrees of 
freedom during gait in children with SCP (Damiano et al. 2000).  
 
Although antagonist coactivation of the TA was associated with PF MVIC torque 
and was found to have a large effect size when identifying differences between the 
paretic limb, non-paretic limb and control groups, it was found from the multiple 
regression that antagonist coactivation was not a significant predictor of PF MVIC 
torque. Previous findings have demonstrated that increased coactivation of the 
antagonist muscle has been associated with decreased MVIC torque in elderly 
individuals without neurological impairment (Macaluso et al. 2002). Although 
antagonist coactivation was not found to be a predictor of muscle torque, muscle 
activation and gastrocnemius ACSA were found to explain 69% of PF MVIC torque 
from the multiple regression assessing the entire participant population in the 
present study. The variables contributed to a large proportion of PF MVIC torque, 
though 31% of variation remains unexplained. In specific relation to the paretic 
limb and in contrast to the present findings across the entire participant population, 
agonist activation was the only predictor identified to influence PF MVIC torque. It 
was found to explain 57% of the variation in PF MVIC torque, which negates 
previous findings that imply that muscle ACSA has an impact on muscle MVC 
torque capabilities in the paretic muscle of individuals with SCP (Elder et al. 2003; 
Stackhouse et al. 2005), which is consistent with the clinical origins of the 
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impairment. Thus, gastrocnemius ACSA is not representative of the recruitable 
muscle mass in the paretic limb of individuals with SCP. As ACSA is not a 
determinant of paretic PF MVIC torque, it must be noted that measurement of the 
bi-pennate gastrocnemius ACSA underestimates the physiological CSA of the 
muscle (Narici et al. 1992). Therefore future research should assess the impact of 
fascicle pennation angle (Aagaard et al. 2001), muscle fascicle length 
(Mohagheghi et al. 2007), and moment arm of the tendon (Maganaris et al. 2000), 
on PF MVIC torque.  
 
The present study shows that agonist activation during PF MVIC in the paretic limb 
accounts for over half of the variation in torque.  Specifically in adults with SCP an 
inability to successfully recruit the agonist muscle contributes significantly to the 
weakness observed in this population.  It is likely that the capacity to improve 
strength from a structured training regime in individuals with SCP may be 
accentuated through improvements in activation capacity to a greater degree than 
unimpaired individuals who experience minimal agonist activation impairments. 
Therefore one of the primary implications for development of muscle strength in 
individuals with SCP is a resistance training program that emphasises the 
recruitment (i.e. neural factors) of the agonist muscle over and above muscle 
hypertrophy. In adults without neurological impairment, the improvement in agonist 
activation with training is accentuated in heavy load resistance training programs 
(Häkkinen et al. 1998; Higbie et al. 1996), however whether such findings are 
applicable to SCP populations needs to be determined. 
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5.6 Conclusion 
The findings from the present study demonstrate that active adults with hemiplegic 
SCP have muscle weakness as a result of muscular and neural differences in the 
paretic limb. This was confirmed as PF MVIC torque was on average 47% weaker 
than the non-paretic limb and control group. The paretic gastrocnemius ACSA was 
smaller compared to the control group, though no difference was observed 
between paretic and non-paretic limbs. The paretic limb demonstrated an inability 
to innervate the PF muscles and increased antagonist coactivation was also 
evident when compared to the non-paretic limb and control group. Although these 
differences between the paretic limb and control group were identified, the multiple 
regression on the paretic limb identified that muscle activation is a significant 
predictor of gastrocnemius PF MVIC torque. This demonstrates that the key 
determinant of weakness in individuals with SCP is their ability to activate the 
gastrocnemius muscle, regardless of the differences identified in paretic 
gastrocnemius ACSA and antagonist coactivation.   
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Chapter 6 
 
Gastrocnemius medialis specific force of 
adults with spastic cerebral palsy 
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6.1 Abstract 
Introduction. Muscle weakness has become synonymous with the paretic 
muscles of individuals with spastic cerebral palsy (SCP). The aim of the present 
study was to establish whether the specific force of the paretic muscle was similar 
to the non-paretic and dominant muscle of individuals without neurological 
impairment.  
Methods. The physiological cross sectional area and specific force of the 
gastrocnemius medialis (GM) were assessed in both paretic and non-paretic legs 
of 11 physically active men with SCP, and the dominant limb for 11 age-matched 
individuals without neurological impairment. GM fascicle force was calculated from 
the plantarflexion isometric maximal voluntary contraction (MVIC) torque with 
interpolated singlet stimuli, whilst moment arm length (estimated from tendon 
excursion), muscle architecture (measured using ultrasonography) and antagonist 
coactivation (estimated from electromyography) were all accounted for. 
Physiological cross sectional area (PCSA) was estimated as GM volume divided 
by fascicle length. Specific force was calculated as fascicle force divided by PCSA. 
Results. Paretic fascicles were 28% longer than that of the control group. 
Pennation angle of the paretic GM was 31% smaller than the non-paretic limb and 
41% smaller than the control group. PCSA of the paretic GM was 41% and 47% 
smaller than the non-paretic and control group, respectively. No difference was 
identified in GM specific force between the groups when accounting for neural 
differences, however, paretic GM fascicle force was 41% less than the non-paretic 
limb and 52% lower than the control GM fascicle force. 
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Conclusion: Based on the difference in findings between the paretic GM fascicle 
force and specific force, contractile weakness is not due to the intrinsic properties 
of the muscle being impaired. Therefore the deficit in strength in relation to the 
material properties of the contractile tissue in the paretic limb of active individuals 
with SCP is due to decreased muscle PCSA.  
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6.2 Introduction 
Muscle weakness (as presented in Chapter 5) in individuals with spastic cerebral 
palsy (SCP) have been shown to originate from impaired neural signalling to the 
paretic muscle, consequently impacting on muscular size and architecture (Elder 
et al. 2003; Malaiya et al. 2007; Mohagheghi et al. 2007; Stackhouse et al. 2005). 
Such weakness of the paretic muscles have been shown to contribute to 
differences in gait patterns (Damiano and Abel 1998), and limit motor control 
performance (Damiano et al. 1995b; Wiley and Damiano 1998). Although muscle 
weakness may limit the performance of daily tasks, only a few studies have 
addressed the underlying determinants of weakness specifically in adults with 
SCP.  
 
It has been reported that larger deficits in weakness exist in the more distal paretic 
musculature of the lower limbs in individuals with SCP (Brown et al. 1991). With 
this in mind, Elder et al. (2003) reported that the isometric plantarflexion (PF) 
torque of the paretic limb relative to the anatomical cross sectional area (ACSA; 
Nm.cm-2) in children with hemiplegic SCP was ~40% lower than either the non-
paretic limb or individuals without neurological impairment. Although such findings 
are crucial to furthering our understanding of the determinants of muscle 
weakness, Chapter 2 discussed how ACSA measurements have been well 
documented for underestimating the true physiological cross sectional area 
(PCSA) of pennate muscles (Morse et al. 2005c; Morse et al. 2008b; Narici et al. 
1992). In support of these findings, correlations between muscle force during PF 
isometric maximal voluntary contraction (MVIC) and PCSA have been shown to be 
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considerably higher  than correlations with ACSA (r = 0.72 vs r = 0.92, 
respectively) (Fukunaga et al. 1996).  
 
The architectural characteristics of pennate muscles are also known to influence 
contractile function as well as muscle size. Changes in architecture as a result of 
resistance training (Aagaard et al. 2001) and bed rest interventions (de Boer et al. 
2008; Reeves et al. 2002) have been suggested to impact on the force output 
capabilities of a muscle in individuals without neurological impairment. In children 
with spastic hemiplegic SCP, the resting fascicle lengths of the paretic muscle in 
the gastrocnemius have been reported to be 8% smaller when compared to the 
muscle of children without neurological impairment (Malaiya et al. 2007) and the 
contralateral non-paretic limb (Mohagheghi et al. 2007). These differences in 
fascicle length and muscle ACSA indicate that there are fewer sarcomeres in 
series and in parallel, respectively, in the paretic muscle of individuals with SCP. 
Additionally, Malaiya et al. (2007) showed that fascicle pennation angle of the 
paretic gastrocnemius medialis (GM) did not differ when compared to the non-
paretic muscle of individuals with SCP and the dominant limb of control 
participants without neurological impairment. Although architectural parameters 
reported at rest provide information to the understanding of fundamental 
differences in the paretic muscle, and in Chapter 5 the neural influence on 
MVC/ACSA was identified, no information is currently available on the contribution 
of architectural factors or PCSA to weakness in adults with SCP. 
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In order to calculate specific force, tendon force is calculated from the measured 
torque during MVIC and moment arm length (Maganaris et al. 2001; Morse et al. 
2005c; Morse et al. 2008b). With moment arm being one of several identified 
determinants of muscle specific force (García-Morales et al. 2003; Rassier et al. 
1999), the comparison of strength between individuals with SCP and individuals 
without neurological impairment, may be influenced by differences in moment arm 
length. However at present there remains no information on moment arm lengths 
in individuals with SCP.  
 
Given the established weakness of the paretic limb and the subsequent limitations 
in motor function, the aim of the present study was to identify whether there is a 
difference in paretic muscle specific force in vivo, when compared to the non-
paretic muscle and the dominant limb of individuals without neurological 
impairment. Therefore it was hypothesised that the GM specific force of the paretic 
limb would be lower than the non-paretic limb and the dominant limb of individuals 
without neurological impairment (form herein this group will be referred to as 
‘controls’). 
 
6.3 Methods 
6.3.1 Participants   
Twenty-two active and ambulant males gave written informed consent to 
participate in the study. Eleven of the participants had spastic hemiplegic CP (age 
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= 21.2 (3.0) years, stature = 1.79 (0.10) m, mass = 70.0 (12.5) kg) and the 11 
control participants had no history of musculoskeletal or neurological impairment 
(age = 21.8 (2.2) years, stature = 1.81 (0.04) cm, mass = 79.0 (8.4) kg). Each 
participant with SCP rated between II and III on the modified Ashworth scale and 
had been formally classified independently by individuals from the Cerebral Palsy 
International Sports and Recreation Association (CPISRA). Both the paretic and 
non-paretic legs were tested in each participant with CP, whereas the dominant 
limb was assessed in the control participants. All participants were free from lower 
limb injury and had not received any form of medication to reduce the effects of 
spasticity within the last year. The study was approved by the local ethics 
committee at Manchester Metropolitan University and conformed to the standards 
set by the latest revision of the Declaration of Helsinki.  
 
6.3.2 Protocol 
Participants attended the laboratory on two occasions. During the first visit, 
familiarisation was carried out which included a series of six PF MVIC followed by 
a series of submaximal percutaneous electrical stimulations. During the second 
visit, participants were assessed for resting measures of muscle size, and moment 
arm length, which were then followed by the MVIC tests.   
 
6.3.3 Strength measurements  
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The PF MVIC torque was recorded with the participants secured to an isokinetic 
dynamometer (Cybex Norm, Cybex International Inc., NY, USA) in a seated 
position with the back angle reclined at 65 deg (Chapter 3-5). The participant’s 
knee was secured in full extension with Velcro straps, which were positioned 
proximal to the knee. The medial malleolus was visually aligned with the 
dynamometer’s central axis of rotation and two Velcro straps were used to secure 
the foot to the footplate in order to minimise heel displacement. The participant’s 
hips were also secured to the seat to limit extraneous movement during PF MVIC 
trials. All participants warmed up by performing three submaximal isometric 
contractions with the ankle angle at 0 deg (the individual’s anatomical zero), each 
of which were separated by a 1 min rest period. In this instance, 0 deg was 
defined as the foot at 90 deg to the tibia. Two out of the 11 participants with CP 
could not achieve the described 0 deg in the paretic leg as their heel did not rest 
on the ground during anatomical stance. In these two cases, 0 deg was calculated 
by using a goniometer to quantify how much their resting ankle angle differed and 
an appropriate correction was measured on the isokinetic dynamometer. After the 
warm up, the participant’s ankle remained fixed at 0 deg where two PF MVICs 
were obtained, separated by a 2 min rest period. Throughout all MVIC trials, 
participants were verbally encouraged to exert as much force as possible and 
online visual feedback was provided on a monitor. Dorsiflexion (DF) MVIC was 
completed after the PF MVICs using the same testing posture and protocol in 
order to calculate tibialis anterior (TA) coactivation.  
 
6.3.4 Agonist Activation 
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In order to account for any deficit in MVIC torque in the quantification of specific 
force, two supramaximal stimuli were applied to the muscle (with a pulse width of 
50 µs), the first of which was applied during MVIC and the second approximately 2 
s after the first stimulus when the muscle was fully relaxed, in order to quantify the 
individual’s ability to voluntary activate the gastrocnemius (Chapter 5; Maganaris 
et al. 2001; Morse et al. 2005c). The stimulus was delivered by applying two 
percutaneous stimuli  (DSVDigitimer Stimulator; Digitimer, Herts., UK) to the 
gastrocnemius using rubber stimulation pads (size ranging from 38 mm x 89 mm 
to 76 mm x 127 mm; Versastim; Conmed, NY, USA), both of which were placed 
transversely distal to the popliteal crease and myotendinous junction of the soleus. 
The amplitude of the stimuli was determined prior to interpolation whilst the 
participant was in a relaxed state; administering twitches starting from 50 mA and 
increasing in increments of 50-100 mA, until no further increase in twitch torque 
was quantified. The voluntary activation level of each participant was assessed 
using the trial that produced the highest contractile torque. Agonist activation was 
calculated by dividing the supramaximal twitch torque during MVIC by the post 
MVIC twitch torque consistent with Morse et al. (2005c). If there was a deficit in 
muscle activation (a value below 100%) and assuming a linear relationship 
between MVIC torque and agonist activation (Gandevia 2001; Herbert and 
Gandevia 1999), a correction was made to PF MVIC if there was a deficit in 
agonist activation to the measured torque, which was calculated as; (PF MVIC 
torque / 100) x deficit in voluntary activation. This value was subsequently added 
to the MVIC torque along with torque contributions in coactivation to estimate PF 
MVIC net torque. 
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6.3.5 Coactivation  
In physically active men with hemiplegic SCP, the level of coactivation in the 
paretic limb was 3 times higher than the non-paretic contralateral limb, and the 
limb of individuals without neurological impairment (Chapter 5). With such large 
deviations in agonist activation during MVIC trials, TA electromyography (EMG) 
activity was recorded using two pre-gelled, unipolar, 10 mm, Ag-AgCl 
percutaneous electrodes (Medicotest, Denmark). Boundaries of the TA were 
determined using ultrasonography to ensure the accurate placement of each 
electrode along the mid sagittal axis of the muscle and to reduce cross-talk. Two 
electrodes were placed distally at two thirds of the TA length and one reference 
electrode was placed over the lateral epicondyle of the femur. Prior to placement 
of the electrodes, the area was shaved and cleaned with an alcohol swab to 
remove residual skin cells and oils, as well as reduce skin impedance. Raw EMG 
data were recorded at 2000 Hz, with a high and low band-pass filter set at 10 and 
500 Hz, respectively, with a notch set at 50 Hz. The integral of the root mean 
square of the raw signal 0.5 s either side of the MVIC PF torque was used to 
quantify the level of muscle coactivation. The torque produced by the DF during 
PF MVIC was estimated by assuming a linear relationship between torque and 
EMG activity, as previously reported (Maganaris et al. 1998b). The relative 
contribution of antagonist coactivation from the DF MVIC was added to estimate 
PF net torque along with any correction in agonist activation as aforementioned. 
 
6.3.6 Muscle volume 
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B-mode ultrasonography (AU5, Esaote, Italy) was used to obtain several axial-
plane images of the GM to measure ACSA (Reeves et al. 2004a). The GM 
proximal insertion and the MTJ were marked to identify 50% of muscle length. 
Strips of Micropore tape were placed axially across the mid-line of the GM at 
approximately 3.5 cm intervals. These strips of tape were used as echo absorptive 
markers that project a shadow onto the ultrasound image to provide a positional 
reference into the scanned structures. With the probe in an axial-plane, a 
recording of the probe moving from the medial to the lateral border of the GM was 
obtained. Individual images were extracted from the recording offline and used to 
construct the muscle by overlapping anatomical landmarks and external markers. 
Image J software (version 1.34; National Institutes of Health) was used to measure 
the ACSA of the constructed GM. The volume of the GM was calculated assuming 
a conical volume using the constructed ACSA. This technique used to estimate 
muscle volume has previously been validated in young men (Morse et al. 2007a). 
 
6.3.7 Muscle architecture  
At the point of peak torque during the MVIC trials, real time ultrasonography was 
used to record fascicle length and pennation angle during contraction, which was 
synchronized with the measured PF torque values. The 5 cm, 7.5 Hz linear array 
probe was held on the mid-sagittal plane of the GM equidistant between the 
proximal and distal tendon insertions previously established by ultrasonography. 
Additionally, the probe was held perpendicular to the surface of the skin to obtain 
several visible fasciculi ranging from the superficial to the deep aponeuroses. After 
the PF MVIC trials were completed, the recording of the highest torque trial was 
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analysed offline using Image J software. Fascicle length was measured as the 
length between the superficial and deep aponeuroses (Narici et al. 1996). 
Pennation angle was defined as the insertion angle of the fascicle into the deep 
aponeurosis (Maganaris et al. 2001). Fascicle length and pennation angle were 
measured at the time point of maximum PF torque, as it has been reported that 
pennation angle is underestimated and fascicle length is overestimated during rest 
conditions by 18.1 deg and 17.0 mm, respectively (Narici et al. 1996). Thus, in 
order to accurately calculate the intrinsic force generating capacity of the GM, data 
must be obtained during contraction and not rest (Maganaris et al. 2001; Morse et 
al. 2005c; Reeves et al. 2004b). The dimensions of the window used for analysis 
was 4.15 cm x 3.5 cm; in some cases fascicle length was estimated using linear 
extrapolation if a whole image of the fascicle was not available for direct 
measurement. 
 
6.3.8 PCSA 
The PCSA was estimated as the ratio of GM muscle volume to fascicle length 
(Alexander and Vernon 1975; Maganaris et al. 2001; Morse et al. 2008b).  
 
6.3.9 Moment arm length 
The tendon excursion method was used to estimate moment arm length during a 
passive stretch trial on an isokinetic dynamometer by passively rotating the ankle 
to calculate tendon excursion whilst in a seated position (as previously described 
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in Chapter 3 and 4). The medial malleolus was visually aligned with the 
dynamometer’s central axis of rotation. Prior to the experimental trial, end 
dorsiflexion end range of motion was identified by the experimenter by rotating the 
ankle at 1 deg.s-1, starting from 15 deg PF, until discomfort caused the participants 
to cease the stretch in dorsiflexion. This velocity was chosen in relation to previous 
findings which elicited minimal neural activity throughout passive stretch trials in 
individuals without neurological impairment (Morse 2011; Morse et al. 2008a). 
Throughout the passive stretch, B-Mode ultrasonography was used to determine 
the displacement of the GM MTJ throughout the passive stretch. MTJ 
displacement was measured relative to an acoustically reflective marker (a thin 
strip of Micropore tape) secured to the skin proximal to the GM MTJ, as previously 
validated by Morse et al. (Morse et al. 2008a).  
 
The total change in MTJ displacement was divided by the change in ankle range 
of motion (rad), to predict the moment arm length for each individual. This 
technique has previously been validated using cadavers when assessing the 
moment arm length of the quadriceps (Spoor et al. 1990).  
 
6.3.10 Achilles tendon force  
Tendon force was calculated by dividing the net plantarflexion torque by the 
Achilles tendon moment arm length (Morse et al. 2005c; Morse et al. 2008b). 
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6.3.11 Fascicle force  
In order to estimate GM fascicle force, PF MVIC net torque was multiplied by the 
relative contribution of the GM PCSA within the triceps surae muscle group. The 
relative PCSA of the PF muscles have previously been used to determine the 
relative contribution of each contributing muscle, whereby the relative PCSA of the 
GM was found to account for 15.4% of the Achilles tendon force (Fukunaga et al. 
1996). Therefore the force generated by the GM was calculated by determining 
ratio of GM contribution to Achilles tendon force. The force generated by the GM 
muscle was subsequently divided by the cosine of the pennation angle measured 
during contraction to determine GM fascicle force. 
 
6.3.12 Specific force  
Specific force was calculated by dividing GM fascicle force by GM PCSA.  
 
6.3.13 Statistics 
All statistical analyses were performed using SPSS software (Version 19, SPSS 
Inc., Chicago Illinois). To ensure the data were parametric, the Shapiro-Wilk and 
Levene’s tests were utilised to assess the distribution and variance of the data. As 
there were no breaches of these statistical assumptions, independent t-test were 
used to assess baseline anthropometric data between CP and control groups. To 
minimise type I error with the main outcome measures (as could occur with 
repeated ANOVA tests), a MANOVA was used to compare the differences and 
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interactions in the joint torque, force, neural and architectural variables (listed in 
Table 6.1-6.3) of the paretic vs. non-paretic limbs vs. the dominant limb of control 
individuals. Statistical significance was accepted at the P < 0.05 level, and all data 
are presented as mean (SD). 
 
6.4 Results 
Adults with CP and matched control individuals were of similar age (P = 0.575), 
stature (P = 0.604) and body mass (P = 0.061).  
 
6.4.1 Torque and moment arm properties 
The PF MVIC torque produced by the paretic limb was 33% less than the non-
paretic limb (P = 0.039), and 46% lower than the control group (P < 0.001). No 
difference in PF MVIC torque was identified between the non-paretic limb and 
control group (P = 0.178). During the PF MVIC trial, was 30% lower than the 
control group (P = 0.017). However, no difference was identified between the 
paretic and non-paretic net PF MVIC torque (P = 0.892), nor between the non-
paretic and control groups (P = 0.193). No differences were identified in DF MVIC 
torque (P = 0.653) or moment arm length (P = 0.281) between groups (Table 6.1). 
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Table 6.1. Joint torque, moment arm and neural properties of the paretic and non-
paretic limbs of individuals with SCP, and individuals without neurological 
impairment. 
 Paretic limb Non-paretic limb Control group 
PF MVIC (Nm) 102 (55.8)*† 153 (47.7) 190 (26.7) 
Net PF MVIC (Nm) 139 (59.5)* 160 (46.9) 198 (27.3) 
DF MVIC (Nm) 17.5 (8.58) 21.3 (11.9) 20.8 (10.6) 
Moment arm (cm) 6.05 (1.69) 5.08 (0.98) 5.54 (1.56) 
*Difference between paretic and control groups (P < 0.001). †Difference between 
paretic and non-paretic groups (P = 0.039). ‡Difference between paretic and non-
paretic groups (P < 0.001). 
 
6.4.2 GM muscle size and architecture 
There was no difference between the paretic and non-paretic fascicle lengths (P = 
0.070), and non-paretic and control fascicle lengths (P = 0.929; Table 6.2). 
However, the paretic fascicles were 28% longer than in the control group (P = 
0.005). The pennation angle at which the fascicles joined the superficial and deep 
aponeurosis during PF MVIC in the paretic GM was 41% smaller than the non-
paretic limb (P = 0.001), and 41% smaller than the control group (P < 0.001). No 
difference in pennation angle was identified between the non-paretic limb and 
control group (P = 0.095).  
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The ACSA of the GM was found to be 20% and 27% smaller than non-paretic 
muscle (P = 0.028) and control group (P = 0.001), respectively. No differences 
were identified between the non-paretic and control group GM ACSA (P = 0.601). 
The paretic GM volume was 27% smaller than that of the non-paretic (P = 0.014) 
and 30% smaller than the control group (P = 0.005). Similarly, the PCSA of the 
paretic GM was 41% and 47% smaller than the non-paretic (P = 0.002) and control 
group (P < 0.001), respectively. However, no difference was identified between 
non-paretic limb and control group when assessing GM volume (P = 1.000) and 
GM PCSA (P = 0.933). Furthermore, no difference between groups was identified 
when assessing GM length (Table 6.2; P = 0.095). 
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Table 6.2. Muscle size and architectural characteristics of the GM muscle in the 
paretic and non-paretic limbs of individuals with SCP, and individuals without 
neurological impairment. 
 Paretic limb Non-paretic limb Control group 
Fascicle length (cm) 3.70 (0.62)* 3.14 (0.56) 2.89 (0.47) 
Pennation angle (deg) 25.7 (4.08)
†§ 37.2 (7.59) 43.4 (7.00) 
GM length (cm) 24.5 (3.75) 26.8 (3.23) 25.7 (2.00) 
GM ACSA (cm2) 12.0 (2.62)‡‖ 15.0 (2.23) 16.5 (2.90) 
GM volume (cm3) 98.0 (28.3)*¶ 135 (31.3) 141 (26.2) 
GM PCSA (cm2) 26.3 (5.83)
†# 44.8 (14.2) 50.0 (12.0) 
*Difference between paretic and control groups (P = 0.005). †Difference between 
paretic and control groups (P < 0.001). ‡Difference between paretic and control 
groups (P = 0.001). §Difference between paretic and non-paretic groups (P = 
0.001). ‖Difference between paretic and non-paretic groups (P = 0.028). 
¶Difference between paretic and non-paretic groups (P = 0.014). #Difference 
between paretic and non-paretic groups (P = 0.002). 
 
6.4.3 Force measurements 
Achilles tendon force (P = 0.010) and GM force (P = 0.010) of the paretic limb was 
41% lower than the control limb. No difference in the non-paretic Achilles tendon 
force and GM force was established when compared to the paretic limb (both P = 
0.100) and control group (both P = 1.000). The paretic GM fascicle force was 41% 
less than the non-paretic limb (P = 0.024) and 52% lower than the control GM 
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fascicle force (P < 0.001). No difference between the non-paretic GM fascicle force 
and control group was identified (P = 0.370). Lastly, no difference between the 
groups was established when assessing GM specific force (Table 6.3; P = 0.393). 
 
Table 6.3. Force measurements in the paretic and non-paretic limbs of individuals 
with SCP, and individuals without neurological impairment. 
 Paretic limb Non-paretic limb Control group 
Achilles tendon force (kN) 2.26 (0.57)* 3.34 (1.59) 3.81 (0.32) 
GM muscle force (N) 347 (88.2)* 515 (244) 586 (161) 
GM fascicle force (N) 388 (104)†‡ 662 (317) 814 (205) 
Specific force (N.cm-2) 15.0 (3.66) 14.6 (4.12) 17.2 (5.94) 
*Difference between paretic and control groups (P = 0.010). †Difference between 
paretic and control groups (P < 0.001). ‡Difference between paretic and non-
paretic groups (P = 0.024).  
 
6.5 Discussion 
This study assessed the specific force of the GM in active individuals with SCP. 
The purpose of which was to establish whether the specific force of the paretic GM 
and the variables used in its calculation, differed when compared to the non-
paretic limb and control participants. Contrary to the hypothesis, the main finding 
of the present study was that there was no difference between the in vivo specific 
force of the paretic and non-paretic GM of active individuals with SCP, and the 
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muscle of control participants. Although specific force of the GM was the same 
across all groups, paretic fascicle force was 41% and 52% lower than the non-
paretic and control group, respectively.  
 
Consistent with the results of Chapter 5, the SCP participants demonstrated 
significantly lower levels of activation than unimpaired counterparts. The aim of the 
electrical stimulation in the present chapter was not to calculate the level of the 
activation deficit, but to account for any neural contribution to weakness and allow 
for a more accurate measure of GM specific force. By accounting for the 
differences in GM activation and TA coactivation across the paretic, non-paretic 
and control groups, the net PF MVIC torque remained 30% lower in the paretic 
limb when compared to the control group, but not different from the non-paretic 
limb. Whereas prior to this correction, the paretic PF MVIC torque was 46% and 
33% lower compared to the control group and non-paretic limb, respectively. The 
remaining difference in net PF MVC torque is therefore attributable to 
morphological or architectural properties of the muscle. 
 
The majority of research concerning muscle weakness in individuals with SCP 
measure the MVIC torque generated by a muscle or group of muscles (Barber et 
al. 2012; Damiano et al. 2001; Elder et al. 2003; Stackhouse et al. 2005). One 
limitation when assessing torque is that moment arm lengths between limbs and/or 
groups of individuals are not taken into account. As individuals with SCP may 
present structural deformities in the paretic limb as a result of increased tonicity of 
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the muscle throughout maturation (Koman et al. 2004), it is possible that the 
internal structures between the paretic, non-paretic and control limbs may be more 
prominent in adults, compared to paediatric populations. It is established that 
Achilles tendon moment arm increases in length with plantarflexion (Maganaris et 
al. 1998a), it remains to be seen however whether the sustained equinus posture 
of CP will alter the moment arm. In the present study, based on the consistent foot 
angle of 0 deg we observed no significant difference in moment arm between the 
SCP and control groups. Nevertheless, when the in vivo forces were calculated in 
the paretic Achilles tendon and GM, it was found to be 41% weaker than the 
control group only, but no difference was established between the paretic and non-
paretic limbs. Although the 1 cm difference in Achilles tendon moment arm as 
observed in our participants does not seem substantial, with all else being equal 
when calculated using the mean PF MVIC net torque in the present SCP 
population, an increase in moment arm length by 1 cm would theoretically 
increase the tendon force in the SCP limb by 240 N. As a result, the assessment 
of specific force using joint torque rather than tendon force would underestimate 
the true force producing capacity of the contractile mass. Accounting for moment 
arm lengths, muscle architecture and neural properties facilitates the assessment 
of the intrinsic material force-producing capacity of muscle in vivo (Morse et al. 
2005c; Reeves et al. 2004b). 
 
In children with SCP, the morphology of the paretic GM during rest showed that 
fascicle length was 18% shorter compared to non-paretic contralateral limb 
(Mohagheghi et al. 2007) and 16% shorter compared to age matched controls 
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(Malaiya et al. 2007). Based on these previous findings, deficits in paretic fascicle 
length would imply that the number of sarcomeres in series is typically lower than 
the control comparisons. However, in contrast to previous architectural data, in the 
present study fascicle length during PF MVIC was 8% longer in SCP than in the 
control group. It is likely that the contrasting results obtained in the present study 
reflect the nature of the measurement technique. Where previous studies have 
reported muscle architecture at rest, GM fascicle length in the present study was 
measured at peak PF MVIC torque; as is consistent with the calculation of specific 
force (Maganaris et al. 2001). Due to the spasticity in the GM muscle, the paretic 
foot of the participant with SCP is typically in an equinus position, consistent with 
immobilisation studies (Williams and Goldspink 1978), where the fascicles would 
be expected to be shortened when measured in this ‘relaxed’ position (Malaiya et 
al. 2007). In addition, as GM fascicle length was measured during PF MVIC, any 
difference in the tendon properties, or force that was produced would influence the 
relative shortening experienced by individuals with and without SCP, as has been 
observed in the elderly (Reeves et al. 2004b). However, at present there remains 
no published data on the fascicle length-tension relation or the influence of tendon 
properties in individuals with SCP.  
 
In the present study, when neural and architectural factors were accounted for, 
there remained a difference in GM fascicle force between SCP and control 
participants which was almost entirely accounted for by the difference in PCSA, as 
evidenced by similar values for specific force between SCP and control 
participants. As PCSA takes into account the volume and fascicle length of the 
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muscle, it provides a more accurate measurement of the true contractile area of 
pennate muscle (Morse et al. 2005c; Morse et al. 2008b; Narici et al. 1992). The 
present study identified that the paretic GM PCSA was ~45% smaller than the 
non-paretic limb and control group, similar to the observed difference in GM 
fascicle force (52% smaller). Such differences indicate that the paretic GM muscle 
has fewer sarcomeres in parallel compared to the non-paretic and control GM 
muscle and any weakness at the whole muscle level is unlikely to be influenced by 
a decrease in the quality of the muscle at the fascicle level.  
 
In the present study no difference in specific force was observed between the SCP 
and control group, or between the paretic and non-paretic limb of the SCP 
participants. This would initially appear to be in contrast to previous work which 
has established that the size/strength relationship of muscles in individuals with 
SCP is reduced compared to individuals without neurological impairment (e.g. 
ACSA/PF MVIC torque (Elder et al. 2003)). However, as previously stated, based 
on the architectural differences between SCP and the control group, and the 
substantial neural contribution to reduced joint torque, the estimation of the size 
strength relation may be erroneous unless these factors are considered. Indeed, 
based on histological data from single fibres of individuals with SCP there appears 
to be no discernible difference between SCP and control individuals at the single 
fibre level (Ito et al. 1996).  
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Although this is the first study to address the intrinsic force generating capacity of 
SCP muscle, several factors may potentially impact on the data presented. Within 
the present study moment arm was estimated during rest, whereas specific force 
should represent the data obtained during MVIC. The difference in Achilles 
moment arm length during MVIC is approximately 1.5 cm longer than resting 
measures in individuals without neurological impairment (Maganaris et al. 1998a). 
In addition, fascicle length was measured at a comparable length rather than the 
angle at which peak torque occurred (Reeves et al. 2004b), due to the fact that in 
the present study, 0 deg ankle angle was used to control for the different resting 
angles between the participants. However, as the plantarflexors are on the 
ascending limb of the force length relation, it is likely that specific force is 
underestimated in the present investigation (Maganaris et al. 2001; Morse et al. 
2007b; Reeves et al. 2004b). To compare between individuals that have limited 
dorsiflexion ROM a consistent joint angle was chosen for the measurement of 
specific force at 0 degrees. Nevertheless, the interaction of the muscle and the 
tendon has yet to be addressed in individuals with SCP. As the elastic component 
of the MTU is pivotal in the transition of force from the muscle to bone, the tendon 
properties in individuals with SCP should be assessed to identify whether the 
functional properties of the tendon are altered in vivo. 
 
6.6 Conclusion  
The present study has showed that the paretic GM of physically active individuals 
with SCP has a similar specific force generating capacity to the non-paretic muscle 
and the GM of control individuals. This study also demonstrates how the pennation 
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angle and fascicle length of the paretic muscle at MVIC is different from the control 
group. Nevertheless, weakness (whilst accounting for neural properties, moment 
arm lengths and muscle architecture) observed in the paretic GM is not due to the 
intrinsic material properties of the muscle, but because of the smaller PCSA of the 
muscle. 
 
  
142 
 
 
 
Chapter 7 
 
Achilles tendon stiffness in adults with 
spastic hemiplegic cerebral palsy 
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7.1 Abstract 
Introduction. The stiffness of the tendon properties have yet to be assessed in 
individuals with spastic cerebral palsy (SCP), despite numerous studies 
investigating the constituent muscle. The aim of the present study was to assess 
the in vivo structural and mechanical properties of the paretic tendon in physically 
active men compared to control tendons.  
Methods. Eleven physically active, ambulant men with hemiplegic SCP (21.2 (3.0) 
years) and age-matched controls without neurological impairment, completed a 
plantarflexion isometric maximal voluntary contraction (MVIC) session, 
respectively. During each session, tendon force and gastrocnemius medialis (GM) 
myotendinous junction (MTJ) displacement was measured. Additionally, tendon 
cross sectional area (CSA), length and moment arm length were measured. 
Subsequently, in vivo stress and strain were determined to calculate Young’s 
modulus. 
Results. At MVIC, the paretic tendon force was lower than individuals without 
neurological impairment. Paretic tendon at MVIC was more compliant than 
individuals without neurological impairment as a result of decreased paretic tendon 
CSA. Young’s modulus at MVIC in individuals without neurological impairment was 
double the stiffness of the paretic tendon, as a result of 30% less paretic tendon 
strain. However, when tendon stiffness and Young’s modulus was calculated at a 
standardised force, no difference was observed in tendon elastic properties across 
all groups.  
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Conclusion. Active individuals with CP exhibit different stiffness and Young’s 
modulus properties in the paretic tendon compared to individuals without 
neurological impairment at MVIC, which is due to large differences in tendon force 
and strain. Whereas the paretic tendon stiffness and Young’s modulus at a 
standardised force, is similar in individuals without neurological impairment. This 
data suggests that active individuals with SCP may have a similar intrinsic tendon 
composition compared to the control limbs, likely as a result of regular physical 
exercise. 
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7.2 Introduction 
The gait and motor performance of individuals with spastic cerebral palsy (SCP) 
have regularly been demonstrated to be impaired (Damiano et al. 2006; Burtner et 
al. 1998; Damiano et al. 1995a; Wiley and Damiano 1998), as a result of 
weakness (Damiano and Abel 1998; Elder et al. 2003) and increased passive 
muscle-tendon unit (MTU) stiffness (Alhusaini et al. 2010; Vaz et al. 2006) in the 
paretic musculature (as previously described in Chapters 4, 5 and 6). Although 
such limitations in motor function are often associated with the impairment of the 
paretic muscle, the tendon plays an integral part within the MTU as it deforms and 
transmits the contractile forces generated by the muscle to the bone, to enable 
joint movement (Maganaris and Paul 2002). Yet research into the properties of the 
tendon in individuals with SCP has yet to be considered. 
 
The elastic properties of the tendon in individuals without neurological impairment 
have regularly been shown to behave in a curvilinear fashion (Maganaris and Paul 
1999; Onambele et al. 2007), with compliant tendons being linked with slower 
rates of torque development and vice versa for stiffer structures (Reeves et al. 
2003; Morse et al. 2005a; Pearson and Onaimbele 2006). Resistance 
interventions have shown that regular increased loading placed on the tendon 
results in stiffer material properties (Kubo et al. 2001b; O'Brien et al. 2010b; 
Reeves et al. 2003), whereas more compliant tendons have been suggested to 
result from disuse (Kubo et al. 2000; Reeves et al. 2005). This demonstrates that 
the elastic component responds to differing patterns of use through changes in the 
dimensions and/or material composition of the tendon (Kjær 2004; Maganaris et 
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al. 2006). Furthermore, as individuals with hemiplegic SCP often employ an 
avoidance strategy and use their non-paretic limbs to perform the majority of motor 
tasks, it may be considered that the paretic limb is subjected to disuse, and thus 
the associated tendon may be more compliant.  
 
It has previously been established that differences in architectural (Mohagheghi et 
al. 2007) and contractile properties (Elder et al. 2003; Stackhouse et al. 2005) of 
the paretic muscle in individuals with SCP are altered when compared to age-
matched controls without neurological impairment. This has been suggested to be 
due to the impaired neural communication between the central nervous system 
and the paretic muscle (Koman et al. 2004). Based on these neuromuscular 
deficits and increased passive stiffness of the paretic MTU, compared to age-
matched controls (Alhusaini et al. 2010; Vaz et al. 2006), it is likely that the 
properties of the paretic tendon may be altered. Indeed, Malaiya and colleagues 
(2007) reported that length of the paretic gastrocnemius medialis relative to limb 
length was shorter than the non-paretic muscle and that of individuals without 
neurological impairment, which is in agreement with in vitro results (Friden and 
Lieber 2003). With such decreases in paretic muscle length, this may provide 
evidence to suggest that tendon length is increased, assuming that no 
discrepancies in length exist between the paretic and non-paretic limbs. Such 
deviations in tendon length between limbs may also result in altered intrinsic 
material properties of the paretic tendon as previously observed in SCP muscle 
(Lieber et al. 2003; Lieber et al. 2004) and in Chapter 6 where the paretic fascicle 
and penation angle was 28% longer and 41% smaller, respectively. 
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In order to measure the in vivo mechanical properties of the tendon, various 
studies have tracked the structural displacement from rest to a ramped isometric 
maximal voluntary contraction (MVIC) by using ultrasonography in individuals 
without neurological impairment (O'Brien et al. 2010b; Aagaard et al. 2001; 
Maganaris et al. 2000, 1998a; Waugh et al. 2012; Onambele et al. 2007; Reeves 
et al. 2003). Currently no data exists in relation to the tendon properties of 
individuals with SCP, despite previous research being conducted into the strength 
and passive stiffness of the paretic muscle. Therefore the aim of the present study 
was to assess the in vivo structural and mechanical properties of the paretic 
tendon in physically active men compared to the contralateral non-paretic tendon 
and that of individuals without neurological impairment.  
 
7.3 Methods 
7.3.1 Participants 
Eleven ambulant men with hemiplegic SCP (age = 21.2 (3.0) years, stature = 1.79 
(0.10) m, mass = 70.0 (12.5) kg) and 11 men without neurological impairment (age 
= 21.8 (2.2) years, stature = 1.81 (0.04) cm, mass = 79.0 (8.4) kg) volunteered to 
participate in the study after written informed consent was obtained. All 
participants with SCP had been classified by physical therapists from the Cerebral 
Palsy International Sports and Recreation Association (CPISRA). All participants, 
including SCP and individuals without neurological impairment, self-reported that 
they undertook 3-5 hours of sport-based exercise per week and did not partake in 
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any structured resistance training regime. The entire cohort was free from lower 
limb injury and had not received any form of medication to reduce the effects of 
spasticity within the last year. The study conformed to the standards set by the 
latest revision of the Declaration of Helsinki and the local ethics committee at 
Manchester Metropolitan University. Both the paretic and non-paretic legs were 
tested in each participant with SCP, whereas the dominant limb was assessed in 
control participants without neurological impairment. 
 
7.3.2 Protocol 
Participants attended the laboratory on two occasions. During the first visit, 
familiarisation was carried out which included a series of six PF MVIC whilst the 
tendon elongation was tracked using ultrasonography. During the second visit, 
participants were assessed for resting measures of GM tendon size, and Achilles 
tendon moment arm length, which were then followed by the PF MVIC tests in 
order to assess tendon elongation.   
 
7.3.3 Maximal plantarflexion and dorsiflexion torque 
Participants were secured to an isokinetic dynamometer (Cybex Norm, Cybex 
International Inc., NY, USA) in a seated position with the back angle reclined at 65 
deg prior to beginning MVC trials (Chapter 3-6). The knee was secured in full 
extension with Velcro straps, which were positioned proximally. The medial 
malleolus was aligned visually with the central axis of rotation of the dynamometer, 
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and 2 Velcro straps were used to secure the foot to the footplate to minimise heel 
displacement. The participant’s hips were also secured to the seat to limit 
extraneous movement during plantarflexion (PF) MVIC trials. Prior to completion of 
the experimental trial, all participants were familiarised with the forthcoming 
procedure. Participants warmed up by performing 3 submaximal ramped isometric 
contractions at 0 deg (the individual’s anatomical zero), each of which were 
separated by a 1-2 min rest period. In this instance, 0 deg was defined as the foot 
at a 90 deg angle to the tibia. Two out of the 11 participants with SCP could not 
achieve the described 0 deg in the paretic leg, as their heel did not rest on the 
ground during anatomical stance. In these 2 individuals, 0 deg was calculated by 
using a goniometer to quantify how much their resting ankle angle differed, and an 
appropriate correction was measured on the isokinetic dynamometer. After the 
warm up, the ankle remained fixed at 0 deg, where a PF MVIC was obtained by 
the participant slowly increasing their effort over a ~4 second period until torque 
plateaued (Onambele et al. 2007; Reeves et al. 2003). Subsequent to this 
procedure, ramped dorsiflexion (DF) MVICs were completed using the same 
testing posture and protocol in order to estimate co-contraction of the tibialis 
anterior (TA) during PF MVIC. 
 
7.3.4 Tendon moment arm length 
The tendon excursion method was used to estimate moment arm length during a 
passive stretch trial on an isokinetic dynamometer by passively rotating the ankle 
to calculate tendon excursion whilst in the seated position (as previously described 
in Chapter 3, 4 and 6). The medial malleolus was visually aligned with the 
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dynamometer’s central axis of rotation. Prior to the experimental trial, DF end 
range of motion was identified by the experimenter rotating the ankle at 1 deg.s-1, 
starting from 15 deg PF, until discomfort caused the participants to cease the 
stretch in DF. As reported in Chapter 4, this velocity was chosen as it has 
previously been found to elicit minimal neural activity throughout passive stretch 
trials in individuals without neurological impairment (Morse 2011; Morse et al. 
2008a). Throughout the passive stretch, B-Mode ultrasonography (AU5, Esaote, 
Italy) was used to determine the displacement of the GM MTJ. As described in 
detail in Chapters 1 and 2, displacement of the GM tendon was measured relative 
to an acoustically reflective marker (a thin strip of Micropore tape) secured to the 
skin proximal to the GM MTJ, as previously validated by Morse et al. (2008a) and 
Morse (2011).  
 
The range of motion used to estimate moment arm length was between 15 deg PF 
to 15 deg DF. The total change in MTJ displacement was divided by the change in 
ankle range of motion (rad), to predict the moment arm length for each individual. 
This technique has previously been validated using cadavers when assessing the 
moment arm length of the quadriceps (Spoor et al. 1990).  
 
7.3.5 Tendon force 
Tendon force was calculated by dividing the net PF MVIC torque by the Achilles 
tendon moment arm length (Kongsgaard et al. 2011). Net PF MVIC torque was 
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calculated by adding the estimated co-contraction torque of the TA to the PF 
torque during the ramped MVIC (Onambele et al. 2007).  
 
7.3.6 Electromyographic activity and cocontraction 
During MVIC trials, TA electromyography (EMG) activity was recorded using 2 pre-
gelled, unipolar, 10 mm, Ag-AgCl percutaneous electrodes (Medicotest, Denmark). 
Boundaries of the TA were determined using B-Mode ultrasonography to ensure 
accurate placement of each electrode along the mid-sagittal axis of the muscle 
and to reduce cross-talk. Two electrodes were placed proximally at two-thirds of 
the TA length, and 1 reference electrode was placed over the lateral epicondyle of 
the femur (Merletti et al. 2003; Zipp 1982). The area where the electrodes were 
positioned was shaved and cleaned with an alcohol swab to remove residual skin 
cells and oils, as well as reduce skin impedance. Raw EMG data were recorded at 
2000 Hz, with band pass filter set at 10-500 Hz and a notch at 50 Hz. 
 
Antagonist coactivation was calculated over 50ms at each 10% increments of PF 
MVIC torque, by taking the root mean square of the TA EMG activity. These 
measures were made relative to the maximal activation of the TA that was 
determined during DF MVIC and measured over 1 s (500 ms either side of 
maximum torque). Assuming a linear relationship between antagonist EMG activity 
and torque (Lippold 1952), the relative contribution of the DF muscles during PF 
MVIC was calculated. 
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7.3.7 GM tendon elongation 
Throughout the ~4 s ramped PF MVIC, B-mode ultrasonography captured the 
elongation of the GM myotendinous junction (MTJ) and was measured offline 
relative to an echo-absorptive marker (thin strip of Micropore tape) fixed distally to 
the GM MTJ at rest. Measurements of tendon elongation were assessed at 10% 
increments of PF MVIC torque, using Image J (version 1.34; National Institutes of 
Health), which has previously been reported as being a reliable method (ICC = 
0.91) when assessing patella tendon elongation (Onambele et al. 2007). To 
ensure reproducibility, the mean of three measurements for each image was 
calculated (Reeves et al. 2003). In order to account for the deficit in force 
generated by the paretic limb (Chapter 4, 5 and 6), tendon elongation was also 
examined at 645 N (the highest force attained by the weakest participant). 
 
7.3.8 GM tendon length and cross sectional area 
Whilst the participant lay relaxed in the prone position, the length of the GM 
tendon was measured using B-mode ultrasonography from the insertion into the 
calcaneus, to the GM MTJ (Maganaris and Paul 2002). The length of the GM 
tendon was measured using an inextensible tape, a method that has been 
previously validated when assessing the length of the GM muscle (Barber et al. 
2011b). 
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Images were obtained using B-mode ultrasonography to measure Achilles tendon 
CSA (Pang and Ying 2006) at the mid-point between the tendon insertion into the 
tuber calcanei and the soleus MTJ. This method has previously been used in the 
assessment of GM tendon properties (Maganaris and Paul 2002) and reported to 
be a reliable technique (ICC = 0.81) in the assessment of Achilles tendon CSA 
(Ying et al. 2003). With the probe in an axial-plane, a video recording of the 
Achilles tendon CSA was obtained and images were extracted from the video for 
analysis offline. The mean Achilles tendon CSA of two images was reported and 
measured using Image J software. 
 
7.3.9 Tendon stress and strain 
GM tendon stress was calculated by dividing GM tendon force by its CSA, and GM 
tendon strain was determined by calculating the ratio of tendon elongation to the 
resting length of the GM tendon (Maganaris and Paul 1999, 2002; Maganaris et al. 
2006; Onambele et al. 2007; Reeves et al. 2003). 
 
7.3.10 Tendon stiffness 
The force-elongation relations of the GM tendon were fitted with a second order 
polynomial function, which was forced through zero. GM tendon stiffness was then 
calculated from the gradient of tangential lines along the force-elongation 
relationship, at 10% intervals of PF MVIC force (Onambele et al. 2007) and the 
standardised force of 645 N. 
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7.3.11 Young’s modulus 
At each 10% interval of PF MVIC force and the 645 N standardised force, Young’s 
modulus was calculated by multiplying GM tendon stiffness to the ratio of its 
respective resting length and CSA. 
 
7.3.12 Statistics 
All statistical analyses were performed using SPSS software (Version 19, SPSS 
Inc., Chicago Illinois). A mixed-design ANOVA was used to distinguish differences 
in tendon displacement, stiffness, stress, strain and Young’s modulus between 
groups (3 levels; paretic, non-paretic and individuals without neurological 
impairment) and within-subject (10 levels; 10% intervals of PF MVIC). To minimise 
type I error with the additional outcome measures (as could occur with repeated 
ANOVA tests), a MANOVA was used to compare the differences and interactions 
in the joint torque, force, architectural, and tendon displacement, stiffness, stress, 
strain and Young’s modulus at 645 N, of the paretic vs. non-paretic limbs vs. the 
dominant limb of control individuals. If a significant interaction was found, 
independent post-hoc t-tests (with Bonferonni corrections) were used to run paired 
comparisons. Where assumptions of sphericity were violated, a Greenhouse-
Geisser correction was used prior to identifying differences in the data. Statistical 
significance was accepted at the P < 0.05. Effect size is reported as partial eta 
squared (pε2) and data are presented as the mean (SD), unless stated otherwise. 
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7.4 Results 
No group differences in participant age (P = 0.575), stature (P = 0.604) and body 
mass (P = 0.061) were identified when comparing individuals with SCP and those 
without neurological impairment.  
 
7.4.1 Tendon length, CSA and moment arm  
With the ankle secured at 0 deg, GM tendon length was not different between the 
paretic limb, non-paretic limb and individuals without neurological impairment. 
Similarly moment arm length estimated at 0 deg, was also found not to be different 
between groups (Table 7.1; P = 0.698 and P = 0.302, respectively). Achilles 
tendon CSA was different between groups (Table 7.1; P = 0.001, ηρ² = 0.378) and 
post hoc pairwise comparisons showed that the Achilles tendon CSA of individuals 
without neurological impairment was 23% and 38% larger than the non-paretic and 
paretic tendons (P = 0.042 and P = 0.001, respectively). Interestingly however, 
there was no difference between the paretic and non-paretic Achilles tendon CSA 
(P = 0.344).  
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Table 7.1. Structural properties and moment arm of the Achilles tendon during rest 
in the paretic and non-paretic limbs of individuals with SCP, and individuals 
without neurological impairment. 
 Paretic limb Non-paretic limb Controls  
Tendon length (mm) 235 (26.7) 229 (22.9) 238 (25.0) 
Tendon CSA (mm2) 42.2 (12.6)* 52 (11.7)† 67.6 (17.2) 
Moment arm length (cm) 6.05 (1.69) 5.08 (0.98) 5.54 (1.56) 
Controls refer to individuals without neurological impairment. *Difference between 
paretic and controls (P = 0.001). †Difference between non-paretic groups and 
controls (P = 0.042).  
 
7.4.2 Tendon force-elongation relation 
The GM MTJ of the Achilles tendon moved proximally as force increased 
throughout the ramped PF MVIC in a curvilinear fashion (Figure 7.1). For both GM 
tendon force and elongation variables, there was a group by force interaction 
effect (P = 0.002, ηρ² = 0.334 and P = 0.010, ηρ² = 0.239, respectively). T-tests 
revealed that there was no difference between the non-paretic tendon forces or 
elongation throughout the PF MVIC, compared to the tendon of individuals without 
neurological impairment (both P > 0.05). The paretic tendon force was different 
from 10-100% of MVIC when compared to the non-paretic tendon (P < 0.01) and 
individuals without neurological impairment (P < 0.001). When assessing force at 
PF MVIC (Table 7.2), individuals without neurological impairment (P < 0.001) and 
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non-paretic tendon force (P = 0.006) was over two-fold greater than the paretic 
GM tendon force.  
 
The elongation properties of the GM tendon followed a similar pattern whereby the 
paretic tendon elongation was different from 20-100% intervals of MVIC when 
compared to the non-paretic tendon (P < 0.05) and individuals without neurological 
impairment (P < 0.01). The paretic GM tendon elongated approximately half the 
distance of the non-paretic tendon (P = 0.015) and tendon individuals without 
neurological impairment (P = 0.005) travelled at PF MVIC (Table 7.2). 
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Figure 7.1. Achilles tendon force-elongation relationship in paretic (open squares) 
and non-paretic (closed squares) limbs and in individuals without neurological 
impairment (closed triangles). Error bars have been omitted for clarity. 
 
7.4.3 Tendon stress-strain relation 
Whereas tendon stress was similar between the paretic and non-paretic tendon 
and individuals without neurological impairment throughout the PF MVIC (P = 
0.092), there was a tendon strain group-by-force interaction (P = 0.025, ηρ² = 
0.202). Indeed, figure 7.2 shows that the paretic tendon strain between 20-100% 
of PF MVIC was lower than non-paretic tendon (P < 0.05) and individuals without 
neurological impairment (P < 0.05). Table 7.2 shows the strain placed upon the 
paretic tendon at PF MVIC was 20% and 30% less than the non-paretic limb (P = 
0.029) and that of individuals without neurological impairment (P = 0.014), 
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respectively. No differences in tendon strain were identified between the non-
paretic limb and individuals without neurological impairment (P > 0.05). 
 
 
Figure 7.2. Achilles tendon stress-strain relationship in paretic (open squares) and 
non-paretic (closed squares) limbs and in individuals without neurological 
impairment (closed triangles). Error bars have been omitted for clarity. 
 
7.4.4 Tendon stiffness  
Figure 7.1 demonstrates how the paretic tendon stiffness follows a similar path to 
non-paretic tendon and tendon of individuals without neurological impairment. 
However the length of the paretic stiffness line at each 10% interval was 
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considerably shorter than non-paretic tendon and tendon of individuals without 
neurological impairment, resulting in a group-by-force interaction effect (P = 0.002, 
ηρ² = 0.343). The non-paretic tendon stiffness did not differ from that of the paretic 
tendon (P > 0.05) or of individuals without neurological impairment (P > 0.05). 
Contrary to this, the stiffness of the paretic limb was different at each 10% interval 
to PF MVIC compared with the tendon of individuals without neurological 
impairment (P < 0.001). Furthermore, at MVIC, the tendon of individuals without 
neurological impairment was over three-fold stiffer than the paretic tendon (P = 
0.001; table 7.2). 
 
7.4.5 Tendon Young’s modulus 
An interaction effect between group and force was identified in terms of Young’s 
modulus (P = 0.009, ηρ² = 0.264). Figure 7.2 illustrates how the length of the 
paretic tendon curve is considerably shorter compared to the non-paretic and 
tendon of individuals without neurological impairment, however a difference from 
60-100% of PF MVIC was only exhibited between the Young’s modulus of the 
paretic tendon and that of individuals without neurological impairment (P < 0.05). 
At PF MVIC, table 7.2 shows the tendon of individuals without neurological 
impairment was double the stiffness of the paretic tendon (P = 0.009). No 
difference was found throughout the PF MVIC between the paretic and non-paretic 
tendons (P > 0.05), and the non-paretic tendon compared to individuals without 
neurological impairment (P < 0.05).  
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Table 7.2. Elastic properties of the Achilles tendon at PF MVIC in the paretic and 
non-paretic limbs of individuals with SCP, and individuals without neurological 
impairment. 
 Paretic limb Non-paretic limb Controls  
Achilles tendon force (N) 1442 (499)ab 3075 (1680) 3285 (1040) 
Tendon elongation (mm) 7.67 (6.00)cd 14.8 (6.49) 16.1 (6.58) 
Tendon stiffness (N.mm-1) 696 (565)e 1312 (858) 2096 (1112) 
Tendon stress (MPa) 37.8 (21.1) 60.0 (30.9) 49.9 (14.0) 
Tendon strain (%) 3.42 (3.07)fg 6.56 (3.20) 6.92 (3.03) 
Young’s modulus (GPa) 3.76 (1.91)h 5.86 (3.49) 7.56 (3.94) 
aDifference between paretic and non-paretic groups (P = 0.003). bDifference 
between paretic and control groups (P = 0.001). cDifference between paretic and 
non-paretic groups (P = 0.015). dDifference between paretic and control groups (P 
= 0.005). eDifference between paretic and control groups (P < 0.001). fDifference 
between paretic and non-paretic groups (P = 0.029). gDifference between paretic 
and control groups (P = 0.014). hDifference between paretic and control groups (P 
= 0.009).  
 
7.4.6 Tendon properties at a standardised force of 645 N 
To account for the deficit in force achieved by the paretic limb, a comparison was 
conducted at the PF MVIC tendon force achieved by the weakest participant 
across all limbs tested (Table 7.3). No difference between individuals without 
neurological impairment, the paretic tendon, non-paretic tendon were identified 
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when assessing absolute displacement (P = 0.131), stiffness (P = 0.525), strain (P 
= 0.236), or Young’s modulus (P = 0.127). Nevertheless, tendon stress was 
different between groups (P = 0.001, ηρ² = 0.371), with the paretic tendon stress 
being 39% higher than that recorded in individuals without neurological 
impairment. 
 
Table 7.3. Elastic properties of the Achilles tendon at a standardised MVIC force 
(645 N) in the paretic and non-paretic limbs of individuals with SCP, and 
individuals without neurological impairment. 
 Paretic limb Non-paretic limb Controls  
Tendon elongation (mm) 3.77 (1.88) 4.63 (1.65) 5.52 (2.31) 
Tendon stiffness (N.mm-1) 392 (274) 291 (158) 360 (182) 
Tendon stress (MPa) 16.6 (5.11)* 13.0 (2.78) 10.1 (2.42) 
Tendon strain (%) 1.65 (0.97) 2.06 (0.81) 2.36 (1.05) 
Young’s modulus (GPa) 2.22 (1.55) 1.35 (0.76) 1.36 (0.86) 
Controls refer to individuals without neurological impairment. *Difference between 
paretic and controls (P = 0.001).  
 
7.5 Discussion 
The purpose of the present study was to establish whether in vivo differences exist 
in the elastic properties of the paretic tendon of individuals with SCP during a 
ramped PF MVIC, compared to the contralateral non-paretic limb and the 
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dominant limb of age-matched controls without neurological impairment. The 
primary findings showed that the GM tendon standardised force elastic properties 
and Young’s modulus (i.e. assessed at 645 N) are not different from the 
contralateral non-paretic limb or the limb of individuals without neurological 
impairment. Due to the competitively lower force generated by the paretic limbs 
compared to the control limbs, at PF MVIC, the paretic GM tendon was more 
compliant compared to individuals without neurological impairment. When the 
tendon force-elongation relation was made relative to the structural properties of 
the tendon CSA and length to calculate stress and strain, respectively, the 
Young’s modulus at PF MVIC showed that the paretic tendon of individuals with 
SCP was up to two times stiffer than the tendon of age-matched controls without 
neurological impairment. 
 
The elongation of the paretic GM tendon at PF MVIC travelled approximately half 
the distance of the non-paretic tendon and individuals without neurological 
impairment. At face value, such a difference in displacement would result in the 
paretic tendon being reported as having stiffer material properties (Onambele et al. 
2006; Pearson and Onambele 2005) than the elastic structures of the dominant 
limb of age-matched controls. However as the tendon deforms relative to the force 
generated by the contractile component, it may be considered that the primary 
difference in the force-elongation and stress-strain relation in the present study is 
due to lower forces generated as a result of impaired neural signalling to the 
paretic muscle of individuals with SCP. Previously in Chapter 5 and 6 the paretic 
muscle of individuals with hemiplegic SCP have been shown to produce lower 
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torques than the non-paretic contralateral limb and the dominant limb of age-
matched controls without neurological impairment primarily as a result of impaired 
activation of the contractile tissue (Elder et al. 2003; Stackhouse et al. 2005). In 
individuals without neurological impairment, lower torques from weaker individuals 
have been reported to follow a similar pattern when tendon force is calculated 
(O'Brien et al. 2010b). Therefore, any apparent difference in the material 
properties of the paretic GM tendon is due to greater strength of the non-paretic 
limb and control participants without neurological impairment.  
 
As a result of weakness, many studies have assessed the effects of the 
morphological properties that are linked with muscle strength (Aagaard et al. 
2001), however no such study has assessed the effects of the in-series elastic 
component. The present study identified no differences between resting moment 
arm and GM tendon length between the limbs of individuals with SCP and 
individuals without neurological impairment. These similarities in GM tendon length 
is consistent with findings construed from Mohaghegi et al. (2007), but are in 
contrast to the clinical definition of the paretic muscle, as it is often referred to as 
being ‘shorter in length’ (Graham and Selber 2003), thus suggesting that the 
tendon would be longer when accounting for the deficit in muscle length. The 
observed deviation in findings is likely to be due to the method employed to 
assess tendon length; Malaiya et al. (2007) did not account for ankle angle, 
whereas in the present study ankle and knee angle was secured at the 
participants anatomical zero and full extension, respectively. Tendon lengths have 
not been reported to be different between individuals with spinal cord injury when 
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joint angle was controlled for, but tendon CSA was also found to be 17% smaller 
when compared to age-matched controls without neurological impairment 
(Maganaris et al. 2006). This reduction in tendon CSA resulted in the tendon being 
more compliant than individuals without neurological impairment, which is similar 
to the findings in the present study at PF MVIC. 
 
The in vivo tendon stress transmitted through the GM tendon at PF MVIC ranged 
from 38-60 MPa and was not different across the different limbs tested in the 
present study, which is similar to previous findings in healthy men without 
neurological impairment (32 MPa; Maganaris and Paul 2002). Although the data 
presented is comparable to results previously reported by others, the level of 
variability in the paretic limb is relatively high in comparison to the control groups 
across all variables presented, which is likely to be due to the range of impairment 
across individuals with SCP. Nevertheless, in cadavers of individuals without 
neurological impairment, the stresses recorded at Achilles tendon failure were 
shown to be velocity dependant, ranging between 71 and 86 MPa (Wren et al. 
2001). Whether these in vitro findings in stress failure apply to the paretic tendon 
is debateable as the in vivo strain at PF MVIC was lower than that reported in the 
control limbs. Resultantly, the Young’s modulus of the paretic tendon was lower 
when compared to the tendon of individuals without neurological impairment. This 
may suggest that the internal collagen and/or extracellular matrix composition of 
the tendon is altered, similar to the reported differences in the composition of the 
paretic muscle of individuals with SCP (Friden and Lieber 2003; Lieber et al. 2003; 
Lieber et al. 2004), however it is likely to be due to the large difference in tendon 
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force between groups. Maganaris et al. (2006) identified this as being a 
considerable factor when assessing the tendon properties individuals with spinal 
cord injury and presented Young’s modulus calculated at a common force 
achieved by all participants.  
 
As with previous reports examining tendon properties, the data is regularly 
presented at MVIC (Abellaneda et al. 2009; Kongsgaard et al. 2011; Kubo et al. 
2001b; Onambele et al. 2007; Onambele et al. 2006; Pearson and Onaimbele 
2006; Reeves et al. 2003). With the large between group differences in PF MVIC 
force in the present study, a standardised force (645 N) was used to examine the 
elastic properties of the tendon. The standardised force compared to the data 
obtained from PF MVIC reflects that the paretic tendon is smaller rather than more 
compliant, as evidenced by a similar tendon stiffness, Young’s modulus and higher 
a stress in the paretic limb compared to the control groups. This finding is 
consistent with the previous reports addressing the properties of the passive and 
active properties of the paretic muscle (as discussed in chapter 3 and 4). This may 
be a result of chronic loading on the tendon complex, as differing mechanical 
properties in the tendon may not be due solely to its CSA, but also improved 
structural integrity of collagen fibril packing, cross-linking and/or the ratio between 
collagen type I and III (Bailey et al. 1998; Kjær 2004; Wang 2006; Reed and Iozzo 
2002). Based on the findings from the present study, this would suggest that the 
material properties of the paretic tendon are similar to that of the non-paretic 
tendon and that of individuals without neurological impairment. This is consistent 
with SCP muscle histological (Ito et al. 1996) and passive stiffness data (Chapter 
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4), which reports no difference compared to age matched controls. Therefore any 
difference in paretic tendon elastic properties in the present study can be 
attributed to regular physical exercise and changes at PF MVIC are due to the 
force applied to the tendon and its respective size. 
 
7.6 Conclusion  
This is the first study to assess the stiffness properties of the paretic tendon in 
hemiplegic individuals with SCP, compared to the non-paretic limb and dominant 
limb of individuals without neurological impairment. At PF MVIC paretic tendon 
stiffness and Young’s modulus was found to be more compliant compared to the 
non-paretic and limb of individuals without neurological impairment. However, 
these findings are predominantly due to differences in tendon force and strain, as 
when standardised stiffness and Young’s modulus were assessed no difference 
was identified between groups. This data suggests that active individuals with SCP 
are likely to have a similar intrinsic tendon composition compared to the control 
limbs a result of regular physical exercise. 
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Chapter 8 
General discussion 
 
 
  
169 
 
The primary aim of this thesis was to ascertain the neuromuscular and tendon 
determinants of strength and range of motion (ROM) in the paretic limb of 
physically active adults with spastic cerebral palsy (SCP). Based on the existing 
literature, it is evident that there is no information available that addresses the 
underpinning neuromuscular and tendon physiology concerning muscular 
weakness and decreased ROM in the paretic limbs in adult individuals with SCP 
(Chapter 2). Prior to the work conducted in the present thesis, the majority of the 
information addressing SCP was based on children and adolescents that have 
previously been described as a sedentary population (Longmuir and Bar-Or 2000). 
In the assessment of the muscle and tendon, it has been shown that the effects of 
disuse have a negative impact on the neural and structural properties of the 
contractile and elastic structures (de Boer et al. 2007; Maganaris et al. 2006; 
Narici and Cerretelli 1998; Narici and Maganaris 2007; Sargeant et al. 1977; de 
Boer et al. 2008). This may exacerbate the severity of the SCP impairment as a 
result of the influences sedentary lifestyles have on functional performance. In 
order to address this notion of elevated impairment as a result of a sedentary 
lifestyle, the present thesis aimed to address the following aims in active men with 
SCP: 
 
1. To assess whether testing posture has an effect on the reliability of passive 
ROM and stiffness measurements of the muscle. 
2. To determine the passive ROM and stiffness properties of the paretic 
muscle, and examine whether anatomical cross sectional area (ACSA) 
and/or muscle length have an influence of the passive properties.  
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3. To ascertain the degree of muscle weakness in men with SCP, and to 
assess whether muscle size, agonist activation and/or antagonist activation 
can account for the deficits in strength. 
4. To identify whether there is a difference in paretic muscle specific force in 
vivo. 
5. To assess the in vivo structural and mechanical properties of the paretic 
tendon in men with SCP. 
 
Prior to assessing individuals with SCP, it was suggested in Chapter 2 that it was 
unknown whether different testing postures have an influence on the measure of 
passive muscle properties. In Chapter 3, the inter- and intra-test reliability was 
assessed in the prone (Morse et al. 2008a) and seated (Kay and Blazevich 2009) 
postures in the assessment of passive muscle properties in individuals without 
neurological impairment. The results showed that the prone testing posture was 
not a reliable method to use when assessing the passive properties of muscle 
stiffness. Although it was not measured, by process of elimination, it was 
estimated that heel displacement and segmental translation of the participant’s 
body during the passive dorsiflexion trial lead to large variances between testing 
day 1 and 2. The agreement between passive muscle stiffness and MTJ 
displacement were also poor, suggesting that the values obtained between the 
different postures are not comparable. In contrast, the seated posture was found 
to be a reliable measure of the passive muscular properties when statistically 
assessed by, ICC, CV and LoA. Unlike the prone posture the seated position 
controlled for the segmental translation and heel displacement simply because of 
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the back support the participant was fastened into during the passive stretch 
procedure. The specific variables identified as being reliable were; gastrocnemius 
medialis (GM) myotendinous junction (MTJ) displacement at a standardised 
passive torque and end ROM, and GM stiffness at a standardised force only.  
 
Following the first experimental study of the thesis (Chapter 3), the seated posture 
was utilised in all subsequent chapters to assess the passive muscle properties of 
the paretic limb in active adults with SCP (Chapter 4). Surprisingly and in contrary 
to the hypothesis, the results showed that the paretic muscle of active individuals 
with SCP was not different from individuals without neurological impairment in 
terms of absolute passive GM stiffness (Chapter 4), GM specific force (Chapter 6), 
and standardised GM tendon stiffness and Young’s modulus (Chapter 7). These 
results were independent of any neural influences directly confounding the 
measures as EMG (during passive protocols), and agonist and antagonist 
activation (during maximal voluntary isometric contraction (MVIC) protocols) were 
accounted for. Subsequently no difference was established between the paretic, 
non-paretic limbs and that of controls without neurological impairment, providing 
additional in vivo data to the clinical definition of active ambulatory men with 
hemiplegic SCP. However, when the passive properties of the muscle were 
quantified relative to the structural dimensions of the paretic muscle, the in vivo 
elastic modulus of the GM muscle was reported to be 2-fold stiffer than that of 
individuals without neurological impairment, which is similar to the results reported 
in children with SCP where muscle tendon unit (MTU) stiffness is higher than the 
control group (Alhusaini et al. 2010; Barber et al. 2011a; Vaz et al. 2006), however 
this is generally at the expense of reduced passive ROM, which is not the case in 
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the present cohort of active men with SCP. As no difference was identified in the in 
vivo passive strain, the increased elastic modulus was due to the increased stress 
placed upon the muscle. The greater stress was due to the smaller ACSA of the 
paretic GM of individuals with SCP. Therefore these differences from previous 
reports must be due to the activity and stretching status of physically active men 
with SCP in the present cohort. Potential mechanisms for these observations in 
passive muscle behaviour may be due to the regular effects of stretching 
‘dampening’ the stretch reflex which is typically activated particularly when the joint 
reaches end ROM as a protective feature of SCP (Sheean 2002). Additionally as 
the paretic fibres rest at a reduced sarcomere length (Friden and Lieber 2003), 
regular stretching may have altered the number of sarcomeres in series over a 
period of time permitting the increased ROM available to the present paretic limb 
without the negative effects of casting immobilisation as previously reported 
(Brouwer et al. 2000; Sargeant et al. 1977). Whilst at a cellular level, the differing 
isoforms of the titin protein within SCP muscle in may also facilitate the changes 
observed within the present study (Magid and Law 1985; Neagoe et al. 2003), 
however, further research is required to confirm whether these mechanisms do 
impact on the passive properties of the paretic muscle. 
 
In the present thesis two measures of stiffness have been included; tendon and 
passive muscle. The stiffness of the tendon is recorded during MVIC, and 
represents a functional measure to proprioception, balance and fascicular 
shortening under contraction (Maganaris et al. 2006; Onambele et al. 2006; 
Pearson and Onambele 2005), the passive stiffness represents an in vivo 
measure of the possible limitations to the diagnostic characteristic of ROM.  
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Although these measures represent the structural components of the MTU; tendon 
stiffness represents the compliance of the Achilles tendon under loading, and 
passive stiffness represents the passive components of the muscle and 
aponeurosis under stretch. Based on these distinctions, it is not surprising that 
tendon compliance is not associated with the passive properties of the muscle 
(Kubo et al. 2001a). 
 
In relation to the active properties of the muscle, Chapter 5 quantified the strength 
of the paretic muscle of individuals with SCP whilst measuring agonist activation, 
antagonist coactivation and size of the gastrocnemius, compared to individuals 
without neurological impairment. Indeed PF MVIC torque of the paretic limb was 
52% less than the torque generated by age-matched controls, which is similar to 
the findings from previous studies (Barber et al. 2012; Elder et al. 2003; 
Stackhouse et al. 2005). More interestingly, the deficit in torque within the paretic 
limb was associated with impaired activation of the gastrocnemius and to a lesser 
degree, lower muscle ACSA. Furthermore when a regression analysis was 
conducted on all of the determinants previously associated with muscle strength 
(Chapter 2), agonist activation was reported to account for 57% of the variation in 
PF MVIC torque. This data showed that agonist activation is a key determinant of 
PF MVIC torque in the paretic limb, and so is muscle ACSA but to a relatively 
lesser degree. Indeed, these findings coincide with the primary mechanism 
effecting functional performance and the severity of the impairment in individuals 
with SCP due to the lesion to the motor cortex. As a result of this central 
impairment resulting in abnormal signalling down the neural tracts, secondary 
impairments, within the skeletal muscle are established (Ito et al. 1996; Koman et 
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al. 2004; Lieber et al. 2003; Malaiya et al. 2007; McNee et al. 2009; Mohagheghi 
et al. 2007). The muscle fibre types in the paretic muscle of individuals with spinal 
cord lesion and stroke have been shown to have an increased proportion of type II 
fibres within the paretic musculature (Grimby et al. 1976; Sjostrom et al. 1980). 
This would suggest that as a result of impaired signalling to the paretic 
musculature, some motor units are unable to be innervated resulting in this 
deviation in fibre type expression and resultant fibre atrophy (Edström 1970), 
which may account for some of the differences observed in gastrocnemius size. 
With the disuse of high-threshold motor units, this would theoretically reduce the 
amount of cross bridges formed during contraction; explaining the reduced PF 
MVIC torque in the paretic musculature. 
 
The findings from Chapter 5 would suggest that during MVIC, a failure to match 
the torque of participants without neurological impairment is almost entirely 
attributable to GM ACSA and agonist activation as previously discussed. However, 
a limitation in the measurement of MVIC torque and ACSA is that they do not 
account for differences in muscle architecture, muscle size, neural activation, and 
moment arm length, unless calculated separately. Alternatively, specific force 
describes the force generating capacity of a muscle whilst accounting for all of the 
factors associated to influence force measurements (Chapter 6). The findings 
showed that the specific force of the GM was not different compared to individuals 
without neurological impairment. This data suggests that in active adults with SCP 
that there is no impairment in material properties of the muscle at fascicle level, 
which provides indirect evidence to support the theory that secondary impairments 
reported within the muscle may be a result of disuse because children with SCP 
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tend to be sedentary (Longmuir and Bar-Or 2000). Though whether this theory is 
true requires further research and should aim to directly assess whether the claims 
made in the present thesis regarding physically active vs sedentary individuals 
with SCP are accurate, now that physically active adults with SCP have been 
compared to active adults without neurological impairment. 
 
As discussed in chapter 6, there were a number of limitations within the calculation 
of specific force. Fascicle length was measured at a comparable length rather than 
the angle at which peak torque occurred (Reeves et al. 2004b), due to the fact that 
0 deg ankle angle was used to control for the different resting angles between the 
participants. As presented in individuals without neurological impairment the 
plantarflexors were on the ascending limb of the force length relation, it can be 
assumed that specific force was underestimated in the investigation (Maganaris et 
al. 2001; Morse et al. 2007b; Reeves et al. 2004b). However, in order to be able to 
compare between individuals that have limited dorsiflexion ROM, a consistent joint 
angle was chosen for the measurement of specific force at 0 degrees. In addition 
to this, in individuals without neurological impairment the difference in Achilles 
moment arm length during MVIC has been shown to be approximately 1.5 cm 
longer than when measured during rest (Maganaris et al. 1998a), which would 
have overestimated Achilles tendon force and specific force. 
 
Despite limitations in strength and range of motion often being linked with the 
contractile tissue within the paretic MTU (Alhusaini et al. 2010; Elder et al. 2003; 
Stackhouse et al. 2005; Vaz et al. 2006), the tendon plays an integral part within 
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the MTU as it deforms and transmits the contractile forces generated by the 
muscle to the bone, to enable joint movement (Maganaris and Paul 2002). The 
rate at which the force is transferred to the bone is due to the stiffness of the 
tendon structures (Reeves et al. 2003; Morse et al. 2005a; Pearson and 
Onaimbele 2006). Yet research into the in vivo structural and mechanical 
properties of the tendon in individuals with SCP is scarce. The findings from 
Chapter 7 reported that the tendon of adults with SCP at MVIC was more 
compliant than the structure of individuals without neurological impairment, and 
when Young’s modulus was examined the tendon of individuals without 
neurological impairment was double the stiffness of the paretic tendon when 
assessed at plantarflexion MVIC. However, these differences in the tendon elastic 
properties at MVIC were largely confounded by the difference in the strain and 
force generated by the paretic limb, compared to the non-paretic limb and that of 
individuals without neurological impairment. Therefore, when the properties of the 
tendon where assessed at a standardised force (645 N), the paretic tendon 
stiffness and Young’s modulus was similar to that of individuals without 
neurological impairment. Based on the data from chapter 7, it can be assumed 
that the intrinsic properties of the tendon across all experimental groups are 
similar. Tendon stress at 645 N was also greater in the paretic limb compared to 
individuals without neurological impairment as a result of the smaller CSA of the 
paretic tendon. The mechanism for this variation in the paretic tendon CSA can be 
related to data from spinal cord injuries (Maganaris et al. 2006) and training (Kubo 
et al. 2001b) studies. Kubo et al. (2001b), demonstrated that through increases in 
muscle MVIC torque and size after a 12 week isometric knee extension 
programme, the tendon stiffness and Young’s modulus properties increased as a 
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result of the training, whereas tendon CSA did not change. This relationship 
between activity and tendon stiffness is also evident when activity is reduced; for 
example, in men that have had spinal cord paralysis ranging from 1.5-24 years the 
tendon CSA decreased as a result of the sustained decrease MVIC torque and 
subsequent forces applied to the paretic tendon over a chronic period of time 
(Maganaris et al. 2006). This finding can be directly applied to the present SCP 
model where the mechanism for impaired paretic tendon CSA is as a result of 
weakness in the paretic musculature.   
 
From the data presented in this thesis (Chapters 4-7), it is clear that the primary 
impairment impacting on plantarflexor MVIC torque (Chapter 5) and GM force 
(Chapter 6) and tendon properties (Chapter 7) in individuals with SCP results from 
impaired neural communication from the central nervous system to the skeletal 
muscle, and to a lesser extent a decline in the contractile ACSA. As a result of this 
decrease in PF MVIC torque and muscle ACSA, this subsequently impacts on the 
size of the tendon (as explained later in the discussion). Although the findings 
were consistent in PF MVIC torque across chapters 4, 5, 6 and 7, there was 
inherent variability within the measure with a difference of approximately 20% 
between the trials (Table 8.1). The lowest MVC was recorded in the assessment of 
activation (Chapter 5), whereby both SCP and individuals without neurological 
impairment produced their lowest PF MVIC values compared to the other 
chapters. It is likely that this variability is one of the limitations of the interpolated 
twitch technique, and can be attributed to 1) the participants being apprehensive of 
the percutaneous electrical stimulation, and 2) the twitch application is applied 
during the plateau of an MVIC, which in this instance was lower than the MVIC 
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acquired from the trials used in Chapter 4 and 6. The lower PF MVIC value 
achieved during the tendon investigation (chapter 7), can be attributed to the lower 
torque that was achieved during an incremental or graded contraction as opposed 
to the maximal exertions during chapter 4 and 6, as has been suggested 
previously (Onambele et al. 2007). It should be noted, that although this variability 
exists during different types of PF MVIC trials, limits of agreement (3.52 ± 10.9 
Nm), CV (6.39%) and ICC (0.942) analyses demonstrated that the seated PF 
MVIC method was reliable between test days 1 and 2.  
 
Table 8.1. Variability of PF MVIC torque data from chapters 4-6. 
PF MVIC torque (Nm) Paretic limb Non-paretic limb Controls  
Chapter 4  100 (57.2)  152 (49.9) 187 (26.9) 
Chapter 5  79.5 (46.6) 138 (42.9) 167 (33.3) 
Chapter 6 102 (55.8) 153 (47.7) 190 (25.7) 
Chapter 7 83.9 (50.5) 139 (51.7) 165 (25.1) 
 
 
With regard to the GM passive properties and whilst accounting for the neural 
influences there appeared to be no limitations to passive ROM, as with the 
findings in chapter 5, 6 and 7, any difference in stiffness were attributable to 
differences in muscle size. Contrary to notions that secondary impairment within 
muscle tissue occurs as a result of the neural impairment in children with SCP, this 
thesis provides evidence to demonstrate that the material properties of the muscle 
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and tendon are likely to be similar to that of age-matched active individuals without 
neurological impairment. To confirm the assumptions in the material properties of 
the paretic MTU in physically active men with SCP, future studies should take 
biopsy samples from active and sedentary individuals with SCP to assess whether 
physical status does impair the intrinsic properties of the muscle and expression of 
proteins such as titin. Nevertheless, the results from the present thesis should be 
used as normative values for individuals that are recovering from injury or as a 
reference to refer to when examining progress after the completion of an exercise 
intervention.  
 
As stated in chapter 1, the spectrum of impairment within SCP alone is vast, 
ranging from independent and ambulant individuals that have minimal impairment 
to severely impaired patients that require care and are non-ambulatory. It is likely 
that the information presented within the current thesis applies predominantly to 
those individuals with CP that are ambulant. However, through the assessment of 
MTU function, it may be possible to determine whether similarities between 
ambulant and non-ambulant individuals with SCP exist. To help confirm the 
concepts developed from the results of this thesis, future work should compare 
physically active and sedentary individuals with SCP to ascertain whether habitual 
exercise is beneficial to the passive and/or active properties of the MTU, and 
performance tasks. It is understood that with resistance training, increases in 
muscle strength have consistently been reported in the paretic limb of children with 
SCP and linked with improved functional performance and gait (Damiano and Abel 
1998; Damiano et al. 1995a; Damiano et al. 1995b), which in part may be linked to 
increases in muscle size (McNee et al. 2009). However, these studies did not 
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provide information regarding neural, architectural and morphological adaptation to 
resistance exercise in individuals with SCP. Understanding whether or to what 
extent muscle activation and coactivation in the paretic SCP muscle adapts with 
training may provide further information into designing specific interventions to 
enhance muscular strength. In elderly individuals without neurological impairment, 
heavy resistance strength training has been showed to increase neural activation 
as measured by surface EMG (Aagaard et al. 2001). Although such findings are 
related to impaired neural signalling to the muscle as a result of disuse, whether 
this information applies to individuals with SCP has yet to be determined.  
 
In individuals with hemiplegic SCP, resistance training could benefit functional 
performance and independence based on the fact that the avoidance strategy of 
selectively loading the non-paretic limb may induce a detraining influence on the 
paretic limb. As with any disuse and reloading study (Narici and Cerretelli 1998; 
Sargeant et al. 1977; Stevens et al. 2006), there is likely to be an observable 
increase in activation in individuals with SCP who are sedentary in nature. It is 
unlikely that in the present SCP population that this activation increase would be 
observed with resistance training, as they are habitually active and familiar with 
the plantarflexor movement in both limbs. Therefore the lower activation levels in 
the present SCP cohort reflect the damage to the motor cortex and the descending 
neural pathways inherent as a result of the impairment; however this remains to be 
confirmed experimentally. 
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Within the SCP research, the mode at which strength is typically assessed is 
completed by performing isometric contractions to assess the MVIC capabilities of 
individuals with SCP at a set angle (Damiano and Abel 1998; Damiano et al. 
1995b). Although isometric contractions can provide reliable information relating to 
muscular strength, it does not provide any information on the dynamic properties 
of the contractile properties throughout the available ROM. As spasticity is defined 
as a velocity dependent resistance to stretch and is associated with impaired ROM 
and muscular weakness (Graham and Selber 2003; Sheean 2002; Sheean and 
McGuire 2009), isokinetic strength tests are able to examine the variability of these 
two variables simultaneously. Previous studies have only assessed the effects of 
strength training in relation to isokinetic strength, whereby the subsequent 
increases in isokinetic strength have been associated with gait, function (MacPhail 
and Kramer 1995; McCubbin and Shasby 1985; Sharp and Brouwer 1997).  
Similarly, the MTU of individuals without neurological impairment are suggested to 
exhibit viscous and elastic properties and have been suggested to adapt acutely to 
exercise or stretch interventions (Magnusson et al. 2008). Changes in tissue 
temperature and/or conditioning exercises have been suggested to change the 
viscoelastic properties of the muscle (Maganaris 2003; Morse et al. 2008a; 
Magnusson et al. 1997). Morse et al. (Morse et al. 2008a) reported that after five 
passive stretches (which consisted of the MTU being taken to end ROM and being 
held for 1 min), a 21% increase in MTJ displacement accounted for the entire 17% 
increase in ROM. Whether such information applies to individuals with SCP is 
debateable as the benefits of manual and passive stretching are conflicting (Pin et 
al. 2006). Although the information in stretching in SCP is limited and inconsistent, 
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improving strength through an increased functional range of motion in the paretic 
limb may improve motor function in the paretic limbs of individuals with SCP.  
 
As a result of impaired foot positioning during the swing phase of gait (Dietz et al. 
1981), increased tendon compliance at PF MVIC (Chapter 7), and muscular 
weakness (Chapter 5) it is possible that falls may occur during such day-to-day 
activities. The prevalence of injuries in elderly populations as a result of accidental 
falls is the fifth leading cause of mortality, with the aetiology resulting in weakness, 
balance deficits and gait deficiencies (Rubenstein 2006). Throughout the thesis it 
has been established that similar deficits exist in individuals with SCP. Weakness 
of individuals with SCP reside not only from inactivity, but in the paretic limbs the 
employment of avoidance strategies result in further weakening of the MTU 
(Chapter 5 and 7) and also the bone due to disuse oesteoperosis (Takata and 
Yasui 2001). Although it is evident that individuals with SCP are likely to be subject 
to an increased risk of injury, a fundamental determinant related to limiting falls 
and improving balance in elderly individuals is elastic properties of the tendon 
(Narici et al. 2005; Karamanidis et al. 2008; Onambélé et al. 2008; Onambele et 
al. 2006; Reeves 2006). Onambele et al. (2006) demonstrated that the stiffness of 
elastic component during single leg balancing trials was associated with single leg 
balance ability in elderly individuals. As elderly individuals have more compliant 
tendons at MVIC, the tendon must elongate further for any given force it is 
subjected to subsequently reducing the transmission time of the forces from the 
contractile tissue to the bone. Although it is likely that balance impairments in 
ambulant individuals with SCP are prevalent (Bax et al. 2005), further research is 
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required to determine whether this data actually applies to the participants studied 
within the present thesis. 
 
 
Conclusion  
In summary, the present thesis aimed to examine the neuromuscular determinants 
of strength and passive properties of the tendon and muscle in physically active 
men hemiplegic SCP. Prior to the investigation of the neuromuscular and tendon 
properties in individuals with SCP, an initial reliability investigation was required 
(as highlighted in Chapter 2) to discriminate between the reliability of the prone 
(Morse 2011; Morse et al. 2008a) and seated postures (Kay and Blazevich 2009) 
used to assess the passive properties of the plantarflexor musculature (Chapter 
3). The elastic properties of the muscle were examined during passive stretch 
conditions at 22 Nm (the highest passive torque attained by all participants) and 
end ROM and the inter-postural agreement between the seated and prone 
postures were too low to make any comparison between the postures. Similarly, 
the intra-postural assessment of the prone posture was found to be unreliable. The 
seated posture, however, was found to be a highly reliable posture when 
assessing GM MTJ displacement, GM stiffness and ankle angle. Although the 
results at end ROM may be subject to psychological and neural confounding 
factors (McHugh et al. 1998; McNair and Stanley 1996; Toft et al. 1989) impacting 
on GM MTJ displacement and GM stiffness measures, presenting these variables 
should be done with an understanding of the increased level of error.  
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As a direct result of the findings from chapter 3, the first experimental study on 
individuals with SCP aimed to assess the passive properties of the muscle 
(Chapter 4). Surprisingly it was identified that no impairment in ROM was 
observed, subsequently providing additional in vivo data to the clinical definition of 
individuals with SCP. When the smaller CSA of individuals with SCP was 
accounted for, the passive stress of the muscle was significantly higher than the 
contralateral non-paretic muscle and the muscle of individuals without neurological 
impairment, subsequently resulting in a stiffer elastic modulus in the paretic GM. 
Therefore, throughout the same ROM a smaller GM CSA in physically active 
adults with SCP have to dissipate larger relative torque compared to the control 
muscles, consequently causing the muscle to elongate to the same extent as the 
non-paretic muscle under stretch. In this particular physically active SCP 
population it is possible that their regular training may have facilitated these 
observed findings. 
 
Having considered the difference in the paretic GM CSA compared to the control 
groups (chapter 4), chapter 5 aimed to address the effects muscle size, activation 
and coactivation have on PF MVIC torque across the paretic, non-paretic and 
control groups. The data from active adults with hemiplegic SCP showed that 
muscle weakness as a result of muscular and neural differences in the paretic 
limb. This was confirmed as PF MVIC torque was on average 47% weaker than 
the non-paretic limb and control group. The paretic gastrocnemius ACSA was 
smaller compared to the control group, though no difference was observed 
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between paretic and non-paretic limbs. The paretic limb demonstrated an inability 
to innervate the PF muscles and increased antagonist coactivation was also 
evident when compared to the non-paretic limb and control group. Although the 
differences between the paretic limb and control group were identified, the multiple 
regression on the paretic limb identified that muscle activation was a significant 
predictor of gastrocnemius PF MVIC torque. This demonstrates that the key 
determinant of weakness in individuals with SCP is their ability to activate the 
gastrocnemius muscle, regardless of the differences identified in paretic 
gastrocnemius ACSA and antagonist coactivation. 
 
As a result of the identified neural and muscular differences in the paretic limb 
(chapter 5), the natural progression was to account for muscle size, neural, 
moment arm length and muscle architectural factors affect PF MVIC and calculate 
the intrinsic force producing capacity of the GM muscle. The findings from chapter 
6 showed that the paretic GM of physically active individuals with SCP has a 
similar specific force generating capacity to the non-paretic muscle and the GM of 
control individuals. This study also demonstrates how the pennation angle and 
fascicle length of the paretic muscle at MVIC were different from the control group. 
Nevertheless, weakness observed in the paretic GM is not due to the intrinsic 
material properties of the muscle, but because of the smaller PCSA of the muscle. 
 
As the majority of research examining SCP impairment is conducted on the active 
and passive neuromuscular properties in vivo (Chapter 4, 5 and 6), chapter 7 was 
the first study to provide data on the elastic properties of the tendon. The data 
186 
 
showed that at PF MVIC, the paretic tendon stiffness and Young’s modulus was 
found to be more compliant compared to the non-paretic and limb of individuals 
without neurological impairment. However, these findings are predominantly due 
to differences in tendon force and strain, as when standardised stiffness and 
Young’s modulus were assessed no difference was identified between groups. 
This data suggests that active individuals with SCP are likely to have a similar 
intrinsic tendon composition compared to the control limbs a result of regular 
physical exercise. 
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